Annotation Cluster 1	Enrichment Score: 4.24274965586001
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
MESH	Organophosphorus Compounds	7	58.3333333333333	8.57944930512421e-09	1241-94-7, 56803-37-3, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	145	5450	29.2337164750958	1	3.5089947657958e-06	8.57944930512421e-09
HTS_ACTIVE	cytotoxicity_RXR/agonism	9	75	0.000335198188493993	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5, 68937-41-7, 13674-87-8, 5436-43-1, 78-30-8, 79-94-7	10	1213	4173	3.0962077493817	1	0.132738482643621	0.000335198188493993
MESH	Organic Chemicals	9	75	0.065011465652838	1241-94-7, 56803-37-3, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 5436-43-1, 78-30-8, 79-94-7	9	3766	5450	1.44715878916622	1	1	0.065011465652838

Annotation Cluster 2	Enrichment Score: 3.53509781288189
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
TOXPRINT_STRUCTURE	bond:P=O_phosphate	9	75	1.67642841550388e-14	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8	11	102	8337	66.8743315508021	1	6.89012078772095e-12	1.67642841550388e-14
TOXPRINT_STRUCTURE	bond:P=O_phosphorus_oxo	9	75	1.67693881927747e-12	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8	11	179	8337	38.1071609954292	1	6.87544915903764e-10	1.67693881927747e-12
MESH	Organophosphorus Compounds	7	58.3333333333333	8.57944930512421e-09	1241-94-7, 56803-37-3, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	145	5450	29.2337164750958	1	3.5089947657958e-06	8.57944930512421e-09
LEADSCOPE_TOXICITY	Reproductive Toxicity -sperm ratPositive	7	58.3333333333333	1.59848627573718e-07	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	321	7444	18.036690896504	1	6.52182400500768e-05	1.59848627573718e-07
MULTICASE_TOX_PREDICTION	RCA fetal weight decrease, mouse	8	66.6666666666667	7.79596203552689e-07	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8	11	561	8032	10.4125749473343	1	0.000317295654845944	7.79596203552689e-07
LEADSCOPE_TOXICITY	Reproductive Toxicity -sperm rodent	7	58.3333333333333	3.1600790930524e-05	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	786	7444	7.36612948826689	1	0.0127983203268622	3.1600790930524e-05
LEADSCOPE_TOXICITY	Reproductive Toxicity -repro rat male	7	58.3333333333333	3.55318197124146e-05	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	802	7444	7.21917428650596	1	0.0143548551638155	3.55318197124146e-05
TOXPRINT_STRUCTURE	bond:P=O_phosphate_alkyl_ester	4	33.3333333333333	7.70420895068242e-05	1241-94-7, 115-96-8, 29761-21-5, 13674-87-8	11	74	8337	40.968058968059	1	0.0310479620712502	7.70420895068242e-05
MULTICASE_TOX_PREDICTION	RCA fetal death, mouse	9	75	9.73685168127724e-05	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8	11	1657	8032	3.96598452844681	1	0.0391421437587345	9.73685168127724e-05
LEADSCOPE_TOXICITY	Genetic Toxicity -mam. mutation	7	58.3333333333333	0.000114741445123192	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	982	7444	5.8959040506902	1	0.0458965780492767	0.000114741445123192
HTS_ACTIVE	cytotoxicity_MMP/inhibition	8	66.6666666666667	0.000158720865953041	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8	10	755	4173	4.42172185430464	1	0.0631709046493103	0.000158720865953041
MULTICASE_TOX_PREDICTION	MRP5 substrates	8	66.6666666666667	0.000370638955610019	56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8	11	1410	8032	4.14287556415216	1	0.146402387465957	0.000370638955610019
LEADSCOPE_TOXICITY	Genetic Toxicity -mam. mutation DL	7	58.3333333333333	0.000372237715240919	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	1206	7444	4.80081076100977	1	0.146661659804922	0.000372237715240919
TOXCAST_ACTIVE	ATG_PXR_TRANS_up	6	50	0.00213268995856035	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 79-94-7	6	505	1723	3.41188118811881	1	0.827483703921416	0.00213268995856035
LEADSCOPE_TOXICITY	Reproductive Toxicity -repro rodent male	6	50	0.00397137093481346	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 78-30-8	9	1202	7444	4.12867443150305	1	1	0.00397137093481346
MULTICASE_TOX_PREDICTION	Draize skin test, 24h, rabbit	10	83.3333333333333	0.00738941398488533	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8, 79-94-7	11	3682	8032	1.98311194508913	1	1	0.00738941398488533
TOXCAST_ACTIVE	NVS_MP_rPBR	4	33.3333333333333	0.0166583393847118	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	219	1723	5.24505327245053	1	1	0.0166583393847118
TOXCAST_ACTIVE	NVS_MP_hPBR	4	33.3333333333333	0.0170883452769438	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	221	1723	5.19758672699849	1	1	0.0170883452769438
CTD_CHEMICALS_DISEASES	Mesothelioma	4	33.3333333333333	0.0208934792889723	1241-94-7, 115-86-6, 13674-87-8, 78-30-8	7	944	8530	5.1634382566586	1	1	0.0208934792889723
HTS_ACTIVE	antagonism_RORr	5	41.6666666666667	0.0301209311786568	56803-37-3, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8	10	605	4173	3.44876033057851	1	1	0.0301209311786568
TOXCAST_ACTIVE	ATG_PXRE_CIS_up	6	50	0.0624572884773724	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 79-94-7	6	881	1723	1.95573212258797	1	1	0.0624572884773724
LEADSCOPE_TOXICITY	Genetic Toxicity -s. cerevisiae	4	33.3333333333333	0.0693412894135144	1330-78-5, 115-86-6, 115-96-8, 13674-87-8	9	942	7444	3.51214909176693	1	1	0.0693412894135144
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
MULTICASE_TOX_PREDICTION	Draize eye irritation test, rabbit	8	66.6666666666667	0.527339053690464	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 78-30-8, 79-94-7	11	4428	8032	1.31920834359859	1	1	0.527339053690464
MULTICASE_TOX_PREDICTION	MCT1 inhibition at 10uM	11	91.6666666666667	0.617041048684598	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 5436-43-1, 78-30-8, 79-94-7	11	7105	8032	1.13047149894441	1	1	0.617041048684598
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro other cells	5	41.6666666666667	0.722334473944609	1241-94-7, 115-86-6, 29761-21-5, 13674-87-8, 78-30-8	9	3012	7444	1.37302641286705	1	1	0.722334473944609
MULTICASE_TOX_PREDICTION	MRP5 inhibition at 50uM	11	91.6666666666667	1	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 5436-43-1, 78-30-8, 79-94-7	11	7642	8032	1.0510337607956	1	1	1

Annotation Cluster 3	Enrichment Score: 2.67990654532515
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
MESH	Organophosphorus Compounds	7	58.3333333333333	8.57944930512421e-09	1241-94-7, 56803-37-3, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	145	5450	29.2337164750958	1	3.5089947657958e-06	8.57944930512421e-09
LEADSCOPE_TOXICITY	Reproductive Toxicity -sperm ratPositive	7	58.3333333333333	1.59848627573718e-07	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	321	7444	18.036690896504	1	6.52182400500768e-05	1.59848627573718e-07
LEADSCOPE_TOXICITY	Reproductive Toxicity -sperm rodent	7	58.3333333333333	3.1600790930524e-05	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	786	7444	7.36612948826689	1	0.0127983203268622	3.1600790930524e-05
LEADSCOPE_TOXICITY	Reproductive Toxicity -repro rat male	7	58.3333333333333	3.55318197124146e-05	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	802	7444	7.21917428650596	1	0.0143548551638155	3.55318197124146e-05
LEADSCOPE_TOXICITY	Genetic Toxicity -mam. mutation	7	58.3333333333333	0.000114741445123192	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	982	7444	5.8959040506902	1	0.0458965780492767	0.000114741445123192
HTS_ACTIVE	cytotoxicity_MMP/inhibition	8	66.6666666666667	0.000158720865953041	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8	10	755	4173	4.42172185430464	1	0.0631709046493103	0.000158720865953041
LEADSCOPE_TOXICITY	Genetic Toxicity -mam. mutation DL	7	58.3333333333333	0.000372237715240919	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	1206	7444	4.80081076100977	1	0.146661659804922	0.000372237715240919
CTD_CHEMICALS_DISEASES	Mesothelioma	4	33.3333333333333	0.0208934792889723	1241-94-7, 115-86-6, 13674-87-8, 78-30-8	7	944	8530	5.1634382566586	1	1	0.0208934792889723
TOXCAST_ACTIVE	ATG_NURR1_TRANS_up	3	25	0.0238269019325617	1241-94-7, 115-86-6, 13674-87-8	6	89	1723	9.67977528089888	1	1	0.0238269019325617
CTD_CHEMICALS_DISEASES	Carcinoma, Transitional Cell	3	25	0.105998495922242	1241-94-7, 115-86-6, 13674-87-8	7	817	8530	4.47455848924637	1	1	0.105998495922242
CTD_CHEMICALS_DISEASES	Hepatitis, Chronic	3	25	0.114438124362943	115-86-6, 13674-87-8, 78-30-8	7	854	8530	4.28069588491134	1	1	0.114438124362943
TOXCAST_ACTIVE	ATG_BRE_CIS_up	3	25	0.169464633348553	1241-94-7, 115-86-6, 13674-87-8	6	263	1723	3.27566539923954	1	1	0.169464633348553
CTD_CHEMICALS_DISEASES	Precancerous Conditions	3	25	0.222792806539573	1241-94-7, 115-86-6, 78-30-8	7	1277	8530	2.8627363239736	1	1	0.222792806539573
CTD_CHEMICALS_DISEASES	Brain Ischemia	3	25	0.239698144481177	115-86-6, 13674-87-8, 78-30-8	7	1338	8530	2.73222293401666	1	1	0.239698144481177
TOXCAST_ACTIVE	ATG_AP_1_CIS_up	3	25	0.32099982906382	1241-94-7, 115-86-6, 13674-87-8	6	393	1723	2.19211195928753	1	1	0.32099982906382
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro other cells	5	41.6666666666667	0.722334473944609	1241-94-7, 115-86-6, 29761-21-5, 13674-87-8, 78-30-8	9	3012	7444	1.37302641286705	1	1	0.722334473944609

Annotation Cluster 4	Enrichment Score: 2.34064677144254
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
MESH	Organophosphorus Compounds	7	58.3333333333333	8.57944930512421e-09	1241-94-7, 56803-37-3, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	145	5450	29.2337164750958	1	3.5089947657958e-06	8.57944930512421e-09
MESH	Organophosphates	5	41.6666666666667	1.02767421516633e-06	1241-94-7, 56803-37-3, 115-86-6, 115-96-8, 78-30-8	9	62	5450	48.8351254480287	1	0.000417235731357528	1.02767421516633e-06
CTD_CHEMICALS_DISEASES	Metabolism, Inborn Errors	3	25	0.0124254744366084	1241-94-7, 56803-37-3, 115-86-6	7	256	8530	14.2801339285714	1	1	0.0124254744366084
CTD_CHEMICALS_DISEASES	Osteoarthritis	3	25	0.134343303374012	1241-94-7, 56803-37-3, 78-30-8	7	938	8530	3.89734998477003	1	1	0.134343303374012
CTD_CHEMICALS_DISEASES	Nerve Degeneration	3	25	0.212379150477592	1241-94-7, 56803-37-3, 78-30-8	7	1239	8530	2.95053614666205	1	1	0.212379150477592
CTD_CHEMICALS_DISEASES	Precancerous Conditions	3	25	0.222792806539573	1241-94-7, 115-86-6, 78-30-8	7	1277	8530	2.8627363239736	1	1	0.222792806539573
CTD_CHEMICALS_DISEASES	Fatty Liver	3	25	0.270376479692687	1241-94-7, 56803-37-3, 78-30-8	7	1447	8530	2.5264093197749	1	1	0.270376479692687
CTD_CHEMICALS_DISEASES	Hypertension	3	25	1	1241-94-7, 56803-37-3, 115-86-6	7	2494	8530	1.46580364302898	1	1	1

Annotation Cluster 5	Enrichment Score: 1.69103823882993
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEM2GENE_25	AR	4	33.3333333333333	0.000415679053734167	115-86-6, 115-96-8, 13674-87-8, 79-94-7	7	190	6732	20.2466165413534	1	0.163361868117527	0.000415679053734167
TOXCAST_ACTIVE	OT_AR_ARSRC1_0960	5	41.6666666666667	0.00100950823203153	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	212	1723	6.77279874213836	1	0.395727226956358	0.00100950823203153
TOXCAST_ACTIVE	ATG_GLI_CIS_up	4	33.3333333333333	0.00174289726900597	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	100	1723	11.4866666666667	1	0.677987037643323	0.00174289726900597
TOXCAST_ACTIVE	ATG_PXR_TRANS_up	6	50	0.00213268995856035	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 79-94-7	6	505	1723	3.41188118811881	1	0.827483703921416	0.00213268995856035
LEADSCOPE_TOXICITY	Reproductive Toxicity -repro rodent male	6	50	0.00397137093481346	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 78-30-8	9	1202	7444	4.12867443150305	1	1	0.00397137093481346
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_0480	5	41.6666666666667	0.00568927368704165	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	331	1723	4.33786505538771	1	1	0.00568927368704165
TOXCAST_ACTIVE	ATG_HSE_CIS_up	4	33.3333333333333	0.0162350265450611	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	217	1723	5.29339477726574	1	1	0.0162350265450611
TOXCAST_ACTIVE	NVS_MP_rPBR	4	33.3333333333333	0.0166583393847118	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	219	1723	5.24505327245053	1	1	0.0166583393847118
TOXCAST_ACTIVE	NVS_MP_hPBR	4	33.3333333333333	0.0170883452769438	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	221	1723	5.19758672699849	1	1	0.0170883452769438
TOXCAST_ACTIVE	ATG_Pax6_CIS_up	4	33.3333333333333	0.0249028500560272	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	253	1723	4.54018445322793	1	1	0.0249028500560272
TOXCAST_ACTIVE	ATG_VDRE_CIS_up	5	41.6666666666667	0.0295241637447702	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	512	1723	2.80436197916667	1	1	0.0295241637447702
TOXCAST_ACTIVE	ATG_PPARg_TRANS_up	5	41.6666666666667	0.0297380450297806	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	513	1723	2.79889538661468	1	1	0.0297380450297806
TOXCAST_ACTIVE	ATG_EGR_CIS_up	4	33.3333333333333	0.0338900667088663	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	283	1723	4.05889281507656	1	1	0.0338900667088663
TOXCAST_ACTIVE	ATG_Xbp1_CIS_up	4	33.3333333333333	0.0379515964026503	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	295	1723	3.89378531073446	1	1	0.0379515964026503
TOXCAST_ACTIVE	ATG_SREBP_CIS_up	4	33.3333333333333	0.0543256667044474	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	337	1723	3.40850642927794	1	1	0.0543256667044474
TOXCAST_ACTIVE	ATG_CMV_CIS_up	4	33.3333333333333	0.0605405838861071	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	351	1723	3.27255460588794	1	1	0.0605405838861071
TOXCAST_ACTIVE	ATG_PXRE_CIS_up	6	50	0.0624572884773724	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 79-94-7	6	881	1723	1.95573212258797	1	1	0.0624572884773724
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_ratio	4	33.3333333333333	0.0676228400695797	1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	366	1723	3.1384335154827	1	1	0.0676228400695797
LEADSCOPE_TOXICITY	Genetic Toxicity -s. cerevisiae	4	33.3333333333333	0.0693412894135144	1330-78-5, 115-86-6, 115-96-8, 13674-87-8	9	942	7444	3.51214909176693	1	1	0.0693412894135144
TOXCAST_ACTIVE	ATG_Oct_MLP_CIS_up	4	33.3333333333333	0.0695855050622816	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	370	1723	3.1045045045045	1	1	0.0695855050622816
TOXCAST_ACTIVE	ATG_MRE_CIS_up	4	33.3333333333333	0.0955624198937236	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	418	1723	2.74800637958533	1	1	0.0955624198937236
TOXCAST_ACTIVE	ACEA_T47D_80hr_Negative	4	33.3333333333333	0.117945552783321	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	454	1723	2.53010279001468	1	1	0.117945552783321
CTD_CHEMICALS_DISEASES	Breast Neoplasms	4	33.3333333333333	0.368996149713612	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	7	2515	8530	1.93808577108776	1	1	0.368996149713612

Annotation Cluster 6	Enrichment Score: 1.33485337162329
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Lipoid congenital adrenal hyperplasia	3	25	0.00222115157849881	1330-78-5, 115-86-6, 79-94-7	7	106	8530	34.4878706199461	1	0.859585660879039	0.00222115157849881
MULTICASE_TOX_PREDICTION	Tox21 ARE activation assay, strong and weak actives by NIEHS calls, research only	8	66.6666666666667	0.0148498046822874	56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	2553	8032	2.28807463590072	1	1	0.0148498046822874
CTD_CHEMICALS_DISEASES	Leukemia, Myeloid, Acute	3	25	0.0711880957448779	56803-37-3, 1330-78-5, 115-86-6	7	652	8530	5.60692375109553	1	1	0.0711880957448779
MULTICASE_TOX_PREDICTION	Dendritic cell activation at 1mM (CD86, CD54)	3	25	0.123282273160931	56803-37-3, 5436-43-1, 79-94-7	11	3656	8032	0.599164511637159	1	1	0.123282273160931
CTD_CHEMICALS_DISEASES	Mammary Neoplasms, Animal	3	25	0.149635793996989	56803-37-3, 1330-78-5, 115-86-6	7	1000	8530	3.65571428571429	1	1	0.149635793996989
HTS_ACTIVE	inhibition_MMP	5	41.6666666666667	0.226067082555815	56803-37-3, 1330-78-5, 115-86-6, 5436-43-1, 79-94-7	10	967	4173	2.15770423991727	1	1	0.226067082555815

Annotation Cluster 7	Enrichment Score: 1.29925611695554
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Amino Acid Metabolism, Inborn Errors	4	33.3333333333333	0.000100525141835556	56803-37-3, 115-86-6, 13674-87-8, 79-94-7	7	149	8530	32.7133269415149	1	0.0403105818760578	0.000100525141835556
CTD_CHEMICALS_DISEASES	Osteosarcoma	4	33.3333333333333	0.0356310624676759	1241-94-7, 56803-37-3, 13674-87-8, 78-30-8	7	1150	8530	4.23850931677019	1	1	0.0356310624676759
CTD_CHEMICALS_DISEASES	Neuroblastoma	3	25	0.103084274367938	56803-37-3, 1330-78-5, 13674-87-8	7	804	8530	4.54690831556503	1	1	0.103084274367938
HTS_ACTIVE	antagonism_AR/partial	4	33.3333333333333	0.162322514675193	56803-37-3, 115-86-6, 68937-41-7, 13674-87-8	10	667	4173	2.50254872563718	1	1	0.162322514675193
CTD_CHEMICALS_DISEASES	Hernia, Diaphragmatic	2	16.6666666666667	0.444971700580699	56803-37-3, 13674-87-8	7	797	8530	3.05789568022943	1	1	0.444971700580699
CTD_CHEMICALS_DISEASES	Dermatitis, Contact	2	16.6666666666667	0.600421533481959	56803-37-3, 13674-87-8	7	1209	8530	2.01583362873685	1	1	0.600421533481959

Annotation Cluster 8	Enrichment Score: 1.24626041268265
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
HTS_ACTIVE	cytotoxicity_RXR/agonism	9	75	0.000335198188493993	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5, 68937-41-7, 13674-87-8, 5436-43-1, 78-30-8, 79-94-7	10	1213	4173	3.0962077493817	1	0.132738482643621	0.000335198188493993
MULTICASE_TOX_PREDICTION	Tox21 ARE activation assay, strong and weak actives by NIEHS calls, research only	8	66.6666666666667	0.0148498046822874	56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	2553	8032	2.28807463590072	1	1	0.0148498046822874
MULTICASE_TOX_PREDICTION	Tox21 ARE activation assay, only strong actives by NIEHS calls, research only	7	58.3333333333333	0.0174833861564937	56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 78-30-8, 79-94-7	11	1961	8032	2.60646238004729	1	1	0.0174833861564937
TOXPRINT_STRUCTURE	ring:aromatic_benzene	9	75	0.20121315842408	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	4611	8337	1.47932808895724	1	1	0.20121315842408
HTS_ACTIVE	activation_Nrf2	5	41.6666666666667	0.268157833148037	56803-37-3, 115-86-6, 29761-21-5, 78-30-8, 79-94-7	10	1141	4173	1.82865907099036	1	1	0.268157833148037
MULTICASE_TOX_PREDICTION	Draize eye irritation test, rabbit	8	66.6666666666667	0.527339053690464	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 78-30-8, 79-94-7	11	4428	8032	1.31920834359859	1	1	0.527339053690464
MULTICASE_TOX_PREDICTION	Local lymph node assay, mouse, weak sensitizers (EC3 < 100%)	6	50	0.762767807673666	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5, 78-30-8, 79-94-7	11	4397	8032	0.99638183058697	1	1	0.762767807673666

Annotation Cluster 9	Enrichment Score: 1.23325345668226
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Amino Acid Metabolism, Inborn Errors	4	33.3333333333333	0.000100525141835556	56803-37-3, 115-86-6, 13674-87-8, 79-94-7	7	149	8530	32.7133269415149	1	0.0403105818760578	0.000100525141835556
CTD_CHEMICALS_DISEASES	Lipodystrophy, Familial Partial	4	33.3333333333333	0.00029045031377117	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	213	8530	22.8839704896043	1	0.115308774567154	0.00029045031377117
CTD_CHEMICALS_DISEASES	Metabolism, Inborn Errors	3	25	0.0124254744366084	1241-94-7, 56803-37-3, 115-86-6	7	256	8530	14.2801339285714	1	1	0.0124254744366084
CTD_CHEMICALS_DISEASES	Cholestasis	4	33.3333333333333	0.0345646412420798	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6	7	1137	8530	4.28697072496545	1	1	0.0345646412420798
CTD_CHEMICALS_DISEASES	Leukemia, Myeloid, Acute	3	25	0.0711880957448779	56803-37-3, 1330-78-5, 115-86-6	7	652	8530	5.60692375109553	1	1	0.0711880957448779
TOXPRINT_STRUCTURE	ring:aromatic_phenyl	4	33.3333333333333	0.143050431796434	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1128	8337	2.68762088974855	1	1	0.143050431796434
CTD_CHEMICALS_DISEASES	Mammary Neoplasms, Animal	3	25	0.149635793996989	56803-37-3, 1330-78-5, 115-86-6	7	1000	8530	3.65571428571429	1	1	0.149635793996989
HTS_ACTIVE	antagonism_AR/partial	4	33.3333333333333	0.162322514675193	56803-37-3, 115-86-6, 68937-41-7, 13674-87-8	10	667	4173	2.50254872563718	1	1	0.162322514675193
CTD_CHEMICALS_DISEASES	Amyloidosis	2	16.6666666666667	0.192776738182884	56803-37-3, 115-86-6	7	299	8530	8.15097945532728	1	1	0.192776738182884
CTD_CHEMICALS_DISEASES	Carcinoma, Hepatocellular	4	33.3333333333333	0.361646452376679	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	2428	8530	2.00753118380795	1	1	0.361646452376679
MULTICASE_TOX_PREDICTION	MRP3 inhibition at 10uM	4	33.3333333333333	0.429302922086973	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1606	8032	1.81863466545907	1	1	0.429302922086973
CTD_CHEMICALS_DISEASES	Obesity	2	16.6666666666667	1	56803-37-3, 115-86-6	7	2317	8530	1.05185276527529	1	1	1
CTD_CHEMICALS_DISEASES	Hypertension	3	25	1	1241-94-7, 56803-37-3, 115-86-6	7	2494	8530	1.46580364302898	1	1	1

Annotation Cluster 10	Enrichment Score: 1.21352195044554
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Female Urogenital Diseases	4	33.3333333333333	0.000136197562539554	56803-37-3, 1330-78-5, 78-30-8, 79-94-7	7	165	8530	29.5411255411255	1	0.0543428274532821	0.000136197562539554
CTD_CHEMICALS_DISEASES	Lipoid congenital adrenal hyperplasia	3	25	0.00222115157849881	1330-78-5, 115-86-6, 79-94-7	7	106	8530	34.4878706199461	1	0.859585660879039	0.00222115157849881
CTD_CHEMICALS_DISEASES	Amyotrophic Lateral Sclerosis	4	33.3333333333333	0.00644174598842861	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	619	8530	7.87445188091392	1	1	0.00644174598842861
CTD_CHEMICALS_DISEASES	Atherosclerosis	4	33.3333333333333	0.0454045866275776	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	1260	8530	3.86848072562358	1	1	0.0454045866275776
CTD_CHEMICALS_DISEASES	Recurrence	3	25	0.0490735368528514	1330-78-5, 78-30-8, 79-94-7	7	531	8530	6.88458434221146	1	1	0.0490735368528514
CTD_CHEMICALS_DISEASES	Gallbladder Neoplasms	3	25	0.0499228202390836	1241-94-7, 1330-78-5, 79-94-7	7	536	8530	6.82036247334755	1	1	0.0499228202390836
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_ratio	4	33.3333333333333	0.0676228400695797	1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	366	1723	3.1384335154827	1	1	0.0676228400695797
CTD_CHEMICALS_DISEASES	Spinal Cord Injuries	3	25	0.103978064079227	1330-78-5, 13674-87-8, 79-94-7	7	808	8530	4.52439886845827	1	1	0.103978064079227
CTD_CHEMICALS_DISEASES	Ischemic Attack, Transient	2	16.6666666666667	0.224613869077806	1330-78-5, 79-94-7	7	354	8530	6.88458434221146	1	1	0.224613869077806
CTD_CHEMICALS_DISEASES	Nervous System Diseases	3	25	0.286887550236254	1330-78-5, 78-30-8, 79-94-7	7	1505	8530	2.42904603701946	1	1	0.286887550236254
CTD_CHEMICALS_DISEASES	Hepatitis, Alcoholic	2	16.6666666666667	0.36998998969574	1330-78-5, 79-94-7	7	632	8530	3.85623869801085	1	1	0.36998998969574
TOXCAST_ACTIVE	OT_NURR1_NURR1RXRa_0480	2	16.6666666666667	0.376187195882305	1330-78-5, 79-94-7	6	155	1723	3.70537634408602	1	1	0.376187195882305
MULTICASE_TOX_PREDICTION	MRP2 substrates	4	33.3333333333333	0.749752598695028	56803-37-3, 1330-78-5, 68937-41-7, 79-94-7	11	3118	8032	0.936731004723308	1	1	0.749752598695028
CTD_CHEMICALS_DISEASES	Liver Diseases	2	16.6666666666667	1	1330-78-5, 79-94-7	7	1373	8530	1.77504942253668	1	1	1

Annotation Cluster 11	Enrichment Score: 1.19842936949975
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEM2GENE_25	AR	4	33.3333333333333	0.000415679053734167	115-86-6, 115-96-8, 13674-87-8, 79-94-7	7	190	6732	20.2466165413534	1	0.163361868117527	0.000415679053734167
TOXINS_TARGETS	BE0000132	2	16.6666666666667	0.0514204545454545	115-96-8, 79-94-7	2	181	3520	19.4475138121547	1	1	0.0514204545454545
CTD_CHEM2DISEASE	Hemorrhage	2	16.6666666666667	0.129920333658279	115-96-8, 79-94-7	5	186	5441	11.7010752688172	1	1	0.129920333658279
CTD_CHEM2DISEASE	Necrosis	2	16.6666666666667	0.366675567758732	115-96-8, 79-94-7	5	587	5441	3.7076660988075	1	1	0.366675567758732
TOXPRINT_STRUCTURE	bond:X[any]_halide	4	33.3333333333333	1	115-96-8, 13674-87-8, 5436-43-1, 79-94-7	11	2431	8337	1.24707378183314	1	1	1

Annotation Cluster 12	Enrichment Score: 1.16057893744888
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
TOXPRINT_STRUCTURE	bond:P=O_phosphate_alkyl_ester	4	33.3333333333333	7.70420895068242e-05	1241-94-7, 115-96-8, 29761-21-5, 13674-87-8	11	74	8337	40.968058968059	1	0.0310479620712502	7.70420895068242e-05
CTD_CHEMICALS_DISEASES	Lipodystrophy, Familial Partial	4	33.3333333333333	0.00029045031377117	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	213	8530	22.8839704896043	1	0.115308774567154	0.00029045031377117
TOXCAST_ACTIVE	ATG_GLI_CIS_up	4	33.3333333333333	0.00174289726900597	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	100	1723	11.4866666666667	1	0.677987037643323	0.00174289726900597
TOXCAST_ACTIVE	ATG_NRF1_CIS_up	3	25	0.0100867459159611	1241-94-7, 13674-87-8, 79-94-7	6	57	1723	15.1140350877193	1	1	0.0100867459159611
CTD_CHEMICALS_DISEASES	Arsenic Poisoning	4	33.3333333333333	0.0105298959712323	1241-94-7, 13674-87-8, 78-30-8, 79-94-7	7	737	8530	6.61368482264005	1	1	0.0105298959712323
CTD_CHEMICALS_DISEASES	Metabolism, Inborn Errors	3	25	0.0124254744366084	1241-94-7, 56803-37-3, 115-86-6	7	256	8530	14.2801339285714	1	1	0.0124254744366084
TOXCAST_ACTIVE	ATG_TAL_CIS_up	3	25	0.015029803571089	1241-94-7, 115-86-6, 79-94-7	6	70	1723	12.3071428571429	1	1	0.015029803571089
TOXCAST_ACTIVE	ATG_HSE_CIS_up	4	33.3333333333333	0.0162350265450611	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	217	1723	5.29339477726574	1	1	0.0162350265450611
TOXCAST_ACTIVE	NVS_MP_rPBR	4	33.3333333333333	0.0166583393847118	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	219	1723	5.24505327245053	1	1	0.0166583393847118
TOXCAST_ACTIVE	NVS_MP_hPBR	4	33.3333333333333	0.0170883452769438	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	221	1723	5.19758672699849	1	1	0.0170883452769438
CTD_CHEMICALS_DISEASES	Mesothelioma	4	33.3333333333333	0.0208934792889723	1241-94-7, 115-86-6, 13674-87-8, 78-30-8	7	944	8530	5.1634382566586	1	1	0.0208934792889723
TOXCAST_ACTIVE	ATG_NURR1_TRANS_up	3	25	0.0238269019325617	1241-94-7, 115-86-6, 13674-87-8	6	89	1723	9.67977528089888	1	1	0.0238269019325617
TOXCAST_ACTIVE	ATG_Pax6_CIS_up	4	33.3333333333333	0.0249028500560272	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	253	1723	4.54018445322793	1	1	0.0249028500560272
CTD_CHEMICALS_DISEASES	Carcinoma, Ductal	3	25	0.0268788306795404	1241-94-7, 13674-87-8, 79-94-7	7	384	8530	9.52008928571428	1	1	0.0268788306795404
TOXCAST_ACTIVE	ATG_Myc_CIS_up	3	25	0.032009704727301	1241-94-7, 13674-87-8, 79-94-7	6	104	1723	8.28365384615385	1	1	0.032009704727301
TOXCAST_ACTIVE	ATG_EGR_CIS_up	4	33.3333333333333	0.0338900667088663	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	283	1723	4.05889281507656	1	1	0.0338900667088663
CTD_CHEMICALS_DISEASES	Cholestasis	4	33.3333333333333	0.0345646412420798	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6	7	1137	8530	4.28697072496545	1	1	0.0345646412420798
CTD_CHEMICALS_DISEASES	Osteosarcoma	4	33.3333333333333	0.0356310624676759	1241-94-7, 56803-37-3, 13674-87-8, 78-30-8	7	1150	8530	4.23850931677019	1	1	0.0356310624676759
TOXCAST_ACTIVE	ATG_Xbp1_CIS_up	4	33.3333333333333	0.0379515964026503	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	295	1723	3.89378531073446	1	1	0.0379515964026503
CTD_CHEMICALS_DISEASES	Adrenocortical Carcinoma	3	25	0.0413816771691881	1241-94-7, 115-86-6, 79-94-7	7	484	8530	7.55312868949233	1	1	0.0413816771691881
TOXCAST_ACTIVE	ATG_TA_CIS_up	3	25	0.0520782531109114	1241-94-7, 115-86-6, 79-94-7	6	135	1723	6.38148148148148	1	1	0.0520782531109114
TOXCAST_ACTIVE	ATG_SREBP_CIS_up	4	33.3333333333333	0.0543256667044474	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	337	1723	3.40850642927794	1	1	0.0543256667044474
TOXCAST_ACTIVE	ATG_CMV_CIS_up	4	33.3333333333333	0.0605405838861071	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	351	1723	3.27255460588794	1	1	0.0605405838861071
CTD_CHEMICALS_DISEASES	Carotid Artery Diseases	3	25	0.0607423904090286	1241-94-7, 1330-78-5, 115-86-6	7	597	8530	6.12347451543431	1	1	0.0607423904090286
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_1440	3	25	0.0624173669639862	1241-94-7, 1330-78-5, 13674-87-8	6	149	1723	5.78187919463087	1	1	0.0624173669639862
TOXCAST_ACTIVE	ATG_Oct_MLP_CIS_up	4	33.3333333333333	0.0695855050622816	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	370	1723	3.1045045045045	1	1	0.0695855050622816
TOXCAST_ACTIVE	ATG_NFI_CIS_up	3	25	0.0835020597426603	1241-94-7, 13674-87-8, 79-94-7	6	175	1723	4.92285714285714	1	1	0.0835020597426603
TOXCAST_ACTIVE	ATG_MRE_CIS_up	4	33.3333333333333	0.0955624198937236	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	418	1723	2.74800637958533	1	1	0.0955624198937236
CTD_CHEMICALS_DISEASES	Carcinoma, Transitional Cell	3	25	0.105998495922242	1241-94-7, 115-86-6, 13674-87-8	7	817	8530	4.47455848924637	1	1	0.105998495922242
TOXPRINT_STRUCTURE	chain:alkaneBranch_isopropyl_C3	4	33.3333333333333	0.111777577542643	1241-94-7, 29761-21-5, 68937-41-7, 13674-87-8	11	1013	8337	2.99273086242484	1	1	0.111777577542643
TOXCAST_ACTIVE	ATG_Sp1_CIS_up	3	25	0.117216427015461	1241-94-7, 13674-87-8, 79-94-7	6	212	1723	4.06367924528302	1	1	0.117216427015461
TOXCAST_ACTIVE	ACEA_T47D_80hr_Negative	4	33.3333333333333	0.117945552783321	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	454	1723	2.53010279001468	1	1	0.117945552783321
TOXPRINT_STRUCTURE	ring:aromatic_phenyl	4	33.3333333333333	0.143050431796434	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1128	8337	2.68762088974855	1	1	0.143050431796434
TOXCAST_ACTIVE	ATG_BRE_CIS_up	3	25	0.169464633348553	1241-94-7, 115-86-6, 13674-87-8	6	263	1723	3.27566539923954	1	1	0.169464633348553
CTD_CHEMICALS_DISEASES	Psoriasis	3	25	0.175492833125261	1241-94-7, 1330-78-5, 13674-87-8	7	1101	8530	3.32035811599844	1	1	0.175492833125261
CTD_CHEMICALS_DISEASES	Penile Neoplasms	2	16.6666666666667	0.176753451764324	1241-94-7, 13674-87-8	7	272	8530	8.96008403361344	1	1	0.176753451764324
CTD_CHEMICALS_DISEASES	Thyroid Neoplasms	3	25	0.180999823066886	1241-94-7, 1330-78-5, 115-86-6	7	1122	8530	3.25821237585943	1	1	0.180999823066886
CTD_CHEMICALS_DISEASES	Hypercholesterolemia	2	16.6666666666667	0.220049150648394	1241-94-7, 115-86-6	7	346	8530	7.04376548307184	1	1	0.220049150648394
CTD_CHEMICALS_DISEASES	Precancerous Conditions	3	25	0.222792806539573	1241-94-7, 115-86-6, 78-30-8	7	1277	8530	2.8627363239736	1	1	0.222792806539573
TOXCAST_ACTIVE	ATG_PPRE_CIS_up	3	25	0.295491396951537	1241-94-7, 115-86-6, 79-94-7	6	372	1723	2.31586021505376	1	1	0.295491396951537
TOXCAST_ACTIVE	ATG_AP_1_CIS_up	3	25	0.32099982906382	1241-94-7, 115-86-6, 13674-87-8	6	393	1723	2.19211195928753	1	1	0.32099982906382
CTD_CHEMICALS_DISEASES	Carcinoma, Hepatocellular	4	33.3333333333333	0.361646452376679	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	2428	8530	2.00753118380795	1	1	0.361646452376679
CTD_CHEMICALS_DISEASES	Breast Neoplasms	4	33.3333333333333	0.368996149713612	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	7	2515	8530	1.93808577108776	1	1	0.368996149713612
TOXCAST_ACTIVE	ATG_HIF1a_CIS_up	2	16.6666666666667	0.411223785361343	1241-94-7, 13674-87-8	6	173	1723	3.31984585741811	1	1	0.411223785361343
MULTICASE_TOX_PREDICTION	MRP3 inhibition at 10uM	4	33.3333333333333	0.429302922086973	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1606	8032	1.81863466545907	1	1	0.429302922086973
TOXCAST_ACTIVE	OT_ER_ERaERb_0480	2	16.6666666666667	0.502028584380322	1241-94-7, 115-86-6	6	224	1723	2.56398809523809	1	1	0.502028584380322
TOXCAST_ACTIVE	Tox21_TR_LUC_GH3_Antagonist	3	25	0.610467510819369	1241-94-7, 13674-87-8, 79-94-7	6	450	1723	1.91444444444444	1	1	0.610467510819369
TOXCAST_ACTIVE	ATG_ERE_CIS_up	3	25	0.661896834740386	1241-94-7, 1330-78-5, 115-86-6	6	559	1723	1.54114490161002	1	1	0.661896834740386
TOXCAST_ACTIVE	ATG_NRF2_ARE_CIS_up	3	25	1	1241-94-7, 115-86-6, 79-94-7	6	747	1723	1.15327978580991	1	1	1
CTD_CHEMICALS_DISEASES	Pancreatic Neoplasms	2	16.6666666666667	1	1241-94-7, 115-86-6	7	1256	8530	1.94040036396724	1	1	1
CTD_CHEMICALS_DISEASES	Hypertension	3	25	1	1241-94-7, 56803-37-3, 115-86-6	7	2494	8530	1.46580364302898	1	1	1
MULTICASE_TOX_PREDICTION	BSEP substrates	2	16.6666666666667	1	1241-94-7, 13674-87-8	11	1286	8032	1.13558603138696	1	1	1

Annotation Cluster 13	Enrichment Score: 1.12691756310778
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Disorder of Sex Development, 46,XY	3	25	0.00150208046295306	1330-78-5, 115-86-6, 78-30-8	7	87	8530	42.0197044334975	1	0.587313461014645	0.00150208046295306
CTD_CHEMICALS_DISEASES	Lipoid congenital adrenal hyperplasia	3	25	0.00222115157849881	1330-78-5, 115-86-6, 79-94-7	7	106	8530	34.4878706199461	1	0.859585660879039	0.00222115157849881
TOXCAST_ACTIVE	NVS_MP_rPBR	4	33.3333333333333	0.0166583393847118	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	219	1723	5.24505327245053	1	1	0.0166583393847118
TOXCAST_ACTIVE	NVS_MP_hPBR	4	33.3333333333333	0.0170883452769438	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	221	1723	5.19758672699849	1	1	0.0170883452769438
CTD_CHEMICALS_DISEASES	Cholestasis	4	33.3333333333333	0.0345646412420798	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6	7	1137	8530	4.28697072496545	1	1	0.0345646412420798
CTD_CHEMICALS_DISEASES	Prostate cancer, familial	3	25	0.0402822347157824	1330-78-5, 115-86-6, 13674-87-8	7	477	8530	7.66397124887691	1	1	0.0402822347157824
CTD_CHEMICALS_DISEASES	Carotid Artery Diseases	3	25	0.0607423904090286	1241-94-7, 1330-78-5, 115-86-6	7	597	8530	6.12347451543431	1	1	0.0607423904090286
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_ratio	4	33.3333333333333	0.0676228400695797	1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	366	1723	3.1384335154827	1	1	0.0676228400695797
LEADSCOPE_TOXICITY	Genetic Toxicity -s. cerevisiae	4	33.3333333333333	0.0693412894135144	1330-78-5, 115-86-6, 115-96-8, 13674-87-8	9	942	7444	3.51214909176693	1	1	0.0693412894135144
CTD_CHEMICALS_DISEASES	Leukemia, Myeloid, Acute	3	25	0.0711880957448779	56803-37-3, 1330-78-5, 115-86-6	7	652	8530	5.60692375109553	1	1	0.0711880957448779
CTD_CHEMICALS_DISEASES	Mammary Neoplasms, Animal	3	25	0.149635793996989	56803-37-3, 1330-78-5, 115-86-6	7	1000	8530	3.65571428571429	1	1	0.149635793996989
CTD_CHEMICALS_DISEASES	Thyroid Neoplasms	3	25	0.180999823066886	1241-94-7, 1330-78-5, 115-86-6	7	1122	8530	3.25821237585943	1	1	0.180999823066886
CTD_CHEMICALS_DISEASES	Hypogonadism	2	16.6666666666667	0.200398449863944	1330-78-5, 115-86-6	7	312	8530	7.81135531135531	1	1	0.200398449863944
CTD_CHEMICALS_DISEASES	Parkinson Disease	3	25	0.311242185238299	1330-78-5, 115-86-6, 78-30-8	7	1590	8530	2.29919137466307	1	1	0.311242185238299
CTD_CHEMICALS_DISEASES	Poisoning	2	16.6666666666667	0.352556917941376	1330-78-5, 115-86-6	7	596	8530	4.08916586768936	1	1	0.352556917941376
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
TOXCAST_ACTIVE	ATG_ERE_CIS_up	3	25	0.661896834740386	1241-94-7, 1330-78-5, 115-86-6	6	559	1723	1.54114490161002	1	1	0.661896834740386
CTD_CHEMICALS_DISEASES	Cardiomegaly	2	16.6666666666667	1	1330-78-5, 115-86-6	7	1263	8530	1.92964596765072	1	1	1

Annotation Cluster 14	Enrichment Score: 1.11824179096452
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Female Urogenital Diseases	4	33.3333333333333	0.000136197562539554	56803-37-3, 1330-78-5, 78-30-8, 79-94-7	7	165	8530	29.5411255411255	1	0.0543428274532821	0.000136197562539554
CTD_CHEMICALS_DISEASES	Bamforth syndrome	3	25	0.00230471663689011	56803-37-3, 1330-78-5, 78-30-8	7	108	8530	33.8492063492063	1	0.889620621839581	0.00230471663689011
CTD_CHEMICALS_DISEASES	Organophosphate Poisoning	3	25	0.0113286557604202	56803-37-3, 1330-78-5, 78-30-8	7	244	8530	14.9824355971897	1	1	0.0113286557604202
CTD_CHEMICALS_DISEASES	Stomatognathic System Abnormalities	2	16.6666666666667	0.0181548795101869	56803-37-3, 78-30-8	7	26	8530	93.7362637362637	1	1	0.0181548795101869
CTD_CHEMICALS_DISEASES	Squamous Cell Carcinoma of Head and Neck	4	33.3333333333333	0.0265597336081754	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1031	8530	4.727726202023	1	1	0.0265597336081754
CTD_CHEMICALS_DISEASES	Osteosarcoma	4	33.3333333333333	0.0356310624676759	1241-94-7, 56803-37-3, 13674-87-8, 78-30-8	7	1150	8530	4.23850931677019	1	1	0.0356310624676759
CTD_CHEMICALS_DISEASES	Colorectal Neoplasms	4	33.3333333333333	0.0813757801662513	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1579	8530	3.08694472089026	1	1	0.0813757801662513
CTD_CHEMICALS_DISEASES	Osteoarthritis	3	25	0.134343303374012	1241-94-7, 56803-37-3, 78-30-8	7	938	8530	3.89734998477003	1	1	0.134343303374012
CTD_CHEMICALS_DISEASES	Muscular Dystrophies	2	16.6666666666667	0.1779493790461	56803-37-3, 78-30-8	7	274	8530	8.89468196037539	1	1	0.1779493790461
CTD_CHEMICALS_DISEASES	Nerve Degeneration	3	25	0.212379150477592	1241-94-7, 56803-37-3, 78-30-8	7	1239	8530	2.95053614666205	1	1	0.212379150477592
CTD_CHEMICALS_DISEASES	Myocardial Ischemia	3	25	0.234965218585722	56803-37-3, 1330-78-5, 78-30-8	7	1321	8530	2.76738401643776	1	1	0.234965218585722
CTD_CHEMICALS_DISEASES	Uremia	2	16.6666666666667	0.258144930095861	56803-37-3, 78-30-8	7	414	8530	5.88681849551415	1	1	0.258144930095861
CTD_CHEMICALS_DISEASES	Fatty Liver	3	25	0.270376479692687	1241-94-7, 56803-37-3, 78-30-8	7	1447	8530	2.5264093197749	1	1	0.270376479692687
CTD_CHEMICALS_DISEASES	Multiple Sclerosis	2	16.6666666666667	0.371424910098637	56803-37-3, 78-30-8	7	635	8530	3.83802024746907	1	1	0.371424910098637
CTD_CHEMICALS_DISEASES	Lung Neoplasms	3	25	0.63540668993478	56803-37-3, 1330-78-5, 78-30-8	7	2053	8530	1.78066940366015	1	1	0.63540668993478
CTD_CHEMICALS_DISEASES	Non-alcoholic Fatty Liver Disease	2	16.6666666666667	1	56803-37-3, 78-30-8	7	1477	8530	1.6500628687494	1	1	1
CTD_CHEMICALS_DISEASES	Neoplasm Invasiveness	2	16.6666666666667	1	56803-37-3, 78-30-8	7	1684	8530	1.44723447573804	1	1	1

Annotation Cluster 15	Enrichment Score: 1.11558881650698
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Female Urogenital Diseases	4	33.3333333333333	0.000136197562539554	56803-37-3, 1330-78-5, 78-30-8, 79-94-7	7	165	8530	29.5411255411255	1	0.0543428274532821	0.000136197562539554
CTD_CHEMICALS_DISEASES	Bamforth syndrome	3	25	0.00230471663689011	56803-37-3, 1330-78-5, 78-30-8	7	108	8530	33.8492063492063	1	0.889620621839581	0.00230471663689011
CTD_CHEMICALS_DISEASES	Organophosphate Poisoning	3	25	0.0113286557604202	56803-37-3, 1330-78-5, 78-30-8	7	244	8530	14.9824355971897	1	1	0.0113286557604202
CTD_CHEMICALS_DISEASES	Squamous Cell Carcinoma of Head and Neck	4	33.3333333333333	0.0265597336081754	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1031	8530	4.727726202023	1	1	0.0265597336081754
CTD_CHEMICALS_DISEASES	Cholestasis	4	33.3333333333333	0.0345646412420798	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6	7	1137	8530	4.28697072496545	1	1	0.0345646412420798
CTD_CHEMICALS_DISEASES	Insulin-Like Growth Factor I Deficiency	2	16.6666666666667	0.0401214982932335	56803-37-3, 1330-78-5	7	58	8530	42.0197044334975	1	1	0.0401214982932335
CTD_CHEMICALS_DISEASES	Demyelinating Diseases	2	16.6666666666667	0.0448716831075569	56803-37-3, 1330-78-5	7	65	8530	37.4945054945055	1	1	0.0448716831075569
CTD_CHEMICALS_DISEASES	Leukemia, Myeloid, Acute	3	25	0.0711880957448779	56803-37-3, 1330-78-5, 115-86-6	7	652	8530	5.60692375109553	1	1	0.0711880957448779
CTD_CHEMICALS_DISEASES	Sleep Apnea Syndromes	2	16.6666666666667	0.0729633346092141	56803-37-3, 1330-78-5	7	107	8530	22.7770360480641	1	1	0.0729633346092141
CTD_CHEMICALS_DISEASES	Colorectal Neoplasms	4	33.3333333333333	0.0813757801662513	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1579	8530	3.08694472089026	1	1	0.0813757801662513
CTD_CHEMICALS_DISEASES	Neuroblastoma	3	25	0.103084274367938	56803-37-3, 1330-78-5, 13674-87-8	7	804	8530	4.54690831556503	1	1	0.103084274367938
CTD_CHEMICALS_DISEASES	Mammary Neoplasms, Animal	3	25	0.149635793996989	56803-37-3, 1330-78-5, 115-86-6	7	1000	8530	3.65571428571429	1	1	0.149635793996989
CTD_CHEMICALS_PATHWAYS	REACT:R-HSA-1430728|Metabolism	2	16.6666666666667	0.175803085204807	56803-37-3, 1330-78-5	6	77	2032	8.7965367965368	1	1	0.175803085204807
CTD_CHEMICALS_DISEASES	Bone Diseases, Metabolic	2	16.6666666666667	0.228589714440913	56803-37-3, 1330-78-5	7	361	8530	6.75108824693312	1	1	0.228589714440913
CTD_CHEMICALS_DISEASES	Myocardial Ischemia	3	25	0.234965218585722	56803-37-3, 1330-78-5, 78-30-8	7	1321	8530	2.76738401643776	1	1	0.234965218585722
CTD_CHEMICALS_DISEASES	Thrombosis	2	16.6666666666667	0.480596377005046	56803-37-3, 1330-78-5	7	882	8530	2.76320051830256	1	1	0.480596377005046
CTD_CHEMICALS_DISEASES	Mesothelioma, Malignant	2	16.6666666666667	0.588817905873937	56803-37-3, 1330-78-5	7	1174	8530	2.07593088342662	1	1	0.588817905873937
CTD_CHEMICALS_DISEASES	Lung Neoplasms	3	25	0.63540668993478	56803-37-3, 1330-78-5, 78-30-8	7	2053	8530	1.78066940366015	1	1	0.63540668993478
MULTICASE_TOX_PREDICTION	MRP2 substrates	4	33.3333333333333	0.749752598695028	56803-37-3, 1330-78-5, 68937-41-7, 79-94-7	11	3118	8032	0.936731004723308	1	1	0.749752598695028
MULTICASE_TOX_PREDICTION	OATP2B1 inhibition at 100uM	4	33.3333333333333	1	56803-37-3, 1330-78-5, 68937-41-7, 5436-43-1	11	2478	8032	1.17866314476484	1	1	1

Annotation Cluster 16	Enrichment Score: 1.0840238228607
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Female Urogenital Diseases	4	33.3333333333333	0.000136197562539554	56803-37-3, 1330-78-5, 78-30-8, 79-94-7	7	165	8530	29.5411255411255	1	0.0543428274532821	0.000136197562539554
CTD_CHEMICALS_DISEASES	Bamforth syndrome	3	25	0.00230471663689011	56803-37-3, 1330-78-5, 78-30-8	7	108	8530	33.8492063492063	1	0.889620621839581	0.00230471663689011
CTD_CHEMICALS_DISEASES	Organophosphate Poisoning	3	25	0.0113286557604202	56803-37-3, 1330-78-5, 78-30-8	7	244	8530	14.9824355971897	1	1	0.0113286557604202
MULTICASE_TOX_PREDICTION	Tox21 ARE activation assay, strong and weak actives by NIEHS calls, research only	8	66.6666666666667	0.0148498046822874	56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	2553	8032	2.28807463590072	1	1	0.0148498046822874
MULTICASE_TOX_PREDICTION	Tox21 ARE activation assay, only strong actives by NIEHS calls, research only	7	58.3333333333333	0.0174833861564937	56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 78-30-8, 79-94-7	11	1961	8032	2.60646238004729	1	1	0.0174833861564937
CTD_CHEMICALS_DISEASES	Recurrence	3	25	0.0490735368528514	1330-78-5, 78-30-8, 79-94-7	7	531	8530	6.88458434221146	1	1	0.0490735368528514
HTS_ACTIVE	antagonism_PPARg	3	25	0.159848619306805	56803-37-3, 68937-41-7, 79-94-7	10	336	4173	3.72589285714286	1	1	0.159848619306805
TOXPRINT_STRUCTURE	ring:aromatic_benzene	9	75	0.20121315842408	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	4611	8337	1.47932808895724	1	1	0.20121315842408
CTD_CHEMICALS_DISEASES	Myocardial Ischemia	3	25	0.234965218585722	56803-37-3, 1330-78-5, 78-30-8	7	1321	8530	2.76738401643776	1	1	0.234965218585722
TOXPRINT_STRUCTURE	chain:aromaticAlkane_Ph-C1_acyclic_connect_noDblBd	5	41.6666666666667	0.242452910245593	56803-37-3, 1330-78-5, 68937-41-7, 78-30-8, 79-94-7	11	1840	8337	2.05953557312253	1	1	0.242452910245593
HTS_ACTIVE	activation_Nrf2	5	41.6666666666667	0.268157833148037	56803-37-3, 115-86-6, 29761-21-5, 78-30-8, 79-94-7	10	1141	4173	1.82865907099036	1	1	0.268157833148037
CTD_CHEMICALS_DISEASES	Nervous System Diseases	3	25	0.286887550236254	1330-78-5, 78-30-8, 79-94-7	7	1505	8530	2.42904603701946	1	1	0.286887550236254
HTS_ACTIVE	cytotoxicity_VDR/antagonism	3	25	0.315643197238987	68937-41-7, 78-30-8, 79-94-7	10	525	4173	2.38457142857143	1	1	0.315643197238987
MULTICASE_TOX_PREDICTION	Draize eye irritation test, rabbit	8	66.6666666666667	0.527339053690464	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 78-30-8, 79-94-7	11	4428	8032	1.31920834359859	1	1	0.527339053690464
CTD_CHEMICALS_DISEASES	Lung Neoplasms	3	25	0.63540668993478	56803-37-3, 1330-78-5, 78-30-8	7	2053	8530	1.78066940366015	1	1	0.63540668993478
TOXPRINT_STRUCTURE	chain:aromaticAlkane_Ph-C1_acyclic_generic	5	41.6666666666667	0.736345331353075	56803-37-3, 1330-78-5, 68937-41-7, 78-30-8, 79-94-7	11	2695	8337	1.40613931523022	1	1	0.736345331353075
MULTICASE_TOX_PREDICTION	MRP2 substrates	4	33.3333333333333	0.749752598695028	56803-37-3, 1330-78-5, 68937-41-7, 79-94-7	11	3118	8032	0.936731004723308	1	1	0.749752598695028

Annotation Cluster 17	Enrichment Score: 1.07978744390889
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Amino Acid Metabolism, Inborn Errors	4	33.3333333333333	0.000100525141835556	56803-37-3, 115-86-6, 13674-87-8, 79-94-7	7	149	8530	32.7133269415149	1	0.0403105818760578	0.000100525141835556
CTD_CHEMICALS_DISEASES	Female Urogenital Diseases	4	33.3333333333333	0.000136197562539554	56803-37-3, 1330-78-5, 78-30-8, 79-94-7	7	165	8530	29.5411255411255	1	0.0543428274532821	0.000136197562539554
CTD_CHEMICALS_DISEASES	Lipodystrophy, Familial Partial	4	33.3333333333333	0.00029045031377117	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	213	8530	22.8839704896043	1	0.115308774567154	0.00029045031377117
CTD_CHEMICALS_DISEASES	Acute Lung Injury	3	25	0.0729564338542693	1241-94-7, 56803-37-3, 79-94-7	7	661	8530	5.53058137021828	1	1	0.0729564338542693
CTD_CHEMICALS_DISEASES	Osteoarthritis, Hip	2	16.6666666666667	0.0874009986124082	56803-37-3, 79-94-7	7	129	8530	18.8925802879291	1	1	0.0874009986124082
MULTICASE_TOX_PREDICTION	Dendritic cell activation at 1mM (CD86, CD54)	3	25	0.123282273160931	56803-37-3, 5436-43-1, 79-94-7	11	3656	8032	0.599164511637159	1	1	0.123282273160931
CTD_CHEMICALS_DISEASES	Cocaine-Related Disorders	3	25	0.158980461851979	1241-94-7, 56803-37-3, 79-94-7	7	1037	8530	3.52527896404463	1	1	0.158980461851979
HTS_ACTIVE	antagonism_PPARg	3	25	0.159848619306805	56803-37-3, 68937-41-7, 79-94-7	10	336	4173	3.72589285714286	1	1	0.159848619306805
TOXPRINT_STRUCTURE	chain:aromaticAlkane_Ph-C1_acyclic_connect_noDblBd	5	41.6666666666667	0.242452910245593	56803-37-3, 1330-78-5, 68937-41-7, 78-30-8, 79-94-7	11	1840	8337	2.05953557312253	1	1	0.242452910245593
MULTICASE_TOX_PREDICTION	Dendritic cell activation at 100uM (CD86, CD54)	2	16.6666666666667	0.298766055395908	56803-37-3, 79-94-7	11	2369	8032	0.616447292681991	1	1	0.298766055395908
HTS_ACTIVE	cytotoxicity_VDR/antagonism	3	25	0.315643197238987	68937-41-7, 78-30-8, 79-94-7	10	525	4173	2.38457142857143	1	1	0.315643197238987
HTS_ACTIVE	antagonism_FXR	2	16.6666666666667	0.356086652288895	56803-37-3, 79-94-7	10	199	4173	4.19396984924623	1	1	0.356086652288895
CTD_CHEMICALS_DISEASES	Carcinoma, Hepatocellular	4	33.3333333333333	0.361646452376679	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	2428	8530	2.00753118380795	1	1	0.361646452376679
TOXPRINT_STRUCTURE	chain:alkaneLinear_ethyl_C2_(connect_noZ_CN=4)	5	41.6666666666667	0.49868042073762	1241-94-7, 56803-37-3, 29761-21-5, 68937-41-7, 79-94-7	11	2495	8337	1.51885589360539	1	1	0.49868042073762
HTS_ACTIVE	cytotoxicity_NFkb/activation	2	16.6666666666667	0.568800583945383	68937-41-7, 79-94-7	10	372	4173	2.24354838709677	1	1	0.568800583945383
TOXPRINT_STRUCTURE	chain:aromaticAlkane_Ph-C1_acyclic_generic	5	41.6666666666667	0.736345331353075	56803-37-3, 1330-78-5, 68937-41-7, 78-30-8, 79-94-7	11	2695	8337	1.40613931523022	1	1	0.736345331353075
MULTICASE_TOX_PREDICTION	MRP2 substrates	4	33.3333333333333	0.749752598695028	56803-37-3, 1330-78-5, 68937-41-7, 79-94-7	11	3118	8032	0.936731004723308	1	1	0.749752598695028
TOXPRINT_STRUCTURE	chain:alkaneBranch_neopentyl_C5	2	16.6666666666667	1	56803-37-3, 79-94-7	11	838	8337	1.80885224560642	1	1	1

Annotation Cluster 18	Enrichment Score: 1.04060826568314
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Lipodystrophy, Familial Partial	4	33.3333333333333	0.00029045031377117	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	213	8530	22.8839704896043	1	0.115308774567154	0.00029045031377117
TOXCAST_ACTIVE	ATG_GLI_CIS_up	4	33.3333333333333	0.00174289726900597	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	100	1723	11.4866666666667	1	0.677987037643323	0.00174289726900597
CTD_CHEMICALS_DISEASES	Amyotrophic Lateral Sclerosis	4	33.3333333333333	0.00644174598842861	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	619	8530	7.87445188091392	1	1	0.00644174598842861
TOXCAST_ACTIVE	ATG_NRF1_CIS_up	3	25	0.0100867459159611	1241-94-7, 13674-87-8, 79-94-7	6	57	1723	15.1140350877193	1	1	0.0100867459159611
CTD_CHEMICALS_DISEASES	Arsenic Poisoning	4	33.3333333333333	0.0105298959712323	1241-94-7, 13674-87-8, 78-30-8, 79-94-7	7	737	8530	6.61368482264005	1	1	0.0105298959712323
TOXCAST_ACTIVE	ATG_TAL_CIS_up	3	25	0.015029803571089	1241-94-7, 115-86-6, 79-94-7	6	70	1723	12.3071428571429	1	1	0.015029803571089
TOXCAST_ACTIVE	ATG_HSE_CIS_up	4	33.3333333333333	0.0162350265450611	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	217	1723	5.29339477726574	1	1	0.0162350265450611
TOXCAST_ACTIVE	ATG_Pax6_CIS_up	4	33.3333333333333	0.0249028500560272	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	253	1723	4.54018445322793	1	1	0.0249028500560272
CTD_CHEMICALS_DISEASES	Carcinoma, Ductal	3	25	0.0268788306795404	1241-94-7, 13674-87-8, 79-94-7	7	384	8530	9.52008928571428	1	1	0.0268788306795404
TOXCAST_ACTIVE	ATG_Myc_CIS_up	3	25	0.032009704727301	1241-94-7, 13674-87-8, 79-94-7	6	104	1723	8.28365384615385	1	1	0.032009704727301
TOXCAST_ACTIVE	ATG_EGR_CIS_up	4	33.3333333333333	0.0338900667088663	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	283	1723	4.05889281507656	1	1	0.0338900667088663
TOXCAST_ACTIVE	ATG_Xbp1_CIS_up	4	33.3333333333333	0.0379515964026503	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	295	1723	3.89378531073446	1	1	0.0379515964026503
CTD_CHEMICALS_DISEASES	Adrenocortical Carcinoma	3	25	0.0413816771691881	1241-94-7, 115-86-6, 79-94-7	7	484	8530	7.55312868949233	1	1	0.0413816771691881
CTD_CHEMICALS_DISEASES	Atherosclerosis	4	33.3333333333333	0.0454045866275776	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	1260	8530	3.86848072562358	1	1	0.0454045866275776
CTD_CHEMICALS_DISEASES	Gallbladder Neoplasms	3	25	0.0499228202390836	1241-94-7, 1330-78-5, 79-94-7	7	536	8530	6.82036247334755	1	1	0.0499228202390836
TOXCAST_ACTIVE	ATG_TA_CIS_up	3	25	0.0520782531109114	1241-94-7, 115-86-6, 79-94-7	6	135	1723	6.38148148148148	1	1	0.0520782531109114
TOXCAST_ACTIVE	ATG_SREBP_CIS_up	4	33.3333333333333	0.0543256667044474	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	337	1723	3.40850642927794	1	1	0.0543256667044474
TOXCAST_ACTIVE	ATG_CMV_CIS_up	4	33.3333333333333	0.0605405838861071	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	351	1723	3.27255460588794	1	1	0.0605405838861071
TOXCAST_ACTIVE	ATG_Oct_MLP_CIS_up	4	33.3333333333333	0.0695855050622816	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	370	1723	3.1045045045045	1	1	0.0695855050622816
CTD_CHEMICALS_DISEASES	Acute Lung Injury	3	25	0.0729564338542693	1241-94-7, 56803-37-3, 79-94-7	7	661	8530	5.53058137021828	1	1	0.0729564338542693
TOXCAST_ACTIVE	ATG_NFI_CIS_up	3	25	0.0835020597426603	1241-94-7, 13674-87-8, 79-94-7	6	175	1723	4.92285714285714	1	1	0.0835020597426603
TOXCAST_ACTIVE	ATG_MRE_CIS_up	4	33.3333333333333	0.0955624198937236	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	418	1723	2.74800637958533	1	1	0.0955624198937236
CTD_CHEMICALS_DISEASES	Chronobiology Disorders	2	16.6666666666667	0.100363072580886	1241-94-7, 79-94-7	7	149	8530	16.3566634707574	1	1	0.100363072580886
CTD_CHEMICALS_DISEASES	Obesity, Morbid	2	16.6666666666667	0.114443786851688	1241-94-7, 79-94-7	7	171	8530	14.2522974101921	1	1	0.114443786851688
TOXCAST_ACTIVE	ATG_Sp1_CIS_up	3	25	0.117216427015461	1241-94-7, 13674-87-8, 79-94-7	6	212	1723	4.06367924528302	1	1	0.117216427015461
TOXCAST_ACTIVE	ACEA_T47D_80hr_Negative	4	33.3333333333333	0.117945552783321	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	454	1723	2.53010279001468	1	1	0.117945552783321
CTD_CHEMICALS_DISEASES	Cocaine-Related Disorders	3	25	0.158980461851979	1241-94-7, 56803-37-3, 79-94-7	7	1037	8530	3.52527896404463	1	1	0.158980461851979
CTD_CHEMICALS_DISEASES	Wilms Tumor	2	16.6666666666667	0.17014990382967	1241-94-7, 79-94-7	7	261	8530	9.33771209633279	1	1	0.17014990382967
CTD_CHEMICALS_DISEASES	Small Cell Lung Carcinoma	2	16.6666666666667	0.260336659012762	1241-94-7, 79-94-7	7	418	8530	5.83048530416951	1	1	0.260336659012762
CTD_CHEMICALS_DISEASES	Adenocarcinoma, Clear Cell	2	16.6666666666667	0.279285169693912	1241-94-7, 79-94-7	7	453	8530	5.38000630715862	1	1	0.279285169693912
TOXCAST_ACTIVE	ATG_PPRE_CIS_up	3	25	0.295491396951537	1241-94-7, 115-86-6, 79-94-7	6	372	1723	2.31586021505376	1	1	0.295491396951537
TOXCAST_ACTIVE	ATG_Sox_CIS_up	2	16.6666666666667	0.298927150920067	1241-94-7, 79-94-7	6	118	1723	4.86723163841808	1	1	0.298927150920067
MULTICASE_TOX_PREDICTION	OCT1 substrates	2	16.6666666666667	0.299222595537677	1241-94-7, 79-94-7	11	2407	8032	0.606715262303131	1	1	0.299222595537677
CTD_CHEMICALS_DISEASES	Drug-Related Side Effects and Adverse Reactions	3	25	0.323321912493274	1241-94-7, 78-30-8, 79-94-7	7	1632	8530	2.24002100840336	1	1	0.323321912493274
CTD_CHEMICALS_DISEASES	Carcinoma, Hepatocellular	4	33.3333333333333	0.361646452376679	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	2428	8530	2.00753118380795	1	1	0.361646452376679
CTD_CHEMICALS_DISEASES	Breast Neoplasms	4	33.3333333333333	0.368996149713612	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	7	2515	8530	1.93808577108776	1	1	0.368996149713612
CTD_CHEMICALS_DISEASES	Papilloma	2	16.6666666666667	0.392159549981154	1241-94-7, 79-94-7	7	679	8530	3.58931201346518	1	1	0.392159549981154
CTD_CHEMICALS_DISEASES	Keratosis	2	16.6666666666667	0.479372331249748	1241-94-7, 79-94-7	7	879	8530	2.77263123679506	1	1	0.479372331249748
CTD_CHEMICALS_DISEASES	Multiple Myeloma	2	16.6666666666667	0.486680693760873	1241-94-7, 79-94-7	7	897	8530	2.71699315177576	1	1	0.486680693760873
CTD_CHEMICALS_DISEASES	Diabetes Mellitus	2	16.6666666666667	0.493504337345268	1241-94-7, 79-94-7	7	914	8530	2.66645826820882	1	1	0.493504337345268
TOXCAST_ACTIVE	Tox21_TR_LUC_GH3_Antagonist	3	25	0.610467510819369	1241-94-7, 13674-87-8, 79-94-7	6	450	1723	1.91444444444444	1	1	0.610467510819369
TOXCAST_ACTIVE	Tox21_FXR_BLA_antagonist_ratio	2	16.6666666666667	1	1241-94-7, 79-94-7	6	323	1723	1.7781217750258	1	1	1
TOXCAST_ACTIVE	ATG_NRF2_ARE_CIS_up	3	25	1	1241-94-7, 115-86-6, 79-94-7	6	747	1723	1.15327978580991	1	1	1
CTD_CHEMICALS_DISEASES	Hepatomegaly	2	16.6666666666667	1	1241-94-7, 79-94-7	7	1278	8530	1.90699754080036	1	1	1
TOXCAST_ACTIVE	ATG_ERa_TRANS_up	2	16.6666666666667	1	1241-94-7, 79-94-7	6	470	1723	1.22198581560284	1	1	1

Annotation Cluster 19	Enrichment Score: 1.02788809899352
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Female Urogenital Diseases	4	33.3333333333333	0.000136197562539554	56803-37-3, 1330-78-5, 78-30-8, 79-94-7	7	165	8530	29.5411255411255	1	0.0543428274532821	0.000136197562539554
CTD_CHEMICALS_DISEASES	Disorder of Sex Development, 46,XY	3	25	0.00150208046295306	1330-78-5, 115-86-6, 78-30-8	7	87	8530	42.0197044334975	1	0.587313461014645	0.00150208046295306
CTD_CHEMICALS_DISEASES	Bamforth syndrome	3	25	0.00230471663689011	56803-37-3, 1330-78-5, 78-30-8	7	108	8530	33.8492063492063	1	0.889620621839581	0.00230471663689011
CTD_CHEMICALS_DISEASES	Amyotrophic Lateral Sclerosis	4	33.3333333333333	0.00644174598842861	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	619	8530	7.87445188091392	1	1	0.00644174598842861
CTD_CHEMICALS_DISEASES	Organophosphate Poisoning	3	25	0.0113286557604202	56803-37-3, 1330-78-5, 78-30-8	7	244	8530	14.9824355971897	1	1	0.0113286557604202
CTD_CHEMICALS_DISEASES	Squamous Cell Carcinoma of Head and Neck	4	33.3333333333333	0.0265597336081754	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1031	8530	4.727726202023	1	1	0.0265597336081754
CTD_CHEMICALS_DISEASES	Atherosclerosis	4	33.3333333333333	0.0454045866275776	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	1260	8530	3.86848072562358	1	1	0.0454045866275776
CTD_CHEMICALS_DISEASES	Hemangiosarcoma	3	25	0.0457353667985919	1241-94-7, 1330-78-5, 78-30-8	7	511	8530	7.15403969807101	1	1	0.0457353667985919
CTD_CHEMICALS_DISEASES	Recurrence	3	25	0.0490735368528514	1330-78-5, 78-30-8, 79-94-7	7	531	8530	6.88458434221146	1	1	0.0490735368528514
CTD_CHEMICALS_DISEASES	Colorectal Neoplasms	4	33.3333333333333	0.0813757801662513	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1579	8530	3.08694472089026	1	1	0.0813757801662513
CTD_CHEMICALS_DISEASES	Esophageal Neoplasms	3	25	0.157962798549802	1241-94-7, 1330-78-5, 78-30-8	7	1033	8530	3.53892960862951	1	1	0.157962798549802
CTD_CHEM2GENE_25	ACHE	2	16.6666666666667	0.161742623273725	1330-78-5, 78-30-8	7	195	6732	9.86373626373626	1	1	0.161742623273725
CTD_CHEMICALS_DISEASES	Carcinoma, Renal Cell	3	25	0.172365007888314	1241-94-7, 1330-78-5, 78-30-8	7	1089	8530	3.35694608421881	1	1	0.172365007888314
CTD_CHEMICALS_DISEASES	Myocardial Ischemia	3	25	0.234965218585722	56803-37-3, 1330-78-5, 78-30-8	7	1321	8530	2.76738401643776	1	1	0.234965218585722
CTD_CHEMICALS_DISEASES	Nervous System Diseases	3	25	0.286887550236254	1330-78-5, 78-30-8, 79-94-7	7	1505	8530	2.42904603701946	1	1	0.286887550236254
CTD_CHEMICALS_DISEASES	Parkinson Disease	3	25	0.311242185238299	1330-78-5, 115-86-6, 78-30-8	7	1590	8530	2.29919137466307	1	1	0.311242185238299
CTD_CHEMICALS_DISEASES	Cardiotoxicity	2	16.6666666666667	0.381864676799689	1330-78-5, 78-30-8	7	657	8530	3.70950206566645	1	1	0.381864676799689
CTD_CHEMICALS_DISEASES	Growth Disorders	2	16.6666666666667	0.419959952920832	1330-78-5, 78-30-8	7	740	8530	3.29343629343629	1	1	0.419959952920832
CTD_CHEMICALS_DISEASES	Abortion, Spontaneous	2	16.6666666666667	0.436736361658375	1330-78-5, 78-30-8	7	778	8530	3.13257436650753	1	1	0.436736361658375
CTD_CHEMICALS_DISEASES	Learning Disabilities	2	16.6666666666667	0.450975426682589	1330-78-5, 78-30-8	7	811	8530	3.00510833186542	1	1	0.450975426682589
CTD_CHEMICALS_DISEASES	Neurotoxicity Syndromes	2	16.6666666666667	0.464495272706425	1330-78-5, 78-30-8	7	843	8530	2.89103541772581	1	1	0.464495272706425
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
CTD_CHEMICALS_DISEASES	Skin Neoplasms	2	16.6666666666667	0.587137556216737	1330-78-5, 78-30-8	7	1169	8530	2.08480997189295	1	1	0.587137556216737
CTD_CHEMICALS_DISEASES	Lung Neoplasms	3	25	0.63540668993478	56803-37-3, 1330-78-5, 78-30-8	7	2053	8530	1.78066940366015	1	1	0.63540668993478
CTD_CHEMICALS_DISEASES	Status Epilepticus	2	16.6666666666667	1	1330-78-5, 78-30-8	7	1253	8530	1.94504617489454	1	1	1
TOXPRINT_STRUCTURE	chain:aromaticAlkane_Ph-C1_acyclic_connect_H_gt_1	2	16.6666666666667	1	1330-78-5, 78-30-8	11	1281	8337	1.1833084947839	1	1	1

Annotation Cluster 20	Enrichment Score: 1.01519764311825
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
TOXCAST_ACTIVE	ATG_NRF1_CIS_up	3	25	0.0100867459159611	1241-94-7, 13674-87-8, 79-94-7	6	57	1723	15.1140350877193	1	1	0.0100867459159611
CTD_CHEMICALS_DISEASES	Carcinoma, Ductal	3	25	0.0268788306795404	1241-94-7, 13674-87-8, 79-94-7	7	384	8530	9.52008928571428	1	1	0.0268788306795404
TOXCAST_ACTIVE	ATG_Myc_CIS_up	3	25	0.032009704727301	1241-94-7, 13674-87-8, 79-94-7	6	104	1723	8.28365384615385	1	1	0.032009704727301
TOXCAST_ACTIVE	ATG_NFI_CIS_up	3	25	0.0835020597426603	1241-94-7, 13674-87-8, 79-94-7	6	175	1723	4.92285714285714	1	1	0.0835020597426603
TOXCAST_ACTIVE	ATG_Sp1_CIS_up	3	25	0.117216427015461	1241-94-7, 13674-87-8, 79-94-7	6	212	1723	4.06367924528302	1	1	0.117216427015461
MULTICASE_TOX_PREDICTION	Sensory irritation, mouse	3	25	0.20260735466091	1241-94-7, 29761-21-5, 5436-43-1	11	3493	8032	0.627124378627385	1	1	0.20260735466091
TOXCAST_ACTIVE	Tox21_TR_LUC_GH3_Antagonist	3	25	0.610467510819369	1241-94-7, 13674-87-8, 79-94-7	6	450	1723	1.91444444444444	1	1	0.610467510819369
LEADSCOPE_TOXICITY	Reproductive Toxicity- C3H10T1-2	5	41.6666666666667	0.719403100193003	1241-94-7, 29761-21-5, 13674-87-8, 5436-43-1, 79-94-7	9	2909	7444	1.42164164852374	1	1	0.719403100193003

Annotation Cluster 21	Enrichment Score: 1.01420222702306
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Disorder of Sex Development, 46,XY	3	25	0.00150208046295306	1330-78-5, 115-86-6, 78-30-8	7	87	8530	42.0197044334975	1	0.587313461014645	0.00150208046295306
MULTICASE_TOX_PREDICTION	Tox21 ARE activation assay, strong and weak actives by NIEHS calls, research only	8	66.6666666666667	0.0148498046822874	56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	2553	8032	2.28807463590072	1	1	0.0148498046822874
CTD_CHEMICALS_DISEASES	Prostate cancer, familial	3	25	0.0402822347157824	1330-78-5, 115-86-6, 13674-87-8	7	477	8530	7.66397124887691	1	1	0.0402822347157824
CTD_CHEMICALS_DISEASES	Hepatitis, Chronic	3	25	0.114438124362943	115-86-6, 13674-87-8, 78-30-8	7	854	8530	4.28069588491134	1	1	0.114438124362943
CTD_CHEMICALS_DISEASES	Brain Ischemia	3	25	0.239698144481177	115-86-6, 13674-87-8, 78-30-8	7	1338	8530	2.73222293401666	1	1	0.239698144481177
LEADSCOPE_TOXICITY	Reproductive Toxicity- sperm mouse	5	41.6666666666667	0.27420259632904	1330-78-5, 115-86-6, 29761-21-5, 5436-43-1, 78-30-8	9	2365	7444	1.748649283533	1	1	0.27420259632904
CTD_CHEMICALS_DISEASES	Parkinson Disease	3	25	0.311242185238299	1330-78-5, 115-86-6, 78-30-8	7	1590	8530	2.29919137466307	1	1	0.311242185238299
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
LEADSCOPE_TOXICITY	Reproductive Toxicity-cell transformation	5	41.6666666666667	0.720812771060649	1330-78-5, 115-86-6, 13674-87-8, 5436-43-1, 78-30-8	9	2966	7444	1.39432082115831	1	1	0.720812771060649

Annotation Cluster 22	Enrichment Score: 0.949191977784694
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
MESH	Organophosphorus Compounds	7	58.3333333333333	8.57944930512421e-09	1241-94-7, 56803-37-3, 115-86-6, 115-96-8, 29761-21-5, 13674-87-8, 78-30-8	9	145	5450	29.2337164750958	1	3.5089947657958e-06	8.57944930512421e-09
CTD_CHEMICALS_DISEASES	Lipodystrophy, Familial Partial	4	33.3333333333333	0.00029045031377117	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	213	8530	22.8839704896043	1	0.115308774567154	0.00029045031377117
CTD_CHEMICALS_DISEASES	Metabolism, Inborn Errors	3	25	0.0124254744366084	1241-94-7, 56803-37-3, 115-86-6	7	256	8530	14.2801339285714	1	1	0.0124254744366084
CTD_CHEMICALS_DISEASES	Squamous Cell Carcinoma of Head and Neck	4	33.3333333333333	0.0265597336081754	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1031	8530	4.727726202023	1	1	0.0265597336081754
CTD_CHEMICALS_DISEASES	Cholestasis	4	33.3333333333333	0.0345646412420798	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6	7	1137	8530	4.28697072496545	1	1	0.0345646412420798
CTD_CHEMICALS_DISEASES	Osteosarcoma	4	33.3333333333333	0.0356310624676759	1241-94-7, 56803-37-3, 13674-87-8, 78-30-8	7	1150	8530	4.23850931677019	1	1	0.0356310624676759
CTD_CHEMICALS_DISEASES	Opioid-Related Disorders	2	16.6666666666667	0.0428382940953191	1241-94-7, 56803-37-3	7	62	8530	39.3087557603687	1	1	0.0428382940953191
CTD_CHEMICALS_DISEASES	Acute Lung Injury	3	25	0.0729564338542693	1241-94-7, 56803-37-3, 79-94-7	7	661	8530	5.53058137021828	1	1	0.0729564338542693
CTD_CHEMICALS_DISEASES	Colorectal Neoplasms	4	33.3333333333333	0.0813757801662513	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1579	8530	3.08694472089026	1	1	0.0813757801662513
CTD_CHEMICALS_DISEASES	Carotid Intimal Medial Thickness 1	2	16.6666666666667	0.0867488316271383	1241-94-7, 56803-37-3	7	128	8530	19.0401785714286	1	1	0.0867488316271383
CTD_CHEMICALS_DISEASES	Thyroid cancer, follicular	2	16.6666666666667	0.120783123916515	1241-94-7, 56803-37-3	7	181	8530	13.4648776637727	1	1	0.120783123916515
CTD_CHEMICALS_DISEASES	Pituitary ACTH Hypersecretion	2	16.6666666666667	0.121414972192536	1241-94-7, 56803-37-3	7	182	8530	13.3908948194662	1	1	0.121414972192536
CTD_CHEMICALS_DISEASES	Osteoarthritis	3	25	0.134343303374012	1241-94-7, 56803-37-3, 78-30-8	7	938	8530	3.89734998477003	1	1	0.134343303374012
TOXPRINT_STRUCTURE	ring:aromatic_phenyl	4	33.3333333333333	0.143050431796434	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1128	8337	2.68762088974855	1	1	0.143050431796434
CTD_CHEMICALS_DISEASES	Cocaine-Related Disorders	3	25	0.158980461851979	1241-94-7, 56803-37-3, 79-94-7	7	1037	8530	3.52527896404463	1	1	0.158980461851979
CTD_CHEMICALS_DISEASES	Polycystic Kidney, Autosomal Dominant	2	16.6666666666667	0.1779493790461	1241-94-7, 56803-37-3	7	274	8530	8.89468196037539	1	1	0.1779493790461
CTD_CHEMICALS_DISEASES	Amyloidosis	2	16.6666666666667	0.192776738182884	56803-37-3, 115-86-6	7	299	8530	8.15097945532728	1	1	0.192776738182884
CTD_CHEMICALS_DISEASES	Nerve Degeneration	3	25	0.212379150477592	1241-94-7, 56803-37-3, 78-30-8	7	1239	8530	2.95053614666205	1	1	0.212379150477592
CTD_CHEMICALS_DISEASES	Hypercholesterolemia	2	16.6666666666667	0.220049150648394	1241-94-7, 115-86-6	7	346	8530	7.04376548307184	1	1	0.220049150648394
CTD_CHEMICALS_DISEASES	Myelodysplastic Syndromes	2	16.6666666666667	0.233112720840143	1241-94-7, 56803-37-3	7	369	8530	6.60472319008904	1	1	0.233112720840143
CTD_CHEMICALS_DISEASES	Fatty Liver	3	25	0.270376479692687	1241-94-7, 56803-37-3, 78-30-8	7	1447	8530	2.5264093197749	1	1	0.270376479692687
MULTICASE_TOX_PREDICTION	RCA survival pre-implantation, mouse	2	16.6666666666667	0.274025246095353	1241-94-7, 56803-37-3	11	253	8032	5.77218828602228	1	1	0.274025246095353
CTD_CHEMICALS_DISEASES	Lymphoma, T-Cell	2	16.6666666666667	0.334723693094977	1241-94-7, 56803-37-3	7	560	8530	4.35204081632653	1	1	0.334723693094977
CTD_CHEMICALS_DISEASES	Carcinoma, Hepatocellular	4	33.3333333333333	0.361646452376679	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	2428	8530	2.00753118380795	1	1	0.361646452376679
MULTICASE_TOX_PREDICTION	MRP3 inhibition at 10uM	4	33.3333333333333	0.429302922086973	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1606	8032	1.81863466545907	1	1	0.429302922086973
TOXPRINT_STRUCTURE	chain:alkaneLinear_propyl_C3	2	16.6666666666667	0.468143566646552	1241-94-7, 29761-21-5	11	2104	8337	0.72044590390598	1	1	0.468143566646552
TOXCAST_ACTIVE	OT_ER_ERaERb_0480	2	16.6666666666667	0.502028584380322	1241-94-7, 115-86-6	6	224	1723	2.56398809523809	1	1	0.502028584380322
CTD_CHEMICALS_DISEASES	Brain Injuries	2	16.6666666666667	0.504186450733823	1241-94-7, 56803-37-3	7	941	8530	2.58994990132078	1	1	0.504186450733823
CTD_CHEMICALS_DISEASES	Subarachnoid Hemorrhage	2	16.6666666666667	0.518136657837481	1241-94-7, 56803-37-3	7	977	8530	2.49451674221377	1	1	0.518136657837481
MULTICASE_TOX_PREDICTION	Local lymph node assay, mouse, weak sensitizers (EC3 < 100%)	6	50	0.762767807673666	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5, 78-30-8, 79-94-7	11	4397	8032	0.99638183058697	1	1	0.762767807673666
CTD_CHEMICALS_DISEASES	Pancreatic Neoplasms	2	16.6666666666667	1	1241-94-7, 115-86-6	7	1256	8530	1.94040036396724	1	1	1
CTD_CHEMICALS_DISEASES	Hypertension	3	25	1	1241-94-7, 56803-37-3, 115-86-6	7	2494	8530	1.46580364302898	1	1	1
CTD_CHEMICALS_DISEASES	Obesity	2	16.6666666666667	1	56803-37-3, 115-86-6	7	2317	8530	1.05185276527529	1	1	1
CTD_CHEMICALS_DISEASES	Chemical and Drug Induced Liver Injury	2	16.6666666666667	1	1241-94-7, 56803-37-3	7	2431	8530	1.00252688487983	1	1	1
CTD_CHEMICALS_DISEASES	Diabetes Mellitus, Type 2	2	16.6666666666667	1	1241-94-7, 56803-37-3	7	1342	8530	1.81605279965936	1	1	1
TOXPRINT_STRUCTURE	chain:alkaneLinear_butyl_C4	2	16.6666666666667	1	1241-94-7, 29761-21-5	11	1203	8337	1.26003173883473	1	1	1

Annotation Cluster 23	Enrichment Score: 0.928730220614399
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Arsenic Poisoning	4	33.3333333333333	0.0105298959712323	1241-94-7, 13674-87-8, 78-30-8, 79-94-7	7	737	8530	6.61368482264005	1	1	0.0105298959712323
CTD_CHEMICALS_DISEASES	Mesothelioma	4	33.3333333333333	0.0208934792889723	1241-94-7, 115-86-6, 13674-87-8, 78-30-8	7	944	8530	5.1634382566586	1	1	0.0208934792889723
CTD_CHEMICALS_DISEASES	Carcinoma, Pancreatic Ductal	3	25	0.0270105855108645	13674-87-8, 78-30-8, 79-94-7	7	385	8530	9.49536178107607	1	1	0.0270105855108645
HTS_ACTIVE	antagonism_RORr	5	41.6666666666667	0.0301209311786568	56803-37-3, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8	10	605	4173	3.44876033057851	1	1	0.0301209311786568
CTD_CHEMICALS_DISEASES	Osteosarcoma	4	33.3333333333333	0.0356310624676759	1241-94-7, 56803-37-3, 13674-87-8, 78-30-8	7	1150	8530	4.23850931677019	1	1	0.0356310624676759
CTD_CHEMICALS_DISEASES	Head and Neck Neoplasms	3	25	0.0932115852761932	13674-87-8, 78-30-8, 79-94-7	7	759	8530	4.81648785996612	1	1	0.0932115852761932
CTD_CHEMICALS_DISEASES	Hepatitis, Chronic	3	25	0.114438124362943	115-86-6, 13674-87-8, 78-30-8	7	854	8530	4.28069588491134	1	1	0.114438124362943
CTD_CHEM2DISEASE	Nervous System Diseases	2	16.6666666666667	0.16578832159282	13674-87-8, 78-30-8	5	241	5441	9.03070539419087	1	1	0.16578832159282
HTS_ACTIVE	antagonism_GR	3	25	0.237263353771975	68937-41-7, 13674-87-8, 78-30-8	10	432	4173	2.89791666666667	1	1	0.237263353771975
CTD_CHEMICALS_DISEASES	Brain Ischemia	3	25	0.239698144481177	115-86-6, 13674-87-8, 78-30-8	7	1338	8530	2.73222293401666	1	1	0.239698144481177
HTS_ACTIVE	cytotoxicity_VDR/antagonism	3	25	0.315643197238987	68937-41-7, 78-30-8, 79-94-7	10	525	4173	2.38457142857143	1	1	0.315643197238987
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
HTS_ACTIVE	cytotoxicity_PPARd/antagonism	2	16.6666666666667	1	68937-41-7, 78-30-8	10	587	4173	1.42180579216354	1	1	1
CTD_CHEMICALS_DISEASES	Heart Failure	2	16.6666666666667	1	13674-87-8, 78-30-8	7	1460	8530	1.6692759295499	1	1	1

Annotation Cluster 24	Enrichment Score: 0.913393432919557
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
TOXPRINT_STRUCTURE	bond:P=O_phosphate_alkyl_ester	4	33.3333333333333	7.70420895068242e-05	1241-94-7, 115-96-8, 29761-21-5, 13674-87-8	11	74	8337	40.968058968059	1	0.0310479620712502	7.70420895068242e-05
TOXPRINT_STRUCTURE	chain:alkaneBranch_isopropyl_C3	4	33.3333333333333	0.111777577542643	1241-94-7, 29761-21-5, 68937-41-7, 13674-87-8	11	1013	8337	2.99273086242484	1	1	0.111777577542643
HTS_ACTIVE	cytotoxicity_TR/antagonism	7	58.3333333333333	0.168245942928303	1241-94-7, 56803-37-3, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8, 79-94-7	10	1651	4173	1.76929133858268	1	1	0.168245942928303
CTD_CHEMICALS_DISEASES	Penile Neoplasms	2	16.6666666666667	0.176753451764324	1241-94-7, 13674-87-8	7	272	8530	8.96008403361344	1	1	0.176753451764324
TOXCAST_ACTIVE	ATG_HIF1a_CIS_up	2	16.6666666666667	0.411223785361343	1241-94-7, 13674-87-8	6	173	1723	3.31984585741811	1	1	0.411223785361343
TOXPRINT_STRUCTURE	chain:alkaneLinear_propyl_C3	2	16.6666666666667	0.468143566646552	1241-94-7, 29761-21-5	11	2104	8337	0.72044590390598	1	1	0.468143566646552
MULTICASE_TOX_PREDICTION	BSEP substrates	2	16.6666666666667	1	1241-94-7, 13674-87-8	11	1286	8032	1.13558603138696	1	1	1
TOXPRINT_STRUCTURE	chain:alkaneLinear_butyl_C4	2	16.6666666666667	1	1241-94-7, 29761-21-5	11	1203	8337	1.26003173883473	1	1	1

Annotation Cluster 25	Enrichment Score: 0.907929170101995
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Amyotrophic Lateral Sclerosis	4	33.3333333333333	0.00644174598842861	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	619	8530	7.87445188091392	1	1	0.00644174598842861
TOXCAST_ACTIVE	NVS_MP_rPBR	4	33.3333333333333	0.0166583393847118	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	219	1723	5.24505327245053	1	1	0.0166583393847118
TOXCAST_ACTIVE	NVS_MP_hPBR	4	33.3333333333333	0.0170883452769438	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	221	1723	5.19758672699849	1	1	0.0170883452769438
CTD_CHEMICALS_DISEASES	Squamous Cell Carcinoma of Head and Neck	4	33.3333333333333	0.0265597336081754	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1031	8530	4.727726202023	1	1	0.0265597336081754
CTD_CHEMICALS_DISEASES	Cholestasis	4	33.3333333333333	0.0345646412420798	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6	7	1137	8530	4.28697072496545	1	1	0.0345646412420798
CTD_CHEMICALS_DISEASES	Atherosclerosis	4	33.3333333333333	0.0454045866275776	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	1260	8530	3.86848072562358	1	1	0.0454045866275776
CTD_CHEMICALS_DISEASES	Hemangiosarcoma	3	25	0.0457353667985919	1241-94-7, 1330-78-5, 78-30-8	7	511	8530	7.15403969807101	1	1	0.0457353667985919
CTD_CHEMICALS_DISEASES	Gallbladder Neoplasms	3	25	0.0499228202390836	1241-94-7, 1330-78-5, 79-94-7	7	536	8530	6.82036247334755	1	1	0.0499228202390836
CTD_CHEMICALS_DISEASES	Carotid Artery Diseases	3	25	0.0607423904090286	1241-94-7, 1330-78-5, 115-86-6	7	597	8530	6.12347451543431	1	1	0.0607423904090286
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_1440	3	25	0.0624173669639862	1241-94-7, 1330-78-5, 13674-87-8	6	149	1723	5.78187919463087	1	1	0.0624173669639862
CTD_CHEMICALS_DISEASES	Colorectal Neoplasms	4	33.3333333333333	0.0813757801662513	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1579	8530	3.08694472089026	1	1	0.0813757801662513
CTD_CHEMICALS_DISEASES	Papilloma, Choroid Plexus	2	16.6666666666667	0.155588828580123	1241-94-7, 1330-78-5	7	237	8530	10.2833031946956	1	1	0.155588828580123
CTD_CHEMICALS_DISEASES	Esophageal Neoplasms	3	25	0.157962798549802	1241-94-7, 1330-78-5, 78-30-8	7	1033	8530	3.53892960862951	1	1	0.157962798549802
CTD_CHEMICALS_DISEASES	Carcinoma, Renal Cell	3	25	0.172365007888314	1241-94-7, 1330-78-5, 78-30-8	7	1089	8530	3.35694608421881	1	1	0.172365007888314
CTD_CHEMICALS_DISEASES	Psoriasis	3	25	0.175492833125261	1241-94-7, 1330-78-5, 13674-87-8	7	1101	8530	3.32035811599844	1	1	0.175492833125261
CTD_CHEMICALS_DISEASES	Thyroid Neoplasms	3	25	0.180999823066886	1241-94-7, 1330-78-5, 115-86-6	7	1122	8530	3.25821237585943	1	1	0.180999823066886
CTD_CHEMICALS_DISEASES	Vulvar Lichen Sclerosus	2	16.6666666666667	0.184501131607708	1241-94-7, 1330-78-5	7	285	8530	8.55137844611529	1	1	0.184501131607708
CTD_CHEMICALS_DISEASES	Cerebral Hemorrhage	2	16.6666666666667	0.376663006498088	1241-94-7, 1330-78-5	7	646	8530	3.77266696152145	1	1	0.376663006498088
CTD_CHEMICALS_DISEASES	Diabetic Angiopathies	2	16.6666666666667	0.467831523870409	1241-94-7, 1330-78-5	7	851	8530	2.86385764646634	1	1	0.467831523870409
CTD_CHEMICALS_DISEASES	Coronary Artery Disease	2	16.6666666666667	0.477326913315133	1241-94-7, 1330-78-5	7	874	8530	2.78849297155933	1	1	0.477326913315133
CTD_CHEMICALS_DISEASES	Polycystic Ovary Syndrome	2	16.6666666666667	0.484254134431339	1241-94-7, 1330-78-5	7	891	8530	2.73528940195607	1	1	0.484254134431339
CTD_CHEMICALS_DISEASES	Glioma	2	16.6666666666667	0.555898185200065	1241-94-7, 1330-78-5	7	1079	8530	2.25870515027142	1	1	0.555898185200065
TOXCAST_ACTIVE	ATG_ERE_CIS_up	3	25	0.661896834740386	1241-94-7, 1330-78-5, 115-86-6	6	559	1723	1.54114490161002	1	1	0.661896834740386
CTD_CHEMICALS_DISEASES	Melanoma	2	16.6666666666667	1	1241-94-7, 1330-78-5	7	1258	8530	1.93731546672723	1	1	1
CTD_CHEMICALS_DISEASES	Liver Neoplasms	2	16.6666666666667	1	1241-94-7, 1330-78-5	7	1581	8530	1.54151983373995	1	1	1

Annotation Cluster 26	Enrichment Score: 0.887238802554276
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
TOXPRINT_STRUCTURE	bond:P=O_phosphate_alkyl_ester	4	33.3333333333333	7.70420895068242e-05	1241-94-7, 115-96-8, 29761-21-5, 13674-87-8	11	74	8337	40.968058968059	1	0.0310479620712502	7.70420895068242e-05
MULTICASE_TOX_PREDICTION	Extent of human metabolism, %	3	25	0.111262172508268	1241-94-7, 5436-43-1, 78-30-8	11	3877	8032	0.565010434497151	1	1	0.111262172508268
TOXPRINT_STRUCTURE	chain:alkaneBranch_isopropyl_C3	4	33.3333333333333	0.111777577542643	1241-94-7, 29761-21-5, 68937-41-7, 13674-87-8	11	1013	8337	2.99273086242484	1	1	0.111777577542643
TOXPRINT_STRUCTURE	ring:aromatic_phenyl	4	33.3333333333333	0.143050431796434	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1128	8337	2.68762088974855	1	1	0.143050431796434
MULTICASE_TOX_PREDICTION	Sensory irritation, mouse	3	25	0.20260735466091	1241-94-7, 29761-21-5, 5436-43-1	11	3493	8032	0.627124378627385	1	1	0.20260735466091
TOXPRINT_STRUCTURE	chain:alkaneLinear_ethyl_C2(H_gt_1)	3	25	0.334135103401555	1241-94-7, 115-96-8, 29761-21-5	11	3229	8337	0.704158337791041	1	1	0.334135103401555
MULTICASE_TOX_PREDICTION	MRP3 inhibition at 10uM	4	33.3333333333333	0.429302922086973	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1606	8032	1.81863466545907	1	1	0.429302922086973
TOXPRINT_STRUCTURE	chain:alkaneLinear_propyl_C3	2	16.6666666666667	0.468143566646552	1241-94-7, 29761-21-5	11	2104	8337	0.72044590390598	1	1	0.468143566646552
LEADSCOPE_TOXICITY	Reproductive Toxicity- C3H10T1-2	5	41.6666666666667	0.719403100193003	1241-94-7, 29761-21-5, 13674-87-8, 5436-43-1, 79-94-7	9	2909	7444	1.42164164852374	1	1	0.719403100193003
TOXPRINT_STRUCTURE	chain:alkaneLinear_butyl_C4	2	16.6666666666667	1	1241-94-7, 29761-21-5	11	1203	8337	1.26003173883473	1	1	1

Annotation Cluster 27	Enrichment Score: 0.879645449221199
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Lipodystrophy, Familial Partial	4	33.3333333333333	0.00029045031377117	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	213	8530	22.8839704896043	1	0.115308774567154	0.00029045031377117
TOXPRINT_STRUCTURE	ring:aromatic_phenyl	4	33.3333333333333	0.143050431796434	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1128	8337	2.68762088974855	1	1	0.143050431796434
HTS_ACTIVE	activation_Nrf2	5	41.6666666666667	0.268157833148037	56803-37-3, 115-86-6, 29761-21-5, 78-30-8, 79-94-7	10	1141	4173	1.82865907099036	1	1	0.268157833148037
CTD_CHEMICALS_DISEASES	Carcinoma, Hepatocellular	4	33.3333333333333	0.361646452376679	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	2428	8530	2.00753118380795	1	1	0.361646452376679
MULTICASE_TOX_PREDICTION	MRP3 inhibition at 10uM	4	33.3333333333333	0.429302922086973	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5	11	1606	8032	1.81863466545907	1	1	0.429302922086973
MULTICASE_TOX_PREDICTION	Draize eye irritation test, rabbit	8	66.6666666666667	0.527339053690464	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 78-30-8, 79-94-7	11	4428	8032	1.31920834359859	1	1	0.527339053690464
MULTICASE_TOX_PREDICTION	Local lymph node assay, mouse, weak sensitizers (EC3 < 100%)	6	50	0.762767807673666	1241-94-7, 56803-37-3, 115-86-6, 29761-21-5, 78-30-8, 79-94-7	11	4397	8032	0.99638183058697	1	1	0.762767807673666

Annotation Cluster 28	Enrichment Score: 0.868776057365012
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Amino Acid Metabolism, Inborn Errors	4	33.3333333333333	0.000100525141835556	56803-37-3, 115-86-6, 13674-87-8, 79-94-7	7	149	8530	32.7133269415149	1	0.0403105818760578	0.000100525141835556
CTD_CHEMICALS_DISEASES	Lipodystrophy, Familial Partial	4	33.3333333333333	0.00029045031377117	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	213	8530	22.8839704896043	1	0.115308774567154	0.00029045031377117
CTD_CHEM2GENE_25	AR	4	33.3333333333333	0.000415679053734167	115-86-6, 115-96-8, 13674-87-8, 79-94-7	7	190	6732	20.2466165413534	1	0.163361868117527	0.000415679053734167
TOXCAST_ACTIVE	OT_AR_ARSRC1_0960	5	41.6666666666667	0.00100950823203153	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	212	1723	6.77279874213836	1	0.395727226956358	0.00100950823203153
CTD_CHEMICALS_DISEASES	Disorder of Sex Development, 46,XY	3	25	0.00150208046295306	1330-78-5, 115-86-6, 78-30-8	7	87	8530	42.0197044334975	1	0.587313461014645	0.00150208046295306
CTD_CHEMICALS_DISEASES	Mouth Neoplasms	5	41.6666666666667	0.00156396851130194	1241-94-7, 56803-37-3, 115-86-6, 13674-87-8, 79-94-7	7	902	8530	6.75483053531834	1	0.609947719407755	0.00156396851130194
TOXCAST_ACTIVE	ATG_GLI_CIS_up	4	33.3333333333333	0.00174289726900597	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	100	1723	11.4866666666667	1	0.677987037643323	0.00174289726900597
TOXCAST_ACTIVE	ATG_PXR_TRANS_up	6	50	0.00213268995856035	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 79-94-7	6	505	1723	3.41188118811881	1	0.827483703921416	0.00213268995856035
CTD_CHEMICALS_DISEASES	Lipoid congenital adrenal hyperplasia	3	25	0.00222115157849881	1330-78-5, 115-86-6, 79-94-7	7	106	8530	34.4878706199461	1	0.859585660879039	0.00222115157849881
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_0480	5	41.6666666666667	0.00568927368704165	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	331	1723	4.33786505538771	1	1	0.00568927368704165
TOXCAST_ACTIVE	ATG_NRF1_CIS_up	3	25	0.0100867459159611	1241-94-7, 13674-87-8, 79-94-7	6	57	1723	15.1140350877193	1	1	0.0100867459159611
CTD_CHEMICALS_DISEASES	Arsenic Poisoning	4	33.3333333333333	0.0105298959712323	1241-94-7, 13674-87-8, 78-30-8, 79-94-7	7	737	8530	6.61368482264005	1	1	0.0105298959712323
CTD_CHEM2DISEASE	Teratogenesis	2	16.6666666666667	0.0117139768575488	13674-87-8, 79-94-7	5	16	5441	136.025	1	1	0.0117139768575488
CTD_CHEMICALS_DISEASES	Metabolism, Inborn Errors	3	25	0.0124254744366084	1241-94-7, 56803-37-3, 115-86-6	7	256	8530	14.2801339285714	1	1	0.0124254744366084
TOXCAST_ACTIVE	ATG_TAL_CIS_up	3	25	0.015029803571089	1241-94-7, 115-86-6, 79-94-7	6	70	1723	12.3071428571429	1	1	0.015029803571089
TOXCAST_ACTIVE	ATG_HSE_CIS_up	4	33.3333333333333	0.0162350265450611	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	217	1723	5.29339477726574	1	1	0.0162350265450611
TOXCAST_ACTIVE	NVS_MP_rPBR	4	33.3333333333333	0.0166583393847118	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	219	1723	5.24505327245053	1	1	0.0166583393847118
TOXCAST_ACTIVE	NVS_MP_hPBR	4	33.3333333333333	0.0170883452769438	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	221	1723	5.19758672699849	1	1	0.0170883452769438
CTD_CHEMICALS_DISEASES	Mesothelioma	4	33.3333333333333	0.0208934792889723	1241-94-7, 115-86-6, 13674-87-8, 78-30-8	7	944	8530	5.1634382566586	1	1	0.0208934792889723
TOXCAST_ACTIVE	ATG_NURR1_TRANS_up	3	25	0.0238269019325617	1241-94-7, 115-86-6, 13674-87-8	6	89	1723	9.67977528089888	1	1	0.0238269019325617
TOXCAST_ACTIVE	ATG_Pax6_CIS_up	4	33.3333333333333	0.0249028500560272	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	253	1723	4.54018445322793	1	1	0.0249028500560272
CTD_CHEMICALS_DISEASES	Carcinoma, Ductal	3	25	0.0268788306795404	1241-94-7, 13674-87-8, 79-94-7	7	384	8530	9.52008928571428	1	1	0.0268788306795404
CTD_CHEMICALS_DISEASES	Carcinoma, Pancreatic Ductal	3	25	0.0270105855108645	13674-87-8, 78-30-8, 79-94-7	7	385	8530	9.49536178107607	1	1	0.0270105855108645
TOXCAST_ACTIVE	ATG_VDRE_CIS_up	5	41.6666666666667	0.0295241637447702	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	512	1723	2.80436197916667	1	1	0.0295241637447702
TOXCAST_ACTIVE	ATG_PPARg_TRANS_up	5	41.6666666666667	0.0297380450297806	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	513	1723	2.79889538661468	1	1	0.0297380450297806
TOXCAST_ACTIVE	ATG_Myc_CIS_up	3	25	0.032009704727301	1241-94-7, 13674-87-8, 79-94-7	6	104	1723	8.28365384615385	1	1	0.032009704727301
TOXCAST_ACTIVE	ATG_EGR_CIS_up	4	33.3333333333333	0.0338900667088663	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	283	1723	4.05889281507656	1	1	0.0338900667088663
TOXCAST_ACTIVE	ATG_Xbp1_CIS_up	4	33.3333333333333	0.0379515964026503	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	295	1723	3.89378531073446	1	1	0.0379515964026503
CTD_CHEMICALS_DISEASES	Protoporphyria, Erythropoietic	2	16.6666666666667	0.0387606925026053	13674-87-8, 79-94-7	7	56	8530	43.5204081632653	1	1	0.0387606925026053
CTD_CHEMICALS_DISEASES	Prostate cancer, familial	3	25	0.0402822347157824	1330-78-5, 115-86-6, 13674-87-8	7	477	8530	7.66397124887691	1	1	0.0402822347157824
CTD_CHEMICALS_DISEASES	Adrenocortical Carcinoma	3	25	0.0413816771691881	1241-94-7, 115-86-6, 79-94-7	7	484	8530	7.55312868949233	1	1	0.0413816771691881
CTD_CHEMICALS_DISEASES	Recurrence	3	25	0.0490735368528514	1330-78-5, 78-30-8, 79-94-7	7	531	8530	6.88458434221146	1	1	0.0490735368528514
CTD_CHEMICALS_DISEASES	Gallbladder Neoplasms	3	25	0.0499228202390836	1241-94-7, 1330-78-5, 79-94-7	7	536	8530	6.82036247334755	1	1	0.0499228202390836
TOXCAST_ACTIVE	ATG_TA_CIS_up	3	25	0.0520782531109114	1241-94-7, 115-86-6, 79-94-7	6	135	1723	6.38148148148148	1	1	0.0520782531109114
TOXCAST_ACTIVE	ATG_SREBP_CIS_up	4	33.3333333333333	0.0543256667044474	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	337	1723	3.40850642927794	1	1	0.0543256667044474
TOXCAST_ACTIVE	ATG_CMV_CIS_up	4	33.3333333333333	0.0605405838861071	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	351	1723	3.27255460588794	1	1	0.0605405838861071
CTD_CHEMICALS_DISEASES	Carotid Artery Diseases	3	25	0.0607423904090286	1241-94-7, 1330-78-5, 115-86-6	7	597	8530	6.12347451543431	1	1	0.0607423904090286
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_1440	3	25	0.0624173669639862	1241-94-7, 1330-78-5, 13674-87-8	6	149	1723	5.78187919463087	1	1	0.0624173669639862
TOXCAST_ACTIVE	ATG_PXRE_CIS_up	6	50	0.0624572884773724	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 79-94-7	6	881	1723	1.95573212258797	1	1	0.0624572884773724
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_ratio	4	33.3333333333333	0.0676228400695797	1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	366	1723	3.1384335154827	1	1	0.0676228400695797
LEADSCOPE_TOXICITY	Genetic Toxicity -s. cerevisiae	4	33.3333333333333	0.0693412894135144	1330-78-5, 115-86-6, 115-96-8, 13674-87-8	9	942	7444	3.51214909176693	1	1	0.0693412894135144
TOXCAST_ACTIVE	ATG_Oct_MLP_CIS_up	4	33.3333333333333	0.0695855050622816	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	370	1723	3.1045045045045	1	1	0.0695855050622816
CTD_CHEMICALS_DISEASES	Spinocerebellar Ataxias	2	16.6666666666667	0.0709798977279731	13674-87-8, 79-94-7	7	104	8530	23.4340659340659	1	1	0.0709798977279731
CTD_CHEMICALS_DISEASES	Leukemia, Myeloid, Acute	3	25	0.0711880957448779	56803-37-3, 1330-78-5, 115-86-6	7	652	8530	5.60692375109553	1	1	0.0711880957448779
CTD_CHEMICALS_DISEASES	Acute Lung Injury	3	25	0.0729564338542693	1241-94-7, 56803-37-3, 79-94-7	7	661	8530	5.53058137021828	1	1	0.0729564338542693
TOXCAST_ACTIVE	ATG_NFI_CIS_up	3	25	0.0835020597426603	1241-94-7, 13674-87-8, 79-94-7	6	175	1723	4.92285714285714	1	1	0.0835020597426603
TOXCAST_ACTIVE	BSK_KF3CT_TGFb1_down	3	25	0.0886898621774221	115-86-6, 13674-87-8, 79-94-7	6	181	1723	4.75966850828729	1	1	0.0886898621774221
CTD_CHEMICALS_DISEASES	Head and Neck Neoplasms	3	25	0.0932115852761932	13674-87-8, 78-30-8, 79-94-7	7	759	8530	4.81648785996612	1	1	0.0932115852761932
TOXCAST_ACTIVE	ATG_MRE_CIS_up	4	33.3333333333333	0.0955624198937236	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	418	1723	2.74800637958533	1	1	0.0955624198937236
MULTICASE_TOX_PREDICTION	Haptenation (DPRA, SH test)	2	16.6666666666667	0.100441529887252	78-30-8, 79-94-7	11	3178	8032	0.459522855998627	1	1	0.100441529887252
CTD_CHEMICALS_DISEASES	Neuroblastoma	3	25	0.103084274367938	56803-37-3, 1330-78-5, 13674-87-8	7	804	8530	4.54690831556503	1	1	0.103084274367938
CTD_CHEMICALS_DISEASES	Spinal Cord Injuries	3	25	0.103978064079227	1330-78-5, 13674-87-8, 79-94-7	7	808	8530	4.52439886845827	1	1	0.103978064079227
TOXCAST_ACTIVE	APR_HepG2_MitoticArrest_24h_up	3	25	0.103990816981376	115-86-6, 13674-87-8, 79-94-7	6	198	1723	4.3510101010101	1	1	0.103990816981376
TOXCAST_ACTIVE	BSK_LPS_IL1a_down	3	25	0.104917414409023	115-86-6, 13674-87-8, 79-94-7	6	199	1723	4.32914572864322	1	1	0.104917414409023
CTD_CHEMICALS_DISEASES	Carcinoma, Transitional Cell	3	25	0.105998495922242	1241-94-7, 115-86-6, 13674-87-8	7	817	8530	4.47455848924637	1	1	0.105998495922242
TOXCAST_ACTIVE	BSK_CASM3C_Thrombomodulin_up	3	25	0.111482406296331	115-86-6, 13674-87-8, 79-94-7	6	206	1723	4.18203883495146	1	1	0.111482406296331
CTD_CHEMICALS_DISEASES	Hepatitis, Chronic	3	25	0.114438124362943	115-86-6, 13674-87-8, 78-30-8	7	854	8530	4.28069588491134	1	1	0.114438124362943
TOXCAST_ACTIVE	ATG_Sp1_CIS_up	3	25	0.117216427015461	1241-94-7, 13674-87-8, 79-94-7	6	212	1723	4.06367924528302	1	1	0.117216427015461
TOXCAST_ACTIVE	ACEA_T47D_80hr_Negative	4	33.3333333333333	0.117945552783321	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	454	1723	2.53010279001468	1	1	0.117945552783321
TOXCAST_ACTIVE	APR_HepG2_OxidativeStress_24h_up	3	25	0.129961882916653	115-86-6, 13674-87-8, 79-94-7	6	225	1723	3.82888888888889	1	1	0.129961882916653
TOXCAST_ACTIVE	APR_HepG2_OxidativeStress_72h_up	3	25	0.138012485835892	115-86-6, 13674-87-8, 79-94-7	6	233	1723	3.69742489270386	1	1	0.138012485835892
CTD_CHEMICALS_DISEASES	Heart Failure, Diastolic	2	16.6666666666667	0.141435285980796	115-86-6, 13674-87-8	7	214	8530	11.388518024032	1	1	0.141435285980796
TOXCAST_ACTIVE	BSK_LPS_IL8_down	3	25	0.14209398605917	115-86-6, 13674-87-8, 79-94-7	6	237	1723	3.63502109704641	1	1	0.14209398605917
TOXCAST_ACTIVE	APR_HepG2_CellCycleArrest_72h_dn	3	25	0.14209398605917	115-86-6, 13674-87-8, 79-94-7	6	237	1723	3.63502109704641	1	1	0.14209398605917
CTD_CHEMICALS_DISEASES	Mammary Neoplasms, Animal	3	25	0.149635793996989	56803-37-3, 1330-78-5, 115-86-6	7	1000	8530	3.65571428571429	1	1	0.149635793996989
TOXCAST_ACTIVE	BSK_SAg_MCP1_down	3	25	0.158772654689096	115-86-6, 13674-87-8, 79-94-7	6	253	1723	3.40513833992095	1	1	0.158772654689096
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_PathologyClinical_ClinicalChemistry	3	25	0.158816668049812	1330-78-5, 115-96-8, 13674-87-8	4	250	990	2.97	1	1	0.158816668049812
CTD_CHEMICALS_DISEASES	Cocaine-Related Disorders	3	25	0.158980461851979	1241-94-7, 56803-37-3, 79-94-7	7	1037	8530	3.52527896404463	1	1	0.158980461851979
HTS_ACTIVE	antagonism_AR/partial	4	33.3333333333333	0.162322514675193	56803-37-3, 115-86-6, 68937-41-7, 13674-87-8	10	667	4173	2.50254872563718	1	1	0.162322514675193
CTD_CHEM2DISEASE	Nervous System Diseases	2	16.6666666666667	0.16578832159282	13674-87-8, 78-30-8	5	241	5441	9.03070539419087	1	1	0.16578832159282
TOXCAST_ACTIVE	BSK_3C_uPAR_down	3	25	0.167310664294066	115-86-6, 13674-87-8, 79-94-7	6	261	1723	3.3007662835249	1	1	0.167310664294066
TOXCAST_ACTIVE	ATG_BRE_CIS_up	3	25	0.169464633348553	1241-94-7, 115-86-6, 13674-87-8	6	263	1723	3.27566539923954	1	1	0.169464633348553
TOXCAST_ACTIVE	APR_HepG2_MitoticArrest_72h_up	3	25	0.171626165916457	115-86-6, 13674-87-8, 79-94-7	6	265	1723	3.25094339622642	1	1	0.171626165916457
CTD_CHEMICALS_DISEASES	Keloid	2	16.6666666666667	0.174956842551032	115-86-6, 13674-87-8	7	269	8530	9.06001062134891	1	1	0.174956842551032
CTD_CHEMICALS_DISEASES	Psoriasis	3	25	0.175492833125261	1241-94-7, 1330-78-5, 13674-87-8	7	1101	8530	3.32035811599844	1	1	0.175492833125261
TOXCAST_ACTIVE	BSK_SAg_IL8_down	3	25	0.177062362802015	115-86-6, 13674-87-8, 79-94-7	6	270	1723	3.19074074074074	1	1	0.177062362802015
TOXCAST_ACTIVE	BSK_SAg_CD69_down	3	25	0.177062362802015	115-86-6, 13674-87-8, 79-94-7	6	270	1723	3.19074074074074	1	1	0.177062362802015
TOXCAST_ACTIVE	BSK_3C_Vis_down	3	25	0.17815504073484	115-86-6, 13674-87-8, 79-94-7	6	271	1723	3.1789667896679	1	1	0.17815504073484
CTD_CHEMICALS_DISEASES	Thyroid Neoplasms	3	25	0.180999823066886	1241-94-7, 1330-78-5, 115-86-6	7	1122	8530	3.25821237585943	1	1	0.180999823066886
TOXCAST_ACTIVE	APR_HepG2_CellLoss_24h_dn	3	25	0.194751378593316	115-86-6, 13674-87-8, 79-94-7	6	286	1723	3.01223776223776	1	1	0.194751378593316
TOXCAST_ACTIVE	BSK_LPS_VCAM1_down	3	25	0.200364729395729	115-86-6, 13674-87-8, 79-94-7	6	291	1723	2.96048109965636	1	1	0.200364729395729
CTD_CHEMICALS_DISEASES	Hypogonadism	2	16.6666666666667	0.200398449863944	1330-78-5, 115-86-6	7	312	8530	7.81135531135531	1	1	0.200398449863944
TOXCAST_ACTIVE	BSK_SAg_CD38_down	3	25	0.20149199762262	115-86-6, 13674-87-8, 79-94-7	6	292	1723	2.95034246575342	1	1	0.20149199762262
TOXCAST_ACTIVE	BSK_SAg_Eselectin_down	3	25	0.20375102838341	115-86-6, 13674-87-8, 79-94-7	6	294	1723	2.93027210884354	1	1	0.20375102838341
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OrganWeight	3	25	0.205636309302958	1330-78-5, 115-96-8, 13674-87-8	4	289	990	2.56920415224914	1	1	0.205636309302958
CTD_CHEMICALS_DISEASES	Infertility, Male	3	25	0.206125013969929	115-86-6, 13674-87-8, 79-94-7	7	1216	8530	3.00634398496241	1	1	0.206125013969929
MULTICASE_TOX_PREDICTION	BSEP inhibition at 100uM	3	25	0.206319690745757	5436-43-1, 78-30-8, 79-94-7	11	3403	8032	0.643710095370395	1	1	0.206319690745757
TOXCAST_ACTIVE	NVS_ADME_hCYP2C19	3	25	0.212845191883873	115-86-6, 13674-87-8, 79-94-7	6	302	1723	2.85264900662252	1	1	0.212845191883873
TOXCAST_ACTIVE	BSK_hDFCGF_CollagenIII_down	3	25	0.213988281529482	115-86-6, 13674-87-8, 79-94-7	6	303	1723	2.84323432343234	1	1	0.213988281529482
CTD_CHEMICALS_DISEASES	Precancerous Conditions	3	25	0.222792806539573	1241-94-7, 115-86-6, 78-30-8	7	1277	8530	2.8627363239736	1	1	0.222792806539573
CTD_CHEMICALS_DISEASES	Ischemic Attack, Transient	2	16.6666666666667	0.224613869077806	1330-78-5, 79-94-7	7	354	8530	6.88458434221146	1	1	0.224613869077806
TOXCAST_ACTIVE	BSK_SAg_CD40_down	3	25	0.225492029754837	115-86-6, 13674-87-8, 79-94-7	6	313	1723	2.75239616613419	1	1	0.225492029754837
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_PathologyClinical	3	25	0.231200424644094	1330-78-5, 115-96-8, 13674-87-8	4	309	990	2.40291262135922	1	1	0.231200424644094
TOXCAST_ACTIVE	NVS_NR_hPR	2	16.6666666666667	0.233174867542205	13674-87-8, 79-94-7	6	89	1723	6.45318352059925	1	1	0.233174867542205
CTD_CHEMICALS_DISEASES	Nasopharyngeal Carcinoma	2	16.6666666666667	0.236490453729394	115-86-6, 13674-87-8	7	375	8530	6.49904761904762	1	1	0.236490453729394
HTS_ACTIVE	antagonism_GR	3	25	0.237263353771975	68937-41-7, 13674-87-8, 78-30-8	10	432	4173	2.89791666666667	1	1	0.237263353771975
CTD_CHEMICALS_DISEASES	Brain Ischemia	3	25	0.239698144481177	115-86-6, 13674-87-8, 78-30-8	7	1338	8530	2.73222293401666	1	1	0.239698144481177
CTD_CHEMICALS_DISEASES	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	2	16.6666666666667	0.241533801872871	78-30-8, 79-94-7	7	384	8530	6.34672619047619	1	1	0.241533801872871
TOXCAST_ACTIVE	BSK_CASM3C_Proliferation_down	3	25	0.244150496078093	115-86-6, 13674-87-8, 79-94-7	6	329	1723	2.61854103343465	1	1	0.244150496078093
CTD_CHEMICALS_DISEASES	Adenocarcinoma Of Esophagus	2	16.6666666666667	0.247104931728636	13674-87-8, 79-94-7	7	394	8530	6.18564176939811	1	1	0.247104931728636
TOXCAST_ACTIVE	BSK_BE3C_MMP1_up	2	16.6666666666667	0.279024124287506	115-86-6, 13674-87-8	6	109	1723	5.26911314984709	1	1	0.279024124287506
CTD_CHEMICALS_DISEASES	Nervous System Diseases	3	25	0.286887550236254	1330-78-5, 78-30-8, 79-94-7	7	1505	8530	2.42904603701946	1	1	0.286887550236254
MESH	Benzene Derivatives	3	25	0.291896008772812	5436-43-1, 78-30-8, 79-94-7	9	730	5450	2.48858447488584	1	1	0.291896008772812
TOXCAST_ACTIVE	ATG_PPRE_CIS_up	3	25	0.295491396951537	1241-94-7, 115-86-6, 79-94-7	6	372	1723	2.31586021505376	1	1	0.295491396951537
CTD_CHEMICALS_DISEASES	MELAS Syndrome	2	16.6666666666667	0.300965817617999	115-86-6, 13674-87-8	7	494	8530	4.93348756506651	1	1	0.300965817617999
CTD_CHEMICALS_DISEASES	Parkinson Disease	3	25	0.311242185238299	1330-78-5, 115-86-6, 78-30-8	7	1590	8530	2.29919137466307	1	1	0.311242185238299
HTS_ACTIVE	cytotoxicity_VDR/antagonism	3	25	0.315643197238987	68937-41-7, 78-30-8, 79-94-7	10	525	4173	2.38457142857143	1	1	0.315643197238987
TOXCAST_ACTIVE	ATG_AP_1_CIS_up	3	25	0.32099982906382	1241-94-7, 115-86-6, 13674-87-8	6	393	1723	2.19211195928753	1	1	0.32099982906382
CTD_CHEMICALS_DISEASES	Drug-Related Side Effects and Adverse Reactions	3	25	0.323321912493274	1241-94-7, 78-30-8, 79-94-7	7	1632	8530	2.24002100840336	1	1	0.323321912493274
TOXCAST_ACTIVE	BSK_3C_Proliferation_down	3	25	0.333207162403635	115-86-6, 13674-87-8, 79-94-7	6	403	1723	2.13771712158809	1	1	0.333207162403635
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_viability	2	16.6666666666667	0.351917187582206	115-86-6, 13674-87-8	6	143	1723	4.01631701631702	1	1	0.351917187582206
CTD_CHEMICALS_DISEASES	Poisoning	2	16.6666666666667	0.352556917941376	1330-78-5, 115-86-6	7	596	8530	4.08916586768936	1	1	0.352556917941376
CTD_CHEMICALS_DISEASES	Carcinoma, Hepatocellular	4	33.3333333333333	0.361646452376679	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	2428	8530	2.00753118380795	1	1	0.361646452376679
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_Endocrine_AdrenalGland	2	16.6666666666667	0.362911670133212	1330-78-5, 13674-87-8	4	138	990	3.58695652173913	1	1	0.362911670133212
TOXCAST_ACTIVE	Tox21_GR_BLA_Antagonist_ratio	2	16.6666666666667	0.364144823383783	13674-87-8, 79-94-7	6	149	1723	3.85458612975391	1	1	0.364144823383783
CTD_CHEMICALS_DISEASES	Astrocytoma	2	16.6666666666667	0.368552340616424	13674-87-8, 79-94-7	7	629	8530	3.87463093345446	1	1	0.368552340616424
CTD_CHEMICALS_DISEASES	Breast Neoplasms	4	33.3333333333333	0.368996149713612	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	7	2515	8530	1.93808577108776	1	1	0.368996149713612
CTD_CHEMICALS_DISEASES	Turner Syndrome	2	16.6666666666667	0.369031860418513	115-86-6, 13674-87-8	7	630	8530	3.86848072562358	1	1	0.369031860418513
CTD_CHEMICALS_DISEASES	Hepatitis, Alcoholic	2	16.6666666666667	0.36998998969574	1330-78-5, 79-94-7	7	632	8530	3.85623869801085	1	1	0.36998998969574
TOXCAST_ACTIVE	OT_NURR1_NURR1RXRa_0480	2	16.6666666666667	0.376187195882305	1330-78-5, 79-94-7	6	155	1723	3.70537634408602	1	1	0.376187195882305
CTD_CHEMICALS_DISEASES	Hepatolenticular Degeneration	2	16.6666666666667	0.379977362090905	115-86-6, 13674-87-8	7	653	8530	3.73222489608401	1	1	0.379977362090905
CTD_CHEMICALS_DISEASES	Atrial Fibrillation	2	16.6666666666667	0.395867531775013	13674-87-8, 79-94-7	7	687	8530	3.54751507589935	1	1	0.395867531775013
CTD_CHEMICALS_DISEASES	Oral Submucous Fibrosis	2	16.6666666666667	0.39679157595159	115-86-6, 13674-87-8	7	689	8530	3.53721749948165	1	1	0.39679157595159
CTD_CHEMICALS_DISEASES	Barrett Esophagus	2	16.6666666666667	0.404141618547843	115-86-6, 13674-87-8	7	705	8530	3.45694022289767	1	1	0.404141618547843
TOXCAST_ACTIVE	NVS_ADME_hCYP2C9	2	16.6666666666667	0.418791508653114	13674-87-8, 79-94-7	6	177	1723	3.24482109227872	1	1	0.418791508653114
CTD_CHEMICALS_DISEASES	Diabetic Neuropathies	2	16.6666666666667	0.452254872364896	115-86-6, 78-30-8	7	814	8530	2.99403299403299	1	1	0.452254872364896
CTD_CHEMICALS_DISEASES	Neoplasm Recurrence, Local	2	16.6666666666667	0.466582465482814	115-86-6, 78-30-8	7	848	8530	2.87398921832884	1	1	0.466582465482814
CTD_CHEMICALS_DISEASES	Liver Cirrhosis, Biliary	2	16.6666666666667	0.471977463300078	13674-87-8, 79-94-7	7	861	8530	2.8305956528953	1	1	0.471977463300078
CTD_CHEM2DISEASE	Drug-Induced Liver Injury	2	16.6666666666667	0.487000843471952	13674-87-8, 79-94-7	5	836	5441	2.60334928229665	1	1	0.487000843471952
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
TOXCAST_ACTIVE	ATG_RORE_CIS_up	2	16.6666666666667	0.505346173221334	13674-87-8, 79-94-7	6	226	1723	2.54129793510324	1	1	0.505346173221334
CTD_CHEMICALS_DISEASES	Peripheral Nervous System Diseases	2	16.6666666666667	0.513523413238507	78-30-8, 79-94-7	7	965	8530	2.52553663952628	1	1	0.513523413238507
CTD_CHEMICALS_DISEASES	Liver Cirrhosis, Alcoholic	2	16.6666666666667	0.513909250584254	115-86-6, 78-30-8	7	966	8530	2.52292221236321	1	1	0.513909250584254
TOXCAST_ACTIVE	NVS_NR_hGR	2	16.6666666666667	0.518440181524237	13674-87-8, 79-94-7	6	234	1723	2.45441595441595	1	1	0.518440181524237
TOXREFDB	CHR_rat_DevelopmentalReproductive	2	16.6666666666667	0.520670976620633	1330-78-5, 13674-87-8	4	215	990	2.30232558139535	1	1	0.520670976620633
TOXCAST_ACTIVE	Tox21_AR_LUC_MDAKB2_Antagonist	2	16.6666666666667	0.532837947610633	13674-87-8, 79-94-7	6	243	1723	2.36351165980796	1	1	0.532837947610633
CTD_CHEMICALS_DISEASES	Endometriosis	2	16.6666666666667	0.56966860756162	1330-78-5, 13674-87-8	7	1118	8530	2.17991311014567	1	1	0.56966860756162
TOXCAST_ACTIVE	BSK_hDFCGF_VCAM1_down	2	16.6666666666667	0.572507565385541	13674-87-8, 79-94-7	6	269	1723	2.13506815365551	1	1	0.572507565385541
TOXCAST_ACTIVE	ATG_CRE_CIS_up	2	16.6666666666667	0.581267367203751	13674-87-8, 79-94-7	6	275	1723	2.08848484848485	1	1	0.581267367203751
TOXCAST_ACTIVE	BSK_SAg_Proliferation_down	3	25	0.599547044990745	115-86-6, 13674-87-8, 79-94-7	6	415	1723	2.07590361445783	1	1	0.599547044990745
TOXCAST_ACTIVE	APR_HepG2_CellLoss_72h_dn	3	25	0.603802407209328	115-86-6, 13674-87-8, 79-94-7	6	430	1723	2.00348837209302	1	1	0.603802407209328
TOXCAST_ACTIVE	BSK_hDFCGF_Proliferation_down	3	25	0.604732306250773	115-86-6, 13674-87-8, 79-94-7	6	433	1723	1.98960739030023	1	1	0.604732306250773
TOXCAST_ACTIVE	Tox21_TR_LUC_GH3_Antagonist	3	25	0.610467510819369	1241-94-7, 13674-87-8, 79-94-7	6	450	1723	1.91444444444444	1	1	0.610467510819369
MESH	Hydrocarbons, Aromatic	3	25	0.640282750789173	5436-43-1, 78-30-8, 79-94-7	9	978	5450	1.85753237900477	1	1	0.640282750789173
HTS_ACTIVE	cytotoxicity_VDR/agonism	3	25	0.653846214452603	5436-43-1, 78-30-8, 79-94-7	10	705	4173	1.77574468085106	1	1	0.653846214452603
TOXCAST_ACTIVE	ATG_ERE_CIS_up	3	25	0.661896834740386	1241-94-7, 1330-78-5, 115-86-6	6	559	1723	1.54114490161002	1	1	0.661896834740386
MESH	Hydrocarbons, Cyclic	3	25	0.66784490387594	5436-43-1, 78-30-8, 79-94-7	9	1105	5450	1.64404223227753	1	1	0.66784490387594
LEADSCOPE_TOXICITY	Reproductive Toxicity-cell transformation	5	41.6666666666667	0.720812771060649	1330-78-5, 115-86-6, 13674-87-8, 5436-43-1, 78-30-8	9	2966	7444	1.39432082115831	1	1	0.720812771060649
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro other cells	5	41.6666666666667	0.722334473944609	1241-94-7, 115-86-6, 29761-21-5, 13674-87-8, 78-30-8	9	3012	7444	1.37302641286705	1	1	0.722334473944609
TOXCAST_ACTIVE	Tox21_Aromatase_Inhibition	2	16.6666666666667	1	13674-87-8, 79-94-7	6	382	1723	1.50349040139616	1	1	1
CTD_CHEMICALS_DISEASES	Liver Diseases	2	16.6666666666667	1	1330-78-5, 79-94-7	7	1373	8530	1.77504942253668	1	1	1
CTD_CHEMICALS_DISEASES	Liver Neoplasms, Experimental	2	16.6666666666667	1	115-86-6, 78-30-8	7	1457	8530	1.67271301107952	1	1	1
TOXCAST_ACTIVE	Tox21_ERa_BLA_Antagonist_ratio	2	16.6666666666667	1	13674-87-8, 79-94-7	6	314	1723	1.82908704883227	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	505	990	1.47029702970297	1	1	1
TOXCAST_ACTIVE	ATG_NRF2_ARE_CIS_up	3	25	1	1241-94-7, 115-86-6, 79-94-7	6	747	1723	1.15327978580991	1	1	1
CTD_CHEMICALS_DISEASES	Stomach Neoplasms	2	16.6666666666667	1	1330-78-5, 13674-87-8	7	1974	8530	1.23462150817774	1	1	1
CTD_CHEMICALS_DISEASES	Heart Failure	2	16.6666666666667	1	13674-87-8, 78-30-8	7	1460	8530	1.6692759295499	1	1	1
CTD_CHEMICALS_DISEASES	Hypertension	3	25	1	1241-94-7, 56803-37-3, 115-86-6	7	2494	8530	1.46580364302898	1	1	1
MESH	Hydrocarbons	3	25	1	5436-43-1, 78-30-8, 79-94-7	9	1471	5450	1.23498753682302	1	1	1
TOXPRINT_STRUCTURE	bond:X[any]_halide	4	33.3333333333333	1	115-96-8, 13674-87-8, 5436-43-1, 79-94-7	11	2431	8337	1.24707378183314	1	1	1
HTS_ACTIVE	antagonism_AR/full/run1	2	16.6666666666667	1	13674-87-8, 79-94-7	10	491	4173	1.69979633401222	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	551	990	1.3475499092559	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	529	990	1.40359168241966	1	1	1
CTD_CHEMICALS_DISEASES	Cardiomegaly	2	16.6666666666667	1	1330-78-5, 115-86-6	7	1263	8530	1.92964596765072	1	1	1

Annotation Cluster 29	Enrichment Score: 0.798735322065636
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Amino Acid Metabolism, Inborn Errors	4	33.3333333333333	0.000100525141835556	56803-37-3, 115-86-6, 13674-87-8, 79-94-7	7	149	8530	32.7133269415149	1	0.0403105818760578	0.000100525141835556
HTS_ACTIVE	antagonism_AR/full/run2	7	58.3333333333333	0.00807576102378947	1241-94-7, 56803-37-3, 115-86-6, 68937-41-7, 13674-87-8, 5436-43-1, 78-30-8	10	1003	4173	2.9123629112662	1	1	0.00807576102378947
CTD_CHEMICALS_DISEASES	Heart Failure, Diastolic	2	16.6666666666667	0.141435285980796	115-86-6, 13674-87-8	7	214	8530	11.388518024032	1	1	0.141435285980796
HTS_ACTIVE	antagonism_AR/partial	4	33.3333333333333	0.162322514675193	56803-37-3, 115-86-6, 68937-41-7, 13674-87-8	10	667	4173	2.50254872563718	1	1	0.162322514675193
CTD_CHEMICALS_DISEASES	Keloid	2	16.6666666666667	0.174956842551032	115-86-6, 13674-87-8	7	269	8530	9.06001062134891	1	1	0.174956842551032
CTD_CHEMICALS_DISEASES	Amyloidosis	2	16.6666666666667	0.192776738182884	56803-37-3, 115-86-6	7	299	8530	8.15097945532728	1	1	0.192776738182884
CTD_CHEMICALS_DISEASES	Nasopharyngeal Carcinoma	2	16.6666666666667	0.236490453729394	115-86-6, 13674-87-8	7	375	8530	6.49904761904762	1	1	0.236490453729394
TOXCAST_ACTIVE	BSK_BE3C_MMP1_up	2	16.6666666666667	0.279024124287506	115-86-6, 13674-87-8	6	109	1723	5.26911314984709	1	1	0.279024124287506
CTD_CHEMICALS_DISEASES	MELAS Syndrome	2	16.6666666666667	0.300965817617999	115-86-6, 13674-87-8	7	494	8530	4.93348756506651	1	1	0.300965817617999
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_viability	2	16.6666666666667	0.351917187582206	115-86-6, 13674-87-8	6	143	1723	4.01631701631702	1	1	0.351917187582206
CTD_CHEMICALS_DISEASES	Turner Syndrome	2	16.6666666666667	0.369031860418513	115-86-6, 13674-87-8	7	630	8530	3.86848072562358	1	1	0.369031860418513
CTD_CHEMICALS_DISEASES	Hepatolenticular Degeneration	2	16.6666666666667	0.379977362090905	115-86-6, 13674-87-8	7	653	8530	3.73222489608401	1	1	0.379977362090905
CTD_CHEMICALS_DISEASES	Oral Submucous Fibrosis	2	16.6666666666667	0.39679157595159	115-86-6, 13674-87-8	7	689	8530	3.53721749948165	1	1	0.39679157595159
CTD_CHEMICALS_DISEASES	Barrett Esophagus	2	16.6666666666667	0.404141618547843	115-86-6, 13674-87-8	7	705	8530	3.45694022289767	1	1	0.404141618547843
CTD_CHEMICALS_DISEASES	Hernia, Diaphragmatic	2	16.6666666666667	0.444971700580699	56803-37-3, 13674-87-8	7	797	8530	3.05789568022943	1	1	0.444971700580699
CTD_CHEMICALS_DISEASES	Dermatitis, Contact	2	16.6666666666667	0.600421533481959	56803-37-3, 13674-87-8	7	1209	8530	2.01583362873685	1	1	0.600421533481959
CTD_CHEMICALS_DISEASES	Obesity	2	16.6666666666667	1	56803-37-3, 115-86-6	7	2317	8530	1.05185276527529	1	1	1

Annotation Cluster 30	Enrichment Score: 0.780358648456556
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
MULTICASE_TOX_PREDICTION	Draize skin test, 24h, rabbit	10	83.3333333333333	0.00738941398488533	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8, 79-94-7	11	3682	8032	1.98311194508913	1	1	0.00738941398488533
MULTICASE_TOX_PREDICTION	MCT1 inhibition at 10uM	11	91.6666666666667	0.617041048684598	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 5436-43-1, 78-30-8, 79-94-7	11	7105	8032	1.13047149894441	1	1	0.617041048684598
MULTICASE_TOX_PREDICTION	MRP5 inhibition at 50uM	11	91.6666666666667	1	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 115-96-8, 29761-21-5, 68937-41-7, 13674-87-8, 5436-43-1, 78-30-8, 79-94-7	11	7642	8032	1.0510337607956	1	1	1

Annotation Cluster 31	Enrichment Score: 0.778096228475843
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Amyotrophic Lateral Sclerosis	4	33.3333333333333	0.00644174598842861	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	619	8530	7.87445188091392	1	1	0.00644174598842861
CTD_CHEMICALS_DISEASES	Arsenic Poisoning	4	33.3333333333333	0.0105298959712323	1241-94-7, 13674-87-8, 78-30-8, 79-94-7	7	737	8530	6.61368482264005	1	1	0.0105298959712323
CTD_CHEMICALS_DISEASES	Mesothelioma	4	33.3333333333333	0.0208934792889723	1241-94-7, 115-86-6, 13674-87-8, 78-30-8	7	944	8530	5.1634382566586	1	1	0.0208934792889723
CTD_CHEMICALS_DISEASES	Squamous Cell Carcinoma of Head and Neck	4	33.3333333333333	0.0265597336081754	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1031	8530	4.727726202023	1	1	0.0265597336081754
CTD_CHEMICALS_DISEASES	Osteosarcoma	4	33.3333333333333	0.0356310624676759	1241-94-7, 56803-37-3, 13674-87-8, 78-30-8	7	1150	8530	4.23850931677019	1	1	0.0356310624676759
CTD_CHEMICALS_DISEASES	Atherosclerosis	4	33.3333333333333	0.0454045866275776	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	1260	8530	3.86848072562358	1	1	0.0454045866275776
CTD_CHEMICALS_DISEASES	Hemangiosarcoma	3	25	0.0457353667985919	1241-94-7, 1330-78-5, 78-30-8	7	511	8530	7.15403969807101	1	1	0.0457353667985919
CTD_CHEMICALS_DISEASES	Colorectal Neoplasms	4	33.3333333333333	0.0813757801662513	1241-94-7, 56803-37-3, 1330-78-5, 78-30-8	7	1579	8530	3.08694472089026	1	1	0.0813757801662513
MULTICASE_TOX_PREDICTION	Extent of human metabolism, %	3	25	0.111262172508268	1241-94-7, 5436-43-1, 78-30-8	11	3877	8032	0.565010434497151	1	1	0.111262172508268
CTD_CHEMICALS_DISEASES	Osteoarthritis	3	25	0.134343303374012	1241-94-7, 56803-37-3, 78-30-8	7	938	8530	3.89734998477003	1	1	0.134343303374012
CTD_CHEMICALS_DISEASES	Esophageal Neoplasms	3	25	0.157962798549802	1241-94-7, 1330-78-5, 78-30-8	7	1033	8530	3.53892960862951	1	1	0.157962798549802
CTD_CHEMICALS_DISEASES	Carcinoma, Renal Cell	3	25	0.172365007888314	1241-94-7, 1330-78-5, 78-30-8	7	1089	8530	3.35694608421881	1	1	0.172365007888314
MULTICASE_TOX_PREDICTION	BCRP substrates	2	16.6666666666667	0.179826247936711	5436-43-1, 78-30-8	11	2723	8032	0.536306880779889	1	1	0.179826247936711
MULTICASE_TOX_PREDICTION	MRP4 inhibition at 50uM	2	16.6666666666667	0.186253666882446	5436-43-1, 78-30-8	11	2532	8032	0.576762889559098	1	1	0.186253666882446
MULTICASE_TOX_PREDICTION	Sensory irritation, mouse	3	25	0.20260735466091	1241-94-7, 29761-21-5, 5436-43-1	11	3493	8032	0.627124378627385	1	1	0.20260735466091
MULTICASE_TOX_PREDICTION	BSEP inhibition at 100uM	3	25	0.206319690745757	5436-43-1, 78-30-8, 79-94-7	11	3403	8032	0.643710095370395	1	1	0.206319690745757
CTD_CHEMICALS_DISEASES	Nerve Degeneration	3	25	0.212379150477592	1241-94-7, 56803-37-3, 78-30-8	7	1239	8530	2.95053614666205	1	1	0.212379150477592
CTD_CHEMICALS_DISEASES	Precancerous Conditions	3	25	0.222792806539573	1241-94-7, 115-86-6, 78-30-8	7	1277	8530	2.8627363239736	1	1	0.222792806539573
CTD_CHEMICALS_DISEASES	Fatty Liver	3	25	0.270376479692687	1241-94-7, 56803-37-3, 78-30-8	7	1447	8530	2.5264093197749	1	1	0.270376479692687
MESH	Benzene Derivatives	3	25	0.291896008772812	5436-43-1, 78-30-8, 79-94-7	9	730	5450	2.48858447488584	1	1	0.291896008772812
CTD_CHEMICALS_DISEASES	Drug-Related Side Effects and Adverse Reactions	3	25	0.323321912493274	1241-94-7, 78-30-8, 79-94-7	7	1632	8530	2.24002100840336	1	1	0.323321912493274
MESH	Phenols	2	16.6666666666667	0.34033986052226	5436-43-1, 78-30-8	9	276	5450	4.38808373590982	1	1	0.34033986052226
CTD_CHEMICALS_DISEASES	Intestinal Neoplasms	2	16.6666666666667	0.346657330279633	1241-94-7, 78-30-8	7	584	8530	4.17318982387475	1	1	0.346657330279633
CTD_CHEMICALS_DISEASES	Diabetic Nephropathies	2	16.6666666666667	0.468247334634412	1241-94-7, 78-30-8	7	852	8530	2.86049631120054	1	1	0.468247334634412
CTD_CHEMICALS_DISEASES	Esophageal Squamous Cell Carcinoma	2	16.6666666666667	0.526876846567641	1241-94-7, 78-30-8	7	1000	8530	2.43714285714286	1	1	0.526876846567641
CTD_CHEMICALS_DISEASES	Infertility, Female	2	16.6666666666667	0.596474298135886	1241-94-7, 78-30-8	7	1197	8530	2.03604248717031	1	1	0.596474298135886
MESH	Hydrocarbons, Aromatic	3	25	0.640282750789173	5436-43-1, 78-30-8, 79-94-7	9	978	5450	1.85753237900477	1	1	0.640282750789173
HTS_ACTIVE	cytotoxicity_VDR/agonism	3	25	0.653846214452603	5436-43-1, 78-30-8, 79-94-7	10	705	4173	1.77574468085106	1	1	0.653846214452603
MESH	Hydrocarbons, Cyclic	3	25	0.66784490387594	5436-43-1, 78-30-8, 79-94-7	9	1105	5450	1.64404223227753	1	1	0.66784490387594
MESH	Hydrocarbons	3	25	1	5436-43-1, 78-30-8, 79-94-7	9	1471	5450	1.23498753682302	1	1	1
CTD_CHEMICALS_DISEASES	Urinary Bladder Neoplasms	2	16.6666666666667	1	1241-94-7, 78-30-8	7	1748	8530	1.39424648577967	1	1	1

Annotation Cluster 32	Enrichment Score: 0.777668143483213
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Disorder of Sex Development, 46,XY	3	25	0.00150208046295306	1330-78-5, 115-86-6, 78-30-8	7	87	8530	42.0197044334975	1	0.587313461014645	0.00150208046295306
CTD_CHEMICALS_DISEASES	Mesothelioma	4	33.3333333333333	0.0208934792889723	1241-94-7, 115-86-6, 13674-87-8, 78-30-8	7	944	8530	5.1634382566586	1	1	0.0208934792889723
CTD_CHEMICALS_DISEASES	Hepatitis, Chronic	3	25	0.114438124362943	115-86-6, 13674-87-8, 78-30-8	7	854	8530	4.28069588491134	1	1	0.114438124362943
HTS_ACTIVE	agonism_ER/full	4	33.3333333333333	0.146359399606026	115-86-6, 68937-41-7, 5436-43-1, 78-30-8	10	637	4173	2.62040816326531	1	1	0.146359399606026
CTD_CHEMICALS_DISEASES	Precancerous Conditions	3	25	0.222792806539573	1241-94-7, 115-86-6, 78-30-8	7	1277	8530	2.8627363239736	1	1	0.222792806539573
CTD_CHEMICALS_DISEASES	Brain Ischemia	3	25	0.239698144481177	115-86-6, 13674-87-8, 78-30-8	7	1338	8530	2.73222293401666	1	1	0.239698144481177
CTD_CHEMICALS_DISEASES	Parkinson Disease	3	25	0.311242185238299	1330-78-5, 115-86-6, 78-30-8	7	1590	8530	2.29919137466307	1	1	0.311242185238299
CTD_CHEMICALS_DISEASES	Diabetic Neuropathies	2	16.6666666666667	0.452254872364896	115-86-6, 78-30-8	7	814	8530	2.99403299403299	1	1	0.452254872364896
CTD_CHEMICALS_DISEASES	Neoplasm Recurrence, Local	2	16.6666666666667	0.466582465482814	115-86-6, 78-30-8	7	848	8530	2.87398921832884	1	1	0.466582465482814
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
CTD_CHEMICALS_DISEASES	Liver Cirrhosis, Alcoholic	2	16.6666666666667	0.513909250584254	115-86-6, 78-30-8	7	966	8530	2.52292221236321	1	1	0.513909250584254
CTD_CHEMICALS_DISEASES	Liver Neoplasms, Experimental	2	16.6666666666667	1	115-86-6, 78-30-8	7	1457	8530	1.67271301107952	1	1	1

Annotation Cluster 33	Enrichment Score: 0.764807776347208
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Female Urogenital Diseases	4	33.3333333333333	0.000136197562539554	56803-37-3, 1330-78-5, 78-30-8, 79-94-7	7	165	8530	29.5411255411255	1	0.0543428274532821	0.000136197562539554
MESH	Polybrominated Biphenyls	2	16.6666666666667	0.00586025368309049	5436-43-1, 79-94-7	9	4	5450	302.777777777778	1	1	0.00586025368309049
CTD_CHEMICALS_DISEASES	Amyotrophic Lateral Sclerosis	4	33.3333333333333	0.00644174598842861	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	619	8530	7.87445188091392	1	1	0.00644174598842861
CTD_CHEMICALS_DISEASES	Arsenic Poisoning	4	33.3333333333333	0.0105298959712323	1241-94-7, 13674-87-8, 78-30-8, 79-94-7	7	737	8530	6.61368482264005	1	1	0.0105298959712323
CTD_CHEMICALS_DISEASES	Carcinoma, Pancreatic Ductal	3	25	0.0270105855108645	13674-87-8, 78-30-8, 79-94-7	7	385	8530	9.49536178107607	1	1	0.0270105855108645
MESH	Hydrocarbons, Brominated	2	16.6666666666667	0.0375576533289049	5436-43-1, 79-94-7	9	26	5450	46.5811965811966	1	1	0.0375576533289049
CTD_CHEMICALS_DISEASES	Atherosclerosis	4	33.3333333333333	0.0454045866275776	1241-94-7, 1330-78-5, 78-30-8, 79-94-7	7	1260	8530	3.86848072562358	1	1	0.0454045866275776
MESH	Biphenyl Compounds	2	16.6666666666667	0.0460473978270343	5436-43-1, 79-94-7	9	32	5450	37.8472222222222	1	1	0.0460473978270343
CTD_CHEMICALS_DISEASES	Recurrence	3	25	0.0490735368528514	1330-78-5, 78-30-8, 79-94-7	7	531	8530	6.88458434221146	1	1	0.0490735368528514
CTD_CHEMICALS_DISEASES	Head and Neck Neoplasms	3	25	0.0932115852761932	13674-87-8, 78-30-8, 79-94-7	7	759	8530	4.81648785996612	1	1	0.0932115852761932
HTS_ACTIVE	cytotoxicity_EndoRS/activation	4	33.3333333333333	0.0978606322006492	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	10	536	4173	3.11417910447761	1	1	0.0978606322006492
MULTICASE_TOX_PREDICTION	Haptenation (DPRA, SH test)	2	16.6666666666667	0.100441529887252	78-30-8, 79-94-7	11	3178	8032	0.459522855998627	1	1	0.100441529887252
MULTICASE_TOX_PREDICTION	Extent of human metabolism, %	3	25	0.111262172508268	1241-94-7, 5436-43-1, 78-30-8	11	3877	8032	0.565010434497151	1	1	0.111262172508268
MULTICASE_TOX_PREDICTION	Dendritic cell activation at 1mM (CD86, CD54)	3	25	0.123282273160931	56803-37-3, 5436-43-1, 79-94-7	11	3656	8032	0.599164511637159	1	1	0.123282273160931
HTS_ACTIVE	agonism_ER/full	4	33.3333333333333	0.146359399606026	115-86-6, 68937-41-7, 5436-43-1, 78-30-8	10	637	4173	2.62040816326531	1	1	0.146359399606026
HTS_ACTIVE	antagonism_PPARg	3	25	0.159848619306805	56803-37-3, 68937-41-7, 79-94-7	10	336	4173	3.72589285714286	1	1	0.159848619306805
HTS_ACTIVE	cytotoxicity_FXR/agonism	4	33.3333333333333	0.163409671041523	29761-21-5, 68937-41-7, 5436-43-1, 79-94-7	10	669	4173	2.49506726457399	1	1	0.163409671041523
MULTICASE_TOX_PREDICTION	BCRP substrates	2	16.6666666666667	0.179826247936711	5436-43-1, 78-30-8	11	2723	8032	0.536306880779889	1	1	0.179826247936711
MULTICASE_TOX_PREDICTION	MRP4 inhibition at 50uM	2	16.6666666666667	0.186253666882446	5436-43-1, 78-30-8	11	2532	8032	0.576762889559098	1	1	0.186253666882446
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_halo_phenol_ortho	2	16.6666666666667	0.19223474121131	5436-43-1, 79-94-7	11	176	8337	8.61260330578512	1	1	0.19223474121131
MULTICASE_TOX_PREDICTION	BSEP inhibition at 100uM	3	25	0.206319690745757	5436-43-1, 78-30-8, 79-94-7	11	3403	8032	0.643710095370395	1	1	0.206319690745757
MESH	Hydrocarbons, Halogenated	2	16.6666666666667	0.232258200971871	5436-43-1, 79-94-7	9	177	5450	6.84243565599498	1	1	0.232258200971871
HTS_ACTIVE	antagonism_GR	3	25	0.237263353771975	68937-41-7, 13674-87-8, 78-30-8	10	432	4173	2.89791666666667	1	1	0.237263353771975
CTD_CHEMICALS_DISEASES	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	2	16.6666666666667	0.241533801872871	78-30-8, 79-94-7	7	384	8530	6.34672619047619	1	1	0.241533801872871
TOXPRINT_STRUCTURE	chain:aromaticAlkane_Ph-C1_acyclic_connect_noDblBd	5	41.6666666666667	0.242452910245593	56803-37-3, 1330-78-5, 68937-41-7, 78-30-8, 79-94-7	11	1840	8337	2.05953557312253	1	1	0.242452910245593
CTD_CHEMICALS_DISEASES	Nervous System Diseases	3	25	0.286887550236254	1330-78-5, 78-30-8, 79-94-7	7	1505	8530	2.42904603701946	1	1	0.286887550236254
MESH	Benzene Derivatives	3	25	0.291896008772812	5436-43-1, 78-30-8, 79-94-7	9	730	5450	2.48858447488584	1	1	0.291896008772812
HTS_ACTIVE	cytotoxicity_VDR/antagonism	3	25	0.315643197238987	68937-41-7, 78-30-8, 79-94-7	10	525	4173	2.38457142857143	1	1	0.315643197238987
CTD_CHEMICALS_DISEASES	Drug-Related Side Effects and Adverse Reactions	3	25	0.323321912493274	1241-94-7, 78-30-8, 79-94-7	7	1632	8530	2.24002100840336	1	1	0.323321912493274
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_dihalo_benzene_(1_3-)	2	16.6666666666667	0.336578957897659	5436-43-1, 79-94-7	11	335	8337	4.52483039348711	1	1	0.336578957897659
MESH	Phenols	2	16.6666666666667	0.34033986052226	5436-43-1, 78-30-8	9	276	5450	4.38808373590982	1	1	0.34033986052226
HTS_ACTIVE	cytotoxicity_H2AX/activation	4	33.3333333333333	0.388814959402494	29761-21-5, 5436-43-1, 78-30-8, 79-94-7	10	808	4173	2.06584158415842	1	1	0.388814959402494
MULTICASE_TOX_PREDICTION	RCA fetal death, rat	2	16.6666666666667	0.470349043592985	5436-43-1, 79-94-7	11	1865	8032	0.783036802339751	1	1	0.470349043592985
CTD_CHEMICALS_DISEASES	Peripheral Nervous System Diseases	2	16.6666666666667	0.513523413238507	78-30-8, 79-94-7	7	965	8530	2.52553663952628	1	1	0.513523413238507
MULTICASE_TOX_PREDICTION	Human plasma protein binding, %bound	4	33.3333333333333	0.527352202944437	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	3622	8032	0.80638522162542	1	1	0.527352202944437
HTS_ACTIVE	cytotoxicity_NFkb/activation	2	16.6666666666667	0.568800583945383	68937-41-7, 79-94-7	10	372	4173	2.24354838709677	1	1	0.568800583945383
MESH	Hydrocarbons, Aromatic	3	25	0.640282750789173	5436-43-1, 78-30-8, 79-94-7	9	978	5450	1.85753237900477	1	1	0.640282750789173
HTS_ACTIVE	cytotoxicity_VDR/agonism	3	25	0.653846214452603	5436-43-1, 78-30-8, 79-94-7	10	705	4173	1.77574468085106	1	1	0.653846214452603
MESH	Hydrocarbons, Cyclic	3	25	0.66784490387594	5436-43-1, 78-30-8, 79-94-7	9	1105	5450	1.64404223227753	1	1	0.66784490387594
TOXPRINT_STRUCTURE	chain:aromaticAlkane_Ph-C1_acyclic_generic	5	41.6666666666667	0.736345331353075	56803-37-3, 1330-78-5, 68937-41-7, 78-30-8, 79-94-7	11	2695	8337	1.40613931523022	1	1	0.736345331353075
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_generic	2	16.6666666666667	1	5436-43-1, 79-94-7	11	1166	8337	1.30001559332606	1	1	1
MULTICASE_TOX_PREDICTION	NTCP substrates	2	16.6666666666667	1	5436-43-1, 79-94-7	11	1156	8032	1.26329034287512	1	1	1
TOXPRINT_STRUCTURE	bond:X[any]_halide	4	33.3333333333333	1	115-96-8, 13674-87-8, 5436-43-1, 79-94-7	11	2431	8337	1.24707378183314	1	1	1
HTS_ACTIVE	activation_AP1	2	16.6666666666667	1	29761-21-5, 78-30-8	10	583	4173	1.43156089193825	1	1	1
MESH	Hydrocarbons	3	25	1	5436-43-1, 78-30-8, 79-94-7	9	1471	5450	1.23498753682302	1	1	1
HTS_ACTIVE	cytotoxicity_PPARd/antagonism	2	16.6666666666667	1	68937-41-7, 78-30-8	10	587	4173	1.42180579216354	1	1	1

Annotation Cluster 34	Enrichment Score: 0.757693614230004
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Amino Acid Metabolism, Inborn Errors	4	33.3333333333333	0.000100525141835556	56803-37-3, 115-86-6, 13674-87-8, 79-94-7	7	149	8530	32.7133269415149	1	0.0403105818760578	0.000100525141835556
CTD_CHEMICALS_DISEASES	Lipodystrophy, Familial Partial	4	33.3333333333333	0.00029045031377117	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	213	8530	22.8839704896043	1	0.115308774567154	0.00029045031377117
CTD_CHEM2GENE_25	AR	4	33.3333333333333	0.000415679053734167	115-86-6, 115-96-8, 13674-87-8, 79-94-7	7	190	6732	20.2466165413534	1	0.163361868117527	0.000415679053734167
TOXCAST_ACTIVE	OT_AR_ARSRC1_0960	5	41.6666666666667	0.00100950823203153	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	212	1723	6.77279874213836	1	0.395727226956358	0.00100950823203153
CTD_CHEMICALS_DISEASES	Disorder of Sex Development, 46,XY	3	25	0.00150208046295306	1330-78-5, 115-86-6, 78-30-8	7	87	8530	42.0197044334975	1	0.587313461014645	0.00150208046295306
CTD_CHEMICALS_DISEASES	Mouth Neoplasms	5	41.6666666666667	0.00156396851130194	1241-94-7, 56803-37-3, 115-86-6, 13674-87-8, 79-94-7	7	902	8530	6.75483053531834	1	0.609947719407755	0.00156396851130194
TOXCAST_ACTIVE	ATG_GLI_CIS_up	4	33.3333333333333	0.00174289726900597	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	100	1723	11.4866666666667	1	0.677987037643323	0.00174289726900597
TOXCAST_ACTIVE	ATG_PXR_TRANS_up	6	50	0.00213268995856035	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 79-94-7	6	505	1723	3.41188118811881	1	0.827483703921416	0.00213268995856035
CTD_CHEMICALS_DISEASES	Lipoid congenital adrenal hyperplasia	3	25	0.00222115157849881	1330-78-5, 115-86-6, 79-94-7	7	106	8530	34.4878706199461	1	0.859585660879039	0.00222115157849881
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_0480	5	41.6666666666667	0.00568927368704165	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	331	1723	4.33786505538771	1	1	0.00568927368704165
MULTICASE_TOX_PREDICTION	Allergic contact dermatitis, guinea pig and human	2	16.6666666666667	0.00693590260561124	115-96-8, 13674-87-8	11	4433	8032	0.329430100691098	1	1	0.00693590260561124
CTD_CHEM2DISEASE	Edema, Cardiac	2	16.6666666666667	0.0087951828966421	115-86-6, 79-94-7	5	12	5441	181.366666666667	1	1	0.0087951828966421
TOXCAST_ACTIVE	ATG_NRF1_CIS_up	3	25	0.0100867459159611	1241-94-7, 13674-87-8, 79-94-7	6	57	1723	15.1140350877193	1	1	0.0100867459159611
CTD_CHEMICALS_DISEASES	Arsenic Poisoning	4	33.3333333333333	0.0105298959712323	1241-94-7, 13674-87-8, 78-30-8, 79-94-7	7	737	8530	6.61368482264005	1	1	0.0105298959712323
CTD_CHEM2DISEASE	Teratogenesis	2	16.6666666666667	0.0117139768575488	13674-87-8, 79-94-7	5	16	5441	136.025	1	1	0.0117139768575488
CTD_CHEMICALS_DISEASES	Metabolism, Inborn Errors	3	25	0.0124254744366084	1241-94-7, 56803-37-3, 115-86-6	7	256	8530	14.2801339285714	1	1	0.0124254744366084
TOXCAST_ACTIVE	ATG_TAL_CIS_up	3	25	0.015029803571089	1241-94-7, 115-86-6, 79-94-7	6	70	1723	12.3071428571429	1	1	0.015029803571089
TOXCAST_ACTIVE	ATG_HSE_CIS_up	4	33.3333333333333	0.0162350265450611	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	217	1723	5.29339477726574	1	1	0.0162350265450611
TOXCAST_ACTIVE	NVS_MP_rPBR	4	33.3333333333333	0.0166583393847118	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	219	1723	5.24505327245053	1	1	0.0166583393847118
TOXCAST_ACTIVE	NVS_MP_hPBR	4	33.3333333333333	0.0170883452769438	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	221	1723	5.19758672699849	1	1	0.0170883452769438
CTD_CHEMICALS_DISEASES	Mesothelioma	4	33.3333333333333	0.0208934792889723	1241-94-7, 115-86-6, 13674-87-8, 78-30-8	7	944	8530	5.1634382566586	1	1	0.0208934792889723
TOXCAST_ACTIVE	ATG_NURR1_TRANS_up	3	25	0.0238269019325617	1241-94-7, 115-86-6, 13674-87-8	6	89	1723	9.67977528089888	1	1	0.0238269019325617
TOXCAST_ACTIVE	ATG_Pax6_CIS_up	4	33.3333333333333	0.0249028500560272	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	253	1723	4.54018445322793	1	1	0.0249028500560272
CTD_CHEMICALS_DISEASES	Carcinoma, Ductal	3	25	0.0268788306795404	1241-94-7, 13674-87-8, 79-94-7	7	384	8530	9.52008928571428	1	1	0.0268788306795404
CTD_CHEMICALS_DISEASES	Carcinoma, Pancreatic Ductal	3	25	0.0270105855108645	13674-87-8, 78-30-8, 79-94-7	7	385	8530	9.49536178107607	1	1	0.0270105855108645
TOXCAST_ACTIVE	ATG_VDRE_CIS_up	5	41.6666666666667	0.0295241637447702	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	512	1723	2.80436197916667	1	1	0.0295241637447702
TOXCAST_ACTIVE	ATG_PPARg_TRANS_up	5	41.6666666666667	0.0297380450297806	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	513	1723	2.79889538661468	1	1	0.0297380450297806
TOXCAST_ACTIVE	ATG_Myc_CIS_up	3	25	0.032009704727301	1241-94-7, 13674-87-8, 79-94-7	6	104	1723	8.28365384615385	1	1	0.032009704727301
TOXCAST_ACTIVE	ATG_EGR_CIS_up	4	33.3333333333333	0.0338900667088663	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	283	1723	4.05889281507656	1	1	0.0338900667088663
CTD_CHEMICALS_DISEASES	Epilepsy, Frontal Lobe	2	16.6666666666667	0.0346686253616941	115-86-6, 79-94-7	7	50	8530	48.7428571428571	1	1	0.0346686253616941
TOXCAST_ACTIVE	ATG_Xbp1_CIS_up	4	33.3333333333333	0.0379515964026503	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	295	1723	3.89378531073446	1	1	0.0379515964026503
CTD_CHEMICALS_DISEASES	Protoporphyria, Erythropoietic	2	16.6666666666667	0.0387606925026053	13674-87-8, 79-94-7	7	56	8530	43.5204081632653	1	1	0.0387606925026053
CTD_CHEMICALS_DISEASES	Prostate cancer, familial	3	25	0.0402822347157824	1330-78-5, 115-86-6, 13674-87-8	7	477	8530	7.66397124887691	1	1	0.0402822347157824
CTD_CHEMICALS_DISEASES	Adrenocortical Carcinoma	3	25	0.0413816771691881	1241-94-7, 115-86-6, 79-94-7	7	484	8530	7.55312868949233	1	1	0.0413816771691881
CTD_CHEMICALS_DISEASES	Recurrence	3	25	0.0490735368528514	1330-78-5, 78-30-8, 79-94-7	7	531	8530	6.88458434221146	1	1	0.0490735368528514
CTD_CHEMICALS_DISEASES	Gallbladder Neoplasms	3	25	0.0499228202390836	1241-94-7, 1330-78-5, 79-94-7	7	536	8530	6.82036247334755	1	1	0.0499228202390836
TOXINS_TARGETS	BE0000132	2	16.6666666666667	0.0514204545454545	115-96-8, 79-94-7	2	181	3520	19.4475138121547	1	1	0.0514204545454545
TOXCAST_ACTIVE	ATG_TA_CIS_up	3	25	0.0520782531109114	1241-94-7, 115-86-6, 79-94-7	6	135	1723	6.38148148148148	1	1	0.0520782531109114
TOXCAST_ACTIVE	ATG_SREBP_CIS_up	4	33.3333333333333	0.0543256667044474	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	337	1723	3.40850642927794	1	1	0.0543256667044474
TOXCAST_ACTIVE	ATG_CMV_CIS_up	4	33.3333333333333	0.0605405838861071	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	351	1723	3.27255460588794	1	1	0.0605405838861071
CTD_CHEMICALS_DISEASES	Carotid Artery Diseases	3	25	0.0607423904090286	1241-94-7, 1330-78-5, 115-86-6	7	597	8530	6.12347451543431	1	1	0.0607423904090286
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_1440	3	25	0.0624173669639862	1241-94-7, 1330-78-5, 13674-87-8	6	149	1723	5.78187919463087	1	1	0.0624173669639862
TOXCAST_ACTIVE	ATG_PXRE_CIS_up	6	50	0.0624572884773724	1241-94-7, 1330-78-5, 115-86-6, 115-96-8, 13674-87-8, 79-94-7	6	881	1723	1.95573212258797	1	1	0.0624572884773724
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_ratio	4	33.3333333333333	0.0676228400695797	1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	366	1723	3.1384335154827	1	1	0.0676228400695797
LEADSCOPE_TOXICITY	Genetic Toxicity -s. cerevisiae	4	33.3333333333333	0.0693412894135144	1330-78-5, 115-86-6, 115-96-8, 13674-87-8	9	942	7444	3.51214909176693	1	1	0.0693412894135144
TOXCAST_ACTIVE	ATG_Oct_MLP_CIS_up	4	33.3333333333333	0.0695855050622816	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	370	1723	3.1045045045045	1	1	0.0695855050622816
CTD_CHEMICALS_DISEASES	Spinocerebellar Ataxias	2	16.6666666666667	0.0709798977279731	13674-87-8, 79-94-7	7	104	8530	23.4340659340659	1	1	0.0709798977279731
CTD_CHEMICALS_DISEASES	Leukemia, Myeloid, Acute	3	25	0.0711880957448779	56803-37-3, 1330-78-5, 115-86-6	7	652	8530	5.60692375109553	1	1	0.0711880957448779
CTD_CHEMICALS_DISEASES	Acute Lung Injury	3	25	0.0729564338542693	1241-94-7, 56803-37-3, 79-94-7	7	661	8530	5.53058137021828	1	1	0.0729564338542693
TOXCAST_ACTIVE	ATG_NFI_CIS_up	3	25	0.0835020597426603	1241-94-7, 13674-87-8, 79-94-7	6	175	1723	4.92285714285714	1	1	0.0835020597426603
CTD_CHEMICALS_DISEASES	Osteoarthritis, Hip	2	16.6666666666667	0.0874009986124082	56803-37-3, 79-94-7	7	129	8530	18.8925802879291	1	1	0.0874009986124082
TOXCAST_ACTIVE	BSK_KF3CT_TGFb1_down	3	25	0.0886898621774221	115-86-6, 13674-87-8, 79-94-7	6	181	1723	4.75966850828729	1	1	0.0886898621774221
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic_Urinary_Kidney	2	16.6666666666667	0.0911177473122021	115-96-8, 13674-87-8	4	31	990	15.9677419354839	1	1	0.0911177473122021
CTD_CHEMICALS_DISEASES	Head and Neck Neoplasms	3	25	0.0932115852761932	13674-87-8, 78-30-8, 79-94-7	7	759	8530	4.81648785996612	1	1	0.0932115852761932
TOXCAST_ACTIVE	ATG_MRE_CIS_up	4	33.3333333333333	0.0955624198937236	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	418	1723	2.74800637958533	1	1	0.0955624198937236
CTD_CHEMICALS_DISEASES	Chronobiology Disorders	2	16.6666666666667	0.100363072580886	1241-94-7, 79-94-7	7	149	8530	16.3566634707574	1	1	0.100363072580886
CTD_CHEMICALS_DISEASES	Spinal Cord Injuries	3	25	0.103978064079227	1330-78-5, 13674-87-8, 79-94-7	7	808	8530	4.52439886845827	1	1	0.103978064079227
TOXCAST_ACTIVE	APR_HepG2_MitoticArrest_24h_up	3	25	0.103990816981376	115-86-6, 13674-87-8, 79-94-7	6	198	1723	4.3510101010101	1	1	0.103990816981376
TOXCAST_ACTIVE	BSK_LPS_IL1a_down	3	25	0.104917414409023	115-86-6, 13674-87-8, 79-94-7	6	199	1723	4.32914572864322	1	1	0.104917414409023
CTD_CHEMICALS_DISEASES	Carcinoma, Transitional Cell	3	25	0.105998495922242	1241-94-7, 115-86-6, 13674-87-8	7	817	8530	4.47455848924637	1	1	0.105998495922242
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-Cl_ethyl	2	16.6666666666667	0.106169126109407	115-96-8, 13674-87-8	11	93	8337	16.2991202346041	1	1	0.106169126109407
TOXCAST_ACTIVE	BSK_CASM3C_Thrombomodulin_up	3	25	0.111482406296331	115-86-6, 13674-87-8, 79-94-7	6	206	1723	4.18203883495146	1	1	0.111482406296331
CTD_CHEMICALS_DISEASES	Hepatitis, Chronic	3	25	0.114438124362943	115-86-6, 13674-87-8, 78-30-8	7	854	8530	4.28069588491134	1	1	0.114438124362943
CTD_CHEMICALS_DISEASES	Obesity, Morbid	2	16.6666666666667	0.114443786851688	1241-94-7, 79-94-7	7	171	8530	14.2522974101921	1	1	0.114443786851688
TOXCAST_ACTIVE	ATG_Sp1_CIS_up	3	25	0.117216427015461	1241-94-7, 13674-87-8, 79-94-7	6	212	1723	4.06367924528302	1	1	0.117216427015461
TOXCAST_ACTIVE	ACEA_T47D_80hr_Negative	4	33.3333333333333	0.117945552783321	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	6	454	1723	2.53010279001468	1	1	0.117945552783321
CTD_CHEM2DISEASE	Hemorrhage	2	16.6666666666667	0.129920333658279	115-96-8, 79-94-7	5	186	5441	11.7010752688172	1	1	0.129920333658279
TOXCAST_ACTIVE	APR_HepG2_OxidativeStress_24h_up	3	25	0.129961882916653	115-86-6, 13674-87-8, 79-94-7	6	225	1723	3.82888888888889	1	1	0.129961882916653
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic_Urinary	2	16.6666666666667	0.135900431677666	115-96-8, 13674-87-8	4	47	990	10.531914893617	1	1	0.135900431677666
TOXCAST_ACTIVE	APR_HepG2_OxidativeStress_72h_up	3	25	0.138012485835892	115-86-6, 13674-87-8, 79-94-7	6	233	1723	3.69742489270386	1	1	0.138012485835892
CTD_CHEMICALS_DISEASES	Heart Failure, Diastolic	2	16.6666666666667	0.141435285980796	115-86-6, 13674-87-8	7	214	8530	11.388518024032	1	1	0.141435285980796
TOXCAST_ACTIVE	BSK_LPS_IL8_down	3	25	0.14209398605917	115-86-6, 13674-87-8, 79-94-7	6	237	1723	3.63502109704641	1	1	0.14209398605917
TOXCAST_ACTIVE	APR_HepG2_CellCycleArrest_72h_dn	3	25	0.14209398605917	115-86-6, 13674-87-8, 79-94-7	6	237	1723	3.63502109704641	1	1	0.14209398605917
CTD_CHEMICALS_DISEASES	Mammary Neoplasms, Animal	3	25	0.149635793996989	56803-37-3, 1330-78-5, 115-86-6	7	1000	8530	3.65571428571429	1	1	0.149635793996989
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-X_ethyl	2	16.6666666666667	0.152770022025416	115-96-8, 13674-87-8	11	137	8337	11.0643662906437	1	1	0.152770022025416
TOXCAST_ACTIVE	BSK_SAg_MCP1_down	3	25	0.158772654689096	115-86-6, 13674-87-8, 79-94-7	6	253	1723	3.40513833992095	1	1	0.158772654689096
CTD_CHEMICALS_DISEASES	Cocaine-Related Disorders	3	25	0.158980461851979	1241-94-7, 56803-37-3, 79-94-7	7	1037	8530	3.52527896404463	1	1	0.158980461851979
HTS_ACTIVE	antagonism_AR/partial	4	33.3333333333333	0.162322514675193	56803-37-3, 115-86-6, 68937-41-7, 13674-87-8	10	667	4173	2.50254872563718	1	1	0.162322514675193
TOXCAST_ACTIVE	BSK_3C_uPAR_down	3	25	0.167310664294066	115-86-6, 13674-87-8, 79-94-7	6	261	1723	3.3007662835249	1	1	0.167310664294066
TOXCAST_ACTIVE	ATG_BRE_CIS_up	3	25	0.169464633348553	1241-94-7, 115-86-6, 13674-87-8	6	263	1723	3.27566539923954	1	1	0.169464633348553
CTD_CHEMICALS_DISEASES	Wilms Tumor	2	16.6666666666667	0.17014990382967	1241-94-7, 79-94-7	7	261	8530	9.33771209633279	1	1	0.17014990382967
TOXCAST_ACTIVE	APR_HepG2_MitoticArrest_72h_up	3	25	0.171626165916457	115-86-6, 13674-87-8, 79-94-7	6	265	1723	3.25094339622642	1	1	0.171626165916457
CTD_CHEMICALS_DISEASES	Keloid	2	16.6666666666667	0.174956842551032	115-86-6, 13674-87-8	7	269	8530	9.06001062134891	1	1	0.174956842551032
CTD_CHEMICALS_DISEASES	Psoriasis	3	25	0.175492833125261	1241-94-7, 1330-78-5, 13674-87-8	7	1101	8530	3.32035811599844	1	1	0.175492833125261
CTD_CHEMICALS_DISEASES	Penile Neoplasms	2	16.6666666666667	0.176753451764324	1241-94-7, 13674-87-8	7	272	8530	8.96008403361344	1	1	0.176753451764324
TOXCAST_ACTIVE	BSK_SAg_IL8_down	3	25	0.177062362802015	115-86-6, 13674-87-8, 79-94-7	6	270	1723	3.19074074074074	1	1	0.177062362802015
TOXCAST_ACTIVE	BSK_SAg_CD69_down	3	25	0.177062362802015	115-86-6, 13674-87-8, 79-94-7	6	270	1723	3.19074074074074	1	1	0.177062362802015
TOXCAST_ACTIVE	BSK_3C_Vis_down	3	25	0.17815504073484	115-86-6, 13674-87-8, 79-94-7	6	271	1723	3.1789667896679	1	1	0.17815504073484
CTD_CHEMICALS_DISEASES	Thyroid Neoplasms	3	25	0.180999823066886	1241-94-7, 1330-78-5, 115-86-6	7	1122	8530	3.25821237585943	1	1	0.180999823066886
CTD_CHEMICALS_DISEASES	Amyloidosis	2	16.6666666666667	0.192776738182884	56803-37-3, 115-86-6	7	299	8530	8.15097945532728	1	1	0.192776738182884
TOXCAST_ACTIVE	APR_HepG2_CellLoss_24h_dn	3	25	0.194751378593316	115-86-6, 13674-87-8, 79-94-7	6	286	1723	3.01223776223776	1	1	0.194751378593316
TOXCAST_ACTIVE	BSK_LPS_VCAM1_down	3	25	0.200364729395729	115-86-6, 13674-87-8, 79-94-7	6	291	1723	2.96048109965636	1	1	0.200364729395729
CTD_CHEMICALS_DISEASES	Hypogonadism	2	16.6666666666667	0.200398449863944	1330-78-5, 115-86-6	7	312	8530	7.81135531135531	1	1	0.200398449863944
TOXCAST_ACTIVE	BSK_SAg_CD38_down	3	25	0.20149199762262	115-86-6, 13674-87-8, 79-94-7	6	292	1723	2.95034246575342	1	1	0.20149199762262
TOXCAST_ACTIVE	BSK_SAg_Eselectin_down	3	25	0.20375102838341	115-86-6, 13674-87-8, 79-94-7	6	294	1723	2.93027210884354	1	1	0.20375102838341
CTD_CHEMICALS_DISEASES	Leukemia, Myelogenous, Chronic, BCR-ABL Positive	2	16.6666666666667	0.2050588554398	115-86-6, 79-94-7	7	320	8530	7.61607142857143	1	1	0.2050588554398
CTD_CHEMICALS_DISEASES	Infertility, Male	3	25	0.206125013969929	115-86-6, 13674-87-8, 79-94-7	7	1216	8530	3.00634398496241	1	1	0.206125013969929
TOXCAST_ACTIVE	NVS_ADME_hCYP2C19	3	25	0.212845191883873	115-86-6, 13674-87-8, 79-94-7	6	302	1723	2.85264900662252	1	1	0.212845191883873
TOXCAST_ACTIVE	BSK_hDFCGF_CollagenIII_down	3	25	0.213988281529482	115-86-6, 13674-87-8, 79-94-7	6	303	1723	2.84323432343234	1	1	0.213988281529482
CTD_CHEMICALS_DISEASES	Hypercholesterolemia	2	16.6666666666667	0.220049150648394	1241-94-7, 115-86-6	7	346	8530	7.04376548307184	1	1	0.220049150648394
CTD_CHEMICALS_DISEASES	Precancerous Conditions	3	25	0.222792806539573	1241-94-7, 115-86-6, 78-30-8	7	1277	8530	2.8627363239736	1	1	0.222792806539573
CTD_CHEMICALS_DISEASES	Ischemic Attack, Transient	2	16.6666666666667	0.224613869077806	1330-78-5, 79-94-7	7	354	8530	6.88458434221146	1	1	0.224613869077806
TOXCAST_ACTIVE	BSK_SAg_CD40_down	3	25	0.225492029754837	115-86-6, 13674-87-8, 79-94-7	6	313	1723	2.75239616613419	1	1	0.225492029754837
HTS_ACTIVE	inhibition_MMP	5	41.6666666666667	0.226067082555815	56803-37-3, 1330-78-5, 115-86-6, 5436-43-1, 79-94-7	10	967	4173	2.15770423991727	1	1	0.226067082555815
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-X_ethyl_generic	2	16.6666666666667	0.230985209585531	115-96-8, 13674-87-8	11	216	8337	7.01767676767677	1	1	0.230985209585531
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-X_primary	2	16.6666666666667	0.230985209585531	115-96-8, 13674-87-8	11	216	8337	7.01767676767677	1	1	0.230985209585531
TOXCAST_ACTIVE	NVS_NR_hPR	2	16.6666666666667	0.233174867542205	13674-87-8, 79-94-7	6	89	1723	6.45318352059925	1	1	0.233174867542205
CTD_CHEMICALS_DISEASES	Nasopharyngeal Carcinoma	2	16.6666666666667	0.236490453729394	115-86-6, 13674-87-8	7	375	8530	6.49904761904762	1	1	0.236490453729394
CTD_CHEMICALS_DISEASES	Brain Ischemia	3	25	0.239698144481177	115-86-6, 13674-87-8, 78-30-8	7	1338	8530	2.73222293401666	1	1	0.239698144481177
TOXCAST_ACTIVE	BSK_CASM3C_Proliferation_down	3	25	0.244150496078093	115-86-6, 13674-87-8, 79-94-7	6	329	1723	2.61854103343465	1	1	0.244150496078093
CTD_CHEMICALS_DISEASES	Adenocarcinoma Of Esophagus	2	16.6666666666667	0.247104931728636	13674-87-8, 79-94-7	7	394	8530	6.18564176939811	1	1	0.247104931728636
CTD_CHEMICALS_DISEASES	Small Cell Lung Carcinoma	2	16.6666666666667	0.260336659012762	1241-94-7, 79-94-7	7	418	8530	5.83048530416951	1	1	0.260336659012762
TOXCAST_ACTIVE	BSK_BE3C_MMP1_up	2	16.6666666666667	0.279024124287506	115-86-6, 13674-87-8	6	109	1723	5.26911314984709	1	1	0.279024124287506
CTD_CHEMICALS_DISEASES	Adenocarcinoma, Clear Cell	2	16.6666666666667	0.279285169693912	1241-94-7, 79-94-7	7	453	8530	5.38000630715862	1	1	0.279285169693912
CTD_CHEMICALS_DISEASES	Nervous System Diseases	3	25	0.286887550236254	1330-78-5, 78-30-8, 79-94-7	7	1505	8530	2.42904603701946	1	1	0.286887550236254
CTD_CHEMICALS_DISEASES	Protein Deficiency	2	16.6666666666667	0.291515409569286	115-86-6, 79-94-7	7	476	8530	5.12004801920768	1	1	0.291515409569286
TOXCAST_ACTIVE	ATG_PPRE_CIS_up	3	25	0.295491396951537	1241-94-7, 115-86-6, 79-94-7	6	372	1723	2.31586021505376	1	1	0.295491396951537
MULTICASE_TOX_PREDICTION	Dendritic cell activation at 100uM (CD86, CD54)	2	16.6666666666667	0.298766055395908	56803-37-3, 79-94-7	11	2369	8032	0.616447292681991	1	1	0.298766055395908
TOXCAST_ACTIVE	ATG_Sox_CIS_up	2	16.6666666666667	0.298927150920067	1241-94-7, 79-94-7	6	118	1723	4.86723163841808	1	1	0.298927150920067
MULTICASE_TOX_PREDICTION	OCT1 substrates	2	16.6666666666667	0.299222595537677	1241-94-7, 79-94-7	11	2407	8032	0.606715262303131	1	1	0.299222595537677
CTD_CHEMICALS_DISEASES	MELAS Syndrome	2	16.6666666666667	0.300965817617999	115-86-6, 13674-87-8	7	494	8530	4.93348756506651	1	1	0.300965817617999
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic_Endocrine	2	16.6666666666667	0.307475470266168	115-96-8, 13674-87-8	4	114	990	4.34210526315789	1	1	0.307475470266168
CTD_CHEMICALS_DISEASES	Parkinson Disease	3	25	0.311242185238299	1330-78-5, 115-86-6, 78-30-8	7	1590	8530	2.29919137466307	1	1	0.311242185238299
TOXCAST_ACTIVE	BSK_3C_MIG_down	2	16.6666666666667	0.311949823200549	115-86-6, 79-94-7	6	124	1723	4.63172043010753	1	1	0.311949823200549
TOXCAST_ACTIVE	ATG_AP_1_CIS_up	3	25	0.32099982906382	1241-94-7, 115-86-6, 13674-87-8	6	393	1723	2.19211195928753	1	1	0.32099982906382
CTD_CHEMICALS_DISEASES	Drug-Related Side Effects and Adverse Reactions	3	25	0.323321912493274	1241-94-7, 78-30-8, 79-94-7	7	1632	8530	2.24002100840336	1	1	0.323321912493274
TOXCAST_ACTIVE	BSK_3C_Proliferation_down	3	25	0.333207162403635	115-86-6, 13674-87-8, 79-94-7	6	403	1723	2.13771712158809	1	1	0.333207162403635
TOXCAST_ACTIVE	BSK_BE3C_IL1a_down	2	16.6666666666667	0.341584434709593	115-86-6, 79-94-7	6	138	1723	4.16183574879227	1	1	0.341584434709593
CTD_PATHWAY	KEGG:04080|Neuroactive ligand-receptor interaction	2	16.6666666666667	0.349689878138826	115-86-6, 79-94-7	3	745	3849	3.44429530201342	1	1	0.349689878138826
MULTICASE_TOX_PREDICTION	RCA sperm toxicity, mammal	2	16.6666666666667	0.350449353198351	115-96-8, 13674-87-8	11	339	8032	4.30785733440601	1	1	0.350449353198351
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_viability	2	16.6666666666667	0.351917187582206	115-86-6, 13674-87-8	6	143	1723	4.01631701631702	1	1	0.351917187582206
CTD_CHEMICALS_DISEASES	Poisoning	2	16.6666666666667	0.352556917941376	1330-78-5, 115-86-6	7	596	8530	4.08916586768936	1	1	0.352556917941376
HTS_ACTIVE	antagonism_FXR	2	16.6666666666667	0.356086652288895	56803-37-3, 79-94-7	10	199	4173	4.19396984924623	1	1	0.356086652288895
CTD_CHEMICALS_DISEASES	Carcinoma, Hepatocellular	4	33.3333333333333	0.361646452376679	1241-94-7, 56803-37-3, 115-86-6, 79-94-7	7	2428	8530	2.00753118380795	1	1	0.361646452376679
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_Endocrine_AdrenalGland	2	16.6666666666667	0.362911670133212	1330-78-5, 13674-87-8	4	138	990	3.58695652173913	1	1	0.362911670133212
TOXCAST_ACTIVE	Tox21_GR_BLA_Antagonist_ratio	2	16.6666666666667	0.364144823383783	13674-87-8, 79-94-7	6	149	1723	3.85458612975391	1	1	0.364144823383783
CTD_CHEM2DISEASE	Necrosis	2	16.6666666666667	0.366675567758732	115-96-8, 79-94-7	5	587	5441	3.7076660988075	1	1	0.366675567758732
CTD_CHEMICALS_DISEASES	Astrocytoma	2	16.6666666666667	0.368552340616424	13674-87-8, 79-94-7	7	629	8530	3.87463093345446	1	1	0.368552340616424
CTD_CHEMICALS_DISEASES	Breast Neoplasms	4	33.3333333333333	0.368996149713612	1241-94-7, 115-86-6, 13674-87-8, 79-94-7	7	2515	8530	1.93808577108776	1	1	0.368996149713612
CTD_CHEMICALS_DISEASES	Turner Syndrome	2	16.6666666666667	0.369031860418513	115-86-6, 13674-87-8	7	630	8530	3.86848072562358	1	1	0.369031860418513
CTD_CHEMICALS_DISEASES	Hepatitis, Alcoholic	2	16.6666666666667	0.36998998969574	1330-78-5, 79-94-7	7	632	8530	3.85623869801085	1	1	0.36998998969574
TOXCAST_ACTIVE	OT_NURR1_NURR1RXRa_0480	2	16.6666666666667	0.376187195882305	1330-78-5, 79-94-7	6	155	1723	3.70537634408602	1	1	0.376187195882305
CTD_CHEMICALS_DISEASES	Hepatolenticular Degeneration	2	16.6666666666667	0.379977362090905	115-86-6, 13674-87-8	7	653	8530	3.73222489608401	1	1	0.379977362090905
TOXCAST_ACTIVE	BSK_SAg_MIG_down	2	16.6666666666667	0.390005296619955	115-86-6, 79-94-7	6	162	1723	3.54526748971193	1	1	0.390005296619955
TOXCAST_ACTIVE	NVS_NR_hPPARg	2	16.6666666666667	0.391959155375176	115-86-6, 79-94-7	6	163	1723	3.52351738241309	1	1	0.391959155375176
CTD_CHEMICALS_DISEASES	Papilloma	2	16.6666666666667	0.392159549981154	1241-94-7, 79-94-7	7	679	8530	3.58931201346518	1	1	0.392159549981154
TOXCAST_ACTIVE	APR_HepG2_CellCycleArrest_24h_dn	2	16.6666666666667	0.393908004236153	115-86-6, 79-94-7	6	164	1723	3.5020325203252	1	1	0.393908004236153
CTD_CHEMICALS_DISEASES	Atrial Fibrillation	2	16.6666666666667	0.395867531775013	13674-87-8, 79-94-7	7	687	8530	3.54751507589935	1	1	0.395867531775013
CTD_CHEMICALS_DISEASES	Oral Submucous Fibrosis	2	16.6666666666667	0.39679157595159	115-86-6, 13674-87-8	7	689	8530	3.53721749948165	1	1	0.39679157595159
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OrganWeight_Urinary	2	16.6666666666667	0.400334454362979	115-96-8, 13674-87-8	4	155	990	3.19354838709677	1	1	0.400334454362979
CTD_CHEMICALS_DISEASES	Barrett Esophagus	2	16.6666666666667	0.404141618547843	115-86-6, 13674-87-8	7	705	8530	3.45694022289767	1	1	0.404141618547843
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations_Mortality	2	16.6666666666667	0.404638261708136	115-96-8, 13674-87-8	4	157	990	3.15286624203822	1	1	0.404638261708136
TOXCAST_ACTIVE	ATG_HIF1a_CIS_up	2	16.6666666666667	0.411223785361343	1241-94-7, 13674-87-8	6	173	1723	3.31984585741811	1	1	0.411223785361343
CTD_CHEMICALS_DISEASES	Hyperinsulinism	2	16.6666666666667	0.416375551539757	115-86-6, 79-94-7	7	732	8530	3.32943013270882	1	1	0.416375551539757
TOXCAST_ACTIVE	NVS_ADME_hCYP2C9	2	16.6666666666667	0.418791508653114	13674-87-8, 79-94-7	6	177	1723	3.24482109227872	1	1	0.418791508653114
CTD_CHEMICALS_DISEASES	Hernia, Diaphragmatic	2	16.6666666666667	0.444971700580699	56803-37-3, 13674-87-8	7	797	8530	3.05789568022943	1	1	0.444971700580699
TOXCAST_ACTIVE	APR_HepG2_p53Act_72h_up	2	16.6666666666667	0.451889505927514	115-86-6, 79-94-7	6	195	1723	2.94529914529915	1	1	0.451889505927514
TOXCAST_ACTIVE	BSK_KF3CT_TIMP2_down	2	16.6666666666667	0.455471918245153	115-86-6, 79-94-7	6	197	1723	2.91539763113367	1	1	0.455471918245153
TOXCAST_ACTIVE	BSK_3C_VCAM1_down	2	16.6666666666667	0.46961474351468	115-86-6, 79-94-7	6	205	1723	2.80162601626016	1	1	0.46961474351468
TOXCAST_ACTIVE	BSK_BE3C_PAI1_down	2	16.6666666666667	0.46961474351468	115-86-6, 79-94-7	6	205	1723	2.80162601626016	1	1	0.46961474351468
TOXCAST_ACTIVE	BSK_3C_TissueFactor_down	2	16.6666666666667	0.471361730525501	115-86-6, 79-94-7	6	206	1723	2.78802588996764	1	1	0.471361730525501
CTD_CHEMICALS_DISEASES	Liver Cirrhosis, Biliary	2	16.6666666666667	0.471977463300078	13674-87-8, 79-94-7	7	861	8530	2.8305956528953	1	1	0.471977463300078
CTD_CHEMICALS_DISEASES	Keratosis	2	16.6666666666667	0.479372331249748	1241-94-7, 79-94-7	7	879	8530	2.77263123679506	1	1	0.479372331249748
TOXCAST_ACTIVE	BSK_hDFCGF_SRB_down	2	16.6666666666667	0.481747236272809	115-86-6, 79-94-7	6	212	1723	2.70911949685535	1	1	0.481747236272809
CTD_CHEMICALS_DISEASES	Multiple Myeloma	2	16.6666666666667	0.486680693760873	1241-94-7, 79-94-7	7	897	8530	2.71699315177576	1	1	0.486680693760873
CTD_CHEM2DISEASE	Drug-Induced Liver Injury	2	16.6666666666667	0.487000843471952	13674-87-8, 79-94-7	5	836	5441	2.60334928229665	1	1	0.487000843471952
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
CTD_CHEMICALS_DISEASES	Diabetes Mellitus	2	16.6666666666667	0.493504337345268	1241-94-7, 79-94-7	7	914	8530	2.66645826820882	1	1	0.493504337345268
TOXCAST_ACTIVE	BSK_3C_IL8_down	2	16.6666666666667	0.498693218809711	115-86-6, 79-94-7	6	222	1723	2.58708708708709	1	1	0.498693218809711
TOXCAST_ACTIVE	BSK_4H_uPAR_down	2	16.6666666666667	0.500363128140791	115-86-6, 79-94-7	6	223	1723	2.57548579970105	1	1	0.500363128140791
TOXCAST_ACTIVE	OT_ER_ERaERb_0480	2	16.6666666666667	0.502028584380322	1241-94-7, 115-86-6	6	224	1723	2.56398809523809	1	1	0.502028584380322
TOXCAST_ACTIVE	BSK_LPS_MCP1_down	2	16.6666666666667	0.503689596440428	115-86-6, 79-94-7	6	225	1723	2.55259259259259	1	1	0.503689596440428
TOXCAST_ACTIVE	ATG_RORE_CIS_up	2	16.6666666666667	0.505346173221334	13674-87-8, 79-94-7	6	226	1723	2.54129793510324	1	1	0.505346173221334
TOXCAST_ACTIVE	BSK_BE3C_IP10_down	2	16.6666666666667	0.518440181524237	115-86-6, 79-94-7	6	234	1723	2.45441595441595	1	1	0.518440181524237
TOXCAST_ACTIVE	NVS_NR_hGR	2	16.6666666666667	0.518440181524237	13674-87-8, 79-94-7	6	234	1723	2.45441595441595	1	1	0.518440181524237
TOXREFDB	CHR_rat_DevelopmentalReproductive	2	16.6666666666667	0.520670976620633	1330-78-5, 13674-87-8	4	215	990	2.30232558139535	1	1	0.520670976620633
TOXCAST_ACTIVE	BSK_KF3CT_MMP9_down	2	16.6666666666667	0.521669950232465	115-86-6, 79-94-7	6	236	1723	2.43361581920904	1	1	0.521669950232465
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic	2	16.6666666666667	0.526223000918334	115-96-8, 13674-87-8	4	218	990	2.27064220183486	1	1	0.526223000918334
TOXCAST_ACTIVE	BSK_3C_MCP1_down	2	16.6666666666667	0.528077499713766	115-86-6, 79-94-7	6	240	1723	2.39305555555556	1	1	0.528077499713766
TOXCAST_ACTIVE	BSK_4H_SRB_down	2	16.6666666666667	0.531255420332891	115-86-6, 79-94-7	6	242	1723	2.3732782369146	1	1	0.531255420332891
TOXCAST_ACTIVE	Tox21_AR_LUC_MDAKB2_Antagonist	2	16.6666666666667	0.532837947610633	13674-87-8, 79-94-7	6	243	1723	2.36351165980796	1	1	0.532837947610633
CTD_CHEMICALS_DISEASES	Amphetamine-Related Disorders	2	16.6666666666667	0.533996984529616	115-86-6, 79-94-7	7	1019	8530	2.39170054675452	1	1	0.533996984529616
TOXCAST_ACTIVE	BSK_BE3C_HLADR_down	2	16.6666666666667	0.534416197787624	115-86-6, 79-94-7	6	244	1723	2.35382513661202	1	1	0.534416197787624
TOXCAST_ACTIVE	BSK_4H_Eotaxin3_down	2	16.6666666666667	0.537559901530258	115-86-6, 79-94-7	6	246	1723	2.33468834688347	1	1	0.537559901530258
TOXCAST_ACTIVE	BSK_LPS_SRB_down	2	16.6666666666667	0.545344917482842	115-86-6, 79-94-7	6	251	1723	2.28818061088977	1	1	0.545344917482842
TOXCAST_ACTIVE	BSK_SAg_SRB_down	2	16.6666666666667	0.54842940746035	115-86-6, 79-94-7	6	253	1723	2.27009222661397	1	1	0.54842940746035
TOXCAST_ACTIVE	BSK_4H_MCP1_down	2	16.6666666666667	0.54842940746035	115-86-6, 79-94-7	6	253	1723	2.27009222661397	1	1	0.54842940746035
TOXCAST_ACTIVE	BSK_4H_VCAM1_down	2	16.6666666666667	0.55149713394028	115-86-6, 79-94-7	6	255	1723	2.25228758169935	1	1	0.55149713394028
CTD_CHEMICALS_DISEASES	Weight Gain	2	16.6666666666667	0.551948510719347	115-86-6, 79-94-7	7	1068	8530	2.28196896736223	1	1	0.551948510719347
TOXCAST_ACTIVE	BSK_hDFCGF_PAI1_down	2	16.6666666666667	0.557582569910349	115-86-6, 79-94-7	6	259	1723	2.21750321750322	1	1	0.557582569910349
TOXCAST_ACTIVE	BSK_4H_Pselectin_down	2	16.6666666666667	0.562103150242597	115-86-6, 79-94-7	6	262	1723	2.19211195928753	1	1	0.562103150242597
CTD_CHEMICALS_DISEASES	Endometriosis	2	16.6666666666667	0.56966860756162	1330-78-5, 13674-87-8	7	1118	8530	2.17991311014567	1	1	0.56966860756162
TOXCAST_ACTIVE	BSK_hDFCGF_VCAM1_down	2	16.6666666666667	0.572507565385541	13674-87-8, 79-94-7	6	269	1723	2.13506815365551	1	1	0.572507565385541
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-X_generic	2	16.6666666666667	0.575371207529448	115-96-8, 13674-87-8	11	684	8337	2.21610845295056	1	1	0.575371207529448
TOXCAST_ACTIVE	ATG_CRE_CIS_up	2	16.6666666666667	0.581267367203751	13674-87-8, 79-94-7	6	275	1723	2.08848484848485	1	1	0.581267367203751
TOXCAST_ACTIVE	BSK_LPS_MCSF_down	2	16.6666666666667	0.588456980354889	115-86-6, 79-94-7	6	280	1723	2.05119047619048	1	1	0.588456980354889
TOXCAST_ACTIVE	BSK_hDFCGF_MCSF_down	2	16.6666666666667	0.589882978343958	115-86-6, 79-94-7	6	281	1723	2.04389086595492	1	1	0.589882978343958
TOXCAST_ACTIVE	BSK_SAg_Proliferation_down	3	25	0.599547044990745	115-86-6, 13674-87-8, 79-94-7	6	415	1723	2.07590361445783	1	1	0.599547044990745
CTD_CHEMICALS_DISEASES	Dermatitis, Contact	2	16.6666666666667	0.600421533481959	56803-37-3, 13674-87-8	7	1209	8530	2.01583362873685	1	1	0.600421533481959
TOXCAST_ACTIVE	APR_HepG2_CellLoss_72h_dn	3	25	0.603802407209328	115-86-6, 13674-87-8, 79-94-7	6	430	1723	2.00348837209302	1	1	0.603802407209328
TOXCAST_ACTIVE	BSK_hDFCGF_Proliferation_down	3	25	0.604732306250773	115-86-6, 13674-87-8, 79-94-7	6	433	1723	1.98960739030023	1	1	0.604732306250773
TOXCAST_ACTIVE	Tox21_TR_LUC_GH3_Antagonist	3	25	0.610467510819369	1241-94-7, 13674-87-8, 79-94-7	6	450	1723	1.91444444444444	1	1	0.610467510819369
TOXCAST_ACTIVE	ATG_ERE_CIS_up	3	25	0.661896834740386	1241-94-7, 1330-78-5, 115-86-6	6	559	1723	1.54114490161002	1	1	0.661896834740386
LEADSCOPE_TOXICITY	Reproductive Toxicity- C3H10T1-2	5	41.6666666666667	0.719403100193003	1241-94-7, 29761-21-5, 13674-87-8, 5436-43-1, 79-94-7	9	2909	7444	1.42164164852374	1	1	0.719403100193003
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro other cells	5	41.6666666666667	0.722334473944609	1241-94-7, 115-86-6, 29761-21-5, 13674-87-8, 78-30-8	9	3012	7444	1.37302641286705	1	1	0.722334473944609
MULTICASE_TOX_PREDICTION	BSEP substrates	2	16.6666666666667	1	1241-94-7, 13674-87-8	11	1286	8032	1.13558603138696	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_Urinary_Kidney	2	16.6666666666667	1	115-96-8, 13674-87-8	4	265	990	1.86792452830189	1	1	1
CTD_CHEMICALS_DISEASES	Liver Diseases	2	16.6666666666667	1	1330-78-5, 79-94-7	7	1373	8530	1.77504942253668	1	1	1
TOXCAST_ACTIVE	ATG_ERa_TRANS_up	2	16.6666666666667	1	1241-94-7, 79-94-7	6	470	1723	1.22198581560284	1	1	1
CTD_CHEMICALS_DISEASES	Hepatomegaly	2	16.6666666666667	1	1241-94-7, 79-94-7	7	1278	8530	1.90699754080036	1	1	1
TOXCAST_ACTIVE	Tox21_Aromatase_Inhibition	2	16.6666666666667	1	13674-87-8, 79-94-7	6	382	1723	1.50349040139616	1	1	1
LEADSCOPE_TOXICITY	Genetic Toxicity -salmonella	2	16.6666666666667	1	115-96-8, 13674-87-8	9	1163	7444	1.42237508359606	1	1	1
CTD_CHEMICALS_DISEASES	Liver Cirrhosis	2	16.6666666666667	1	115-86-6, 79-94-7	7	1363	8530	1.788072529085	1	1	1
CTD_CHEMICALS_DISEASES	Obesity	2	16.6666666666667	1	56803-37-3, 115-86-6	7	2317	8530	1.05185276527529	1	1	1
TOXCAST_ACTIVE	BSK_LPS_CD40_down	2	16.6666666666667	1	115-86-6, 79-94-7	6	288	1723	1.99421296296296	1	1	1
CTD_CHEMICALS_DISEASES	Stomach Neoplasms	2	16.6666666666667	1	1330-78-5, 13674-87-8	7	1974	8530	1.23462150817774	1	1	1
TOXCAST_ACTIVE	Tox21_FXR_BLA_antagonist_ratio	2	16.6666666666667	1	1241-94-7, 79-94-7	6	323	1723	1.7781217750258	1	1	1
CTD_CHEMICALS_DISEASES	Hypertension	3	25	1	1241-94-7, 56803-37-3, 115-86-6	7	2494	8530	1.46580364302898	1	1	1
CTD_CHEMICALS_DISEASES	Pancreatic Neoplasms	2	16.6666666666667	1	1241-94-7, 115-86-6	7	1256	8530	1.94040036396724	1	1	1
TOXCAST_ACTIVE	Tox21_ERa_BLA_Antagonist_ratio	2	16.6666666666667	1	13674-87-8, 79-94-7	6	314	1723	1.82908704883227	1	1	1
TOXCAST_ACTIVE	ATG_NRF2_ARE_CIS_up	3	25	1	1241-94-7, 115-86-6, 79-94-7	6	747	1723	1.15327978580991	1	1	1
TOXCAST_ACTIVE	BSK_3C_HLADR_down	2	16.6666666666667	1	115-86-6, 79-94-7	6	342	1723	1.67933723196881	1	1	1
HTS_ACTIVE	antagonism_AR/full/run1	2	16.6666666666667	1	13674-87-8, 79-94-7	10	491	4173	1.69979633401222	1	1	1
TOXPRINT_STRUCTURE	chain:alkaneBranch_neopentyl_C5	2	16.6666666666667	1	56803-37-3, 79-94-7	11	838	8337	1.80885224560642	1	1	1
TOXPRINT_STRUCTURE	bond:X[any]_halide	4	33.3333333333333	1	115-96-8, 13674-87-8, 5436-43-1, 79-94-7	11	2431	8337	1.24707378183314	1	1	1
TOXCAST_ACTIVE	BSK_3C_SRB_down	2	16.6666666666667	1	115-86-6, 79-94-7	6	304	1723	1.88925438596491	1	1	1
CTD_CHEMICALS_DISEASES	Cardiomegaly	2	16.6666666666667	1	1330-78-5, 115-86-6	7	1263	8530	1.92964596765072	1	1	1

Annotation Cluster 35	Enrichment Score: 0.729918738279316
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
TOXCAST_ACTIVE	NVS_MP_rPBR	4	33.3333333333333	0.0166583393847118	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	219	1723	5.24505327245053	1	1	0.0166583393847118
TOXCAST_ACTIVE	NVS_MP_hPBR	4	33.3333333333333	0.0170883452769438	1241-94-7, 1330-78-5, 115-86-6, 13674-87-8	6	221	1723	5.19758672699849	1	1	0.0170883452769438
CTD_CHEMICALS_DISEASES	Prostate cancer, familial	3	25	0.0402822347157824	1330-78-5, 115-86-6, 13674-87-8	7	477	8530	7.66397124887691	1	1	0.0402822347157824
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_1440	3	25	0.0624173669639862	1241-94-7, 1330-78-5, 13674-87-8	6	149	1723	5.78187919463087	1	1	0.0624173669639862
TOXCAST_ACTIVE	Tox21_MitochondrialToxicity_ratio	4	33.3333333333333	0.0676228400695797	1330-78-5, 115-86-6, 13674-87-8, 79-94-7	6	366	1723	3.1384335154827	1	1	0.0676228400695797
LEADSCOPE_TOXICITY	Genetic Toxicity -s. cerevisiae	4	33.3333333333333	0.0693412894135144	1330-78-5, 115-86-6, 115-96-8, 13674-87-8	9	942	7444	3.51214909176693	1	1	0.0693412894135144
CTD_CHEMICALS_DISEASES	Neuroblastoma	3	25	0.103084274367938	56803-37-3, 1330-78-5, 13674-87-8	7	804	8530	4.54690831556503	1	1	0.103084274367938
CTD_CHEMICALS_DISEASES	Spinal Cord Injuries	3	25	0.103978064079227	1330-78-5, 13674-87-8, 79-94-7	7	808	8530	4.52439886845827	1	1	0.103978064079227
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_PathologyClinical_ClinicalChemistry	3	25	0.158816668049812	1330-78-5, 115-96-8, 13674-87-8	4	250	990	2.97	1	1	0.158816668049812
CTD_CHEMICALS_DISEASES	Psoriasis	3	25	0.175492833125261	1241-94-7, 1330-78-5, 13674-87-8	7	1101	8530	3.32035811599844	1	1	0.175492833125261
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OrganWeight	3	25	0.205636309302958	1330-78-5, 115-96-8, 13674-87-8	4	289	990	2.56920415224914	1	1	0.205636309302958
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_PathologyClinical	3	25	0.231200424644094	1330-78-5, 115-96-8, 13674-87-8	4	309	990	2.40291262135922	1	1	0.231200424644094
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_Endocrine_AdrenalGland	2	16.6666666666667	0.362911670133212	1330-78-5, 13674-87-8	4	138	990	3.58695652173913	1	1	0.362911670133212
LEADSCOPE_TOXICITY	Genetic Toxicity -SCE in vitro CHO	4	33.3333333333333	0.491388024023911	1330-78-5, 115-86-6, 13674-87-8, 78-30-8	9	3886	7444	0.85137530737119	1	1	0.491388024023911
TOXREFDB	CHR_rat_DevelopmentalReproductive	2	16.6666666666667	0.520670976620633	1330-78-5, 13674-87-8	4	215	990	2.30232558139535	1	1	0.520670976620633
CTD_CHEMICALS_DISEASES	Endometriosis	2	16.6666666666667	0.56966860756162	1330-78-5, 13674-87-8	7	1118	8530	2.17991311014567	1	1	0.56966860756162
CTD_CHEMICALS_DISEASES	Stomach Neoplasms	2	16.6666666666667	1	1330-78-5, 13674-87-8	7	1974	8530	1.23462150817774	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	505	990	1.47029702970297	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	551	990	1.3475499092559	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	529	990	1.40359168241966	1	1	1

Annotation Cluster 36	Enrichment Score: 0.705298595937826
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
MESH	Polybrominated Biphenyls	2	16.6666666666667	0.00586025368309049	5436-43-1, 79-94-7	9	4	5450	302.777777777778	1	1	0.00586025368309049
MESH	Hydrocarbons, Brominated	2	16.6666666666667	0.0375576533289049	5436-43-1, 79-94-7	9	26	5450	46.5811965811966	1	1	0.0375576533289049
MESH	Biphenyl Compounds	2	16.6666666666667	0.0460473978270343	5436-43-1, 79-94-7	9	32	5450	37.8472222222222	1	1	0.0460473978270343
HTS_ACTIVE	cytotoxicity_EndoRS/activation	4	33.3333333333333	0.0978606322006492	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	10	536	4173	3.11417910447761	1	1	0.0978606322006492
HTS_ACTIVE	cytotoxicity_FXR/agonism	4	33.3333333333333	0.163409671041523	29761-21-5, 68937-41-7, 5436-43-1, 79-94-7	10	669	4173	2.49506726457399	1	1	0.163409671041523
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_halo_phenol_ortho	2	16.6666666666667	0.19223474121131	5436-43-1, 79-94-7	11	176	8337	8.61260330578512	1	1	0.19223474121131
MESH	Hydrocarbons, Halogenated	2	16.6666666666667	0.232258200971871	5436-43-1, 79-94-7	9	177	5450	6.84243565599498	1	1	0.232258200971871
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_dihalo_benzene_(1_3-)	2	16.6666666666667	0.336578957897659	5436-43-1, 79-94-7	11	335	8337	4.52483039348711	1	1	0.336578957897659
HTS_ACTIVE	cytotoxicity_H2AX/activation	4	33.3333333333333	0.388814959402494	29761-21-5, 5436-43-1, 78-30-8, 79-94-7	10	808	4173	2.06584158415842	1	1	0.388814959402494
MULTICASE_TOX_PREDICTION	RCA fetal death, rat	2	16.6666666666667	0.470349043592985	5436-43-1, 79-94-7	11	1865	8032	0.783036802339751	1	1	0.470349043592985
MULTICASE_TOX_PREDICTION	Human plasma protein binding, %bound	4	33.3333333333333	0.527352202944437	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	3622	8032	0.80638522162542	1	1	0.527352202944437
HTS_ACTIVE	cytotoxicity_NFkb/activation	2	16.6666666666667	0.568800583945383	68937-41-7, 79-94-7	10	372	4173	2.24354838709677	1	1	0.568800583945383
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_generic	2	16.6666666666667	1	5436-43-1, 79-94-7	11	1166	8337	1.30001559332606	1	1	1
MULTICASE_TOX_PREDICTION	NTCP substrates	2	16.6666666666667	1	5436-43-1, 79-94-7	11	1156	8032	1.26329034287512	1	1	1

Annotation Cluster 37	Enrichment Score: 0.681004484293246
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
CTD_CHEMICALS_DISEASES	Acute Lung Injury	3	25	0.0729564338542693	1241-94-7, 56803-37-3, 79-94-7	7	661	8530	5.53058137021828	1	1	0.0729564338542693
CTD_CHEMICALS_DISEASES	Cocaine-Related Disorders	3	25	0.158980461851979	1241-94-7, 56803-37-3, 79-94-7	7	1037	8530	3.52527896404463	1	1	0.158980461851979
HTS_ACTIVE	antagonism_PPARg	3	25	0.159848619306805	56803-37-3, 68937-41-7, 79-94-7	10	336	4173	3.72589285714286	1	1	0.159848619306805
HTS_ACTIVE	cytotoxicity_TR/antagonism	7	58.3333333333333	0.168245942928303	1241-94-7, 56803-37-3, 29761-21-5, 68937-41-7, 13674-87-8, 78-30-8, 79-94-7	10	1651	4173	1.76929133858268	1	1	0.168245942928303
TOXPRINT_STRUCTURE	chain:alkaneLinear_ethyl_C2_(connect_noZ_CN=4)	5	41.6666666666667	0.49868042073762	1241-94-7, 56803-37-3, 29761-21-5, 68937-41-7, 79-94-7	11	2495	8337	1.51885589360539	1	1	0.49868042073762
MULTICASE_TOX_PREDICTION	Draize eye irritation test, rabbit	8	66.6666666666667	0.527339053690464	1241-94-7, 56803-37-3, 1330-78-5, 115-86-6, 29761-21-5, 68937-41-7, 78-30-8, 79-94-7	11	4428	8032	1.31920834359859	1	1	0.527339053690464

Annotation Cluster 38	Enrichment Score: 0.634871686080717
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
MESH	Polybrominated Biphenyls	2	16.6666666666667	0.00586025368309049	5436-43-1, 79-94-7	9	4	5450	302.777777777778	1	1	0.00586025368309049
MESH	Hydrocarbons, Brominated	2	16.6666666666667	0.0375576533289049	5436-43-1, 79-94-7	9	26	5450	46.5811965811966	1	1	0.0375576533289049
MESH	Biphenyl Compounds	2	16.6666666666667	0.0460473978270343	5436-43-1, 79-94-7	9	32	5450	37.8472222222222	1	1	0.0460473978270343
CTD_CHEMICALS_DISEASES	Acute Lung Injury	3	25	0.0729564338542693	1241-94-7, 56803-37-3, 79-94-7	7	661	8530	5.53058137021828	1	1	0.0729564338542693
CTD_CHEMICALS_DISEASES	Osteoarthritis, Hip	2	16.6666666666667	0.0874009986124082	56803-37-3, 79-94-7	7	129	8530	18.8925802879291	1	1	0.0874009986124082
MULTICASE_TOX_PREDICTION	Dendritic cell activation at 1mM (CD86, CD54)	3	25	0.123282273160931	56803-37-3, 5436-43-1, 79-94-7	11	3656	8032	0.599164511637159	1	1	0.123282273160931
CTD_CHEMICALS_DISEASES	Cocaine-Related Disorders	3	25	0.158980461851979	1241-94-7, 56803-37-3, 79-94-7	7	1037	8530	3.52527896404463	1	1	0.158980461851979
HTS_ACTIVE	antagonism_PPARg	3	25	0.159848619306805	56803-37-3, 68937-41-7, 79-94-7	10	336	4173	3.72589285714286	1	1	0.159848619306805
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_halo_phenol_ortho	2	16.6666666666667	0.19223474121131	5436-43-1, 79-94-7	11	176	8337	8.61260330578512	1	1	0.19223474121131
MULTICASE_TOX_PREDICTION	BSEP inhibition at 100uM	3	25	0.206319690745757	5436-43-1, 78-30-8, 79-94-7	11	3403	8032	0.643710095370395	1	1	0.206319690745757
HTS_ACTIVE	inhibition_MMP	5	41.6666666666667	0.226067082555815	56803-37-3, 1330-78-5, 115-86-6, 5436-43-1, 79-94-7	10	967	4173	2.15770423991727	1	1	0.226067082555815
MESH	Hydrocarbons, Halogenated	2	16.6666666666667	0.232258200971871	5436-43-1, 79-94-7	9	177	5450	6.84243565599498	1	1	0.232258200971871
MESH	Benzene Derivatives	3	25	0.291896008772812	5436-43-1, 78-30-8, 79-94-7	9	730	5450	2.48858447488584	1	1	0.291896008772812
MULTICASE_TOX_PREDICTION	Dendritic cell activation at 100uM (CD86, CD54)	2	16.6666666666667	0.298766055395908	56803-37-3, 79-94-7	11	2369	8032	0.616447292681991	1	1	0.298766055395908
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_dihalo_benzene_(1_3-)	2	16.6666666666667	0.336578957897659	5436-43-1, 79-94-7	11	335	8337	4.52483039348711	1	1	0.336578957897659
HTS_ACTIVE	antagonism_FXR	2	16.6666666666667	0.356086652288895	56803-37-3, 79-94-7	10	199	4173	4.19396984924623	1	1	0.356086652288895
MULTICASE_TOX_PREDICTION	RCA fetal death, rat	2	16.6666666666667	0.470349043592985	5436-43-1, 79-94-7	11	1865	8032	0.783036802339751	1	1	0.470349043592985
MESH	Hydrocarbons, Aromatic	3	25	0.640282750789173	5436-43-1, 78-30-8, 79-94-7	9	978	5450	1.85753237900477	1	1	0.640282750789173
HTS_ACTIVE	cytotoxicity_VDR/agonism	3	25	0.653846214452603	5436-43-1, 78-30-8, 79-94-7	10	705	4173	1.77574468085106	1	1	0.653846214452603
MESH	Hydrocarbons, Cyclic	3	25	0.66784490387594	5436-43-1, 78-30-8, 79-94-7	9	1105	5450	1.64404223227753	1	1	0.66784490387594
MULTICASE_TOX_PREDICTION	NTCP substrates	2	16.6666666666667	1	5436-43-1, 79-94-7	11	1156	8032	1.26329034287512	1	1	1
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_generic	2	16.6666666666667	1	5436-43-1, 79-94-7	11	1166	8337	1.30001559332606	1	1	1
TOXPRINT_STRUCTURE	chain:alkaneBranch_neopentyl_C5	2	16.6666666666667	1	56803-37-3, 79-94-7	11	838	8337	1.80885224560642	1	1	1
MESH	Hydrocarbons	3	25	1	5436-43-1, 78-30-8, 79-94-7	9	1471	5450	1.23498753682302	1	1	1

Annotation Cluster 39	Enrichment Score: 0.586283232196281
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
MESH	Polybrominated Biphenyls	2	16.6666666666667	0.00586025368309049	5436-43-1, 79-94-7	9	4	5450	302.777777777778	1	1	0.00586025368309049
MESH	Hydrocarbons, Brominated	2	16.6666666666667	0.0375576533289049	5436-43-1, 79-94-7	9	26	5450	46.5811965811966	1	1	0.0375576533289049
MESH	Biphenyl Compounds	2	16.6666666666667	0.0460473978270343	5436-43-1, 79-94-7	9	32	5450	37.8472222222222	1	1	0.0460473978270343
HTS_ACTIVE	cytotoxicity_EndoRS/activation	4	33.3333333333333	0.0978606322006492	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	10	536	4173	3.11417910447761	1	1	0.0978606322006492
MULTICASE_TOX_PREDICTION	Dendritic cell activation at 1mM (CD86, CD54)	3	25	0.123282273160931	56803-37-3, 5436-43-1, 79-94-7	11	3656	8032	0.599164511637159	1	1	0.123282273160931
HTS_ACTIVE	cytotoxicity_FXR/agonism	4	33.3333333333333	0.163409671041523	29761-21-5, 68937-41-7, 5436-43-1, 79-94-7	10	669	4173	2.49506726457399	1	1	0.163409671041523
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_halo_phenol_ortho	2	16.6666666666667	0.19223474121131	5436-43-1, 79-94-7	11	176	8337	8.61260330578512	1	1	0.19223474121131
MULTICASE_TOX_PREDICTION	BSEP inhibition at 100uM	3	25	0.206319690745757	5436-43-1, 78-30-8, 79-94-7	11	3403	8032	0.643710095370395	1	1	0.206319690745757
MESH	Hydrocarbons, Halogenated	2	16.6666666666667	0.232258200971871	5436-43-1, 79-94-7	9	177	5450	6.84243565599498	1	1	0.232258200971871
MESH	Benzene Derivatives	3	25	0.291896008772812	5436-43-1, 78-30-8, 79-94-7	9	730	5450	2.48858447488584	1	1	0.291896008772812
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_dihalo_benzene_(1_3-)	2	16.6666666666667	0.336578957897659	5436-43-1, 79-94-7	11	335	8337	4.52483039348711	1	1	0.336578957897659
HTS_ACTIVE	cytotoxicity_H2AX/activation	4	33.3333333333333	0.388814959402494	29761-21-5, 5436-43-1, 78-30-8, 79-94-7	10	808	4173	2.06584158415842	1	1	0.388814959402494
MULTICASE_TOX_PREDICTION	RCA fetal death, rat	2	16.6666666666667	0.470349043592985	5436-43-1, 79-94-7	11	1865	8032	0.783036802339751	1	1	0.470349043592985
MULTICASE_TOX_PREDICTION	Human plasma protein binding, %bound	4	33.3333333333333	0.527352202944437	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	3622	8032	0.80638522162542	1	1	0.527352202944437
MESH	Hydrocarbons, Aromatic	3	25	0.640282750789173	5436-43-1, 78-30-8, 79-94-7	9	978	5450	1.85753237900477	1	1	0.640282750789173
HTS_ACTIVE	cytotoxicity_VDR/agonism	3	25	0.653846214452603	5436-43-1, 78-30-8, 79-94-7	10	705	4173	1.77574468085106	1	1	0.653846214452603
MESH	Hydrocarbons, Cyclic	3	25	0.66784490387594	5436-43-1, 78-30-8, 79-94-7	9	1105	5450	1.64404223227753	1	1	0.66784490387594
TOXPRINT_STRUCTURE	bond:CX_halide_aromatic-X_generic	2	16.6666666666667	1	5436-43-1, 79-94-7	11	1166	8337	1.30001559332606	1	1	1
TOXPRINT_STRUCTURE	bond:X[any]_halide	4	33.3333333333333	1	115-96-8, 13674-87-8, 5436-43-1, 79-94-7	11	2431	8337	1.24707378183314	1	1	1
MESH	Hydrocarbons	3	25	1	5436-43-1, 78-30-8, 79-94-7	9	1471	5450	1.23498753682302	1	1	1
MULTICASE_TOX_PREDICTION	NTCP substrates	2	16.6666666666667	1	5436-43-1, 79-94-7	11	1156	8032	1.26329034287512	1	1	1

Annotation Cluster 40	Enrichment Score: 0.541240583388034
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
HTS_ACTIVE	cytotoxicity_EndoRS/activation	4	33.3333333333333	0.0978606322006492	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	10	536	4173	3.11417910447761	1	1	0.0978606322006492
HTS_ACTIVE	agonism_ER/full	4	33.3333333333333	0.146359399606026	115-86-6, 68937-41-7, 5436-43-1, 78-30-8	10	637	4173	2.62040816326531	1	1	0.146359399606026
HTS_ACTIVE	antagonism_GR	3	25	0.237263353771975	68937-41-7, 13674-87-8, 78-30-8	10	432	4173	2.89791666666667	1	1	0.237263353771975
HTS_ACTIVE	cytotoxicity_VDR/antagonism	3	25	0.315643197238987	68937-41-7, 78-30-8, 79-94-7	10	525	4173	2.38457142857143	1	1	0.315643197238987
MULTICASE_TOX_PREDICTION	Human plasma protein binding, %bound	4	33.3333333333333	0.527352202944437	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	3622	8032	0.80638522162542	1	1	0.527352202944437
HTS_ACTIVE	cytotoxicity_PPARd/antagonism	2	16.6666666666667	1	68937-41-7, 78-30-8	10	587	4173	1.42180579216354	1	1	1

Annotation Cluster 41	Enrichment Score: 0.534461446588234
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
HTS_ACTIVE	cytotoxicity_EndoRS/activation	4	33.3333333333333	0.0978606322006492	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	10	536	4173	3.11417910447761	1	1	0.0978606322006492
HTS_ACTIVE	antagonism_PPARg	3	25	0.159848619306805	56803-37-3, 68937-41-7, 79-94-7	10	336	4173	3.72589285714286	1	1	0.159848619306805
HTS_ACTIVE	cytotoxicity_FXR/agonism	4	33.3333333333333	0.163409671041523	29761-21-5, 68937-41-7, 5436-43-1, 79-94-7	10	669	4173	2.49506726457399	1	1	0.163409671041523
HTS_ACTIVE	cytotoxicity_VDR/antagonism	3	25	0.315643197238987	68937-41-7, 78-30-8, 79-94-7	10	525	4173	2.38457142857143	1	1	0.315643197238987
MULTICASE_TOX_PREDICTION	Human plasma protein binding, %bound	4	33.3333333333333	0.527352202944437	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	3622	8032	0.80638522162542	1	1	0.527352202944437
HTS_ACTIVE	cytotoxicity_NFkb/activation	2	16.6666666666667	0.568800583945383	68937-41-7, 79-94-7	10	372	4173	2.24354838709677	1	1	0.568800583945383
MULTICASE_TOX_PREDICTION	MRP2 substrates	4	33.3333333333333	0.749752598695028	56803-37-3, 1330-78-5, 68937-41-7, 79-94-7	11	3118	8032	0.936731004723308	1	1	0.749752598695028

Annotation Cluster 42	Enrichment Score: 0.514472678537058
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
HTS_ACTIVE	cytotoxicity_EndoRS/activation	4	33.3333333333333	0.0978606322006492	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	10	536	4173	3.11417910447761	1	1	0.0978606322006492
MULTICASE_TOX_PREDICTION	Extent of human metabolism, %	3	25	0.111262172508268	1241-94-7, 5436-43-1, 78-30-8	11	3877	8032	0.565010434497151	1	1	0.111262172508268
HTS_ACTIVE	agonism_ER/full	4	33.3333333333333	0.146359399606026	115-86-6, 68937-41-7, 5436-43-1, 78-30-8	10	637	4173	2.62040816326531	1	1	0.146359399606026
MULTICASE_TOX_PREDICTION	BCRP substrates	2	16.6666666666667	0.179826247936711	5436-43-1, 78-30-8	11	2723	8032	0.536306880779889	1	1	0.179826247936711
MULTICASE_TOX_PREDICTION	MRP4 inhibition at 50uM	2	16.6666666666667	0.186253666882446	5436-43-1, 78-30-8	11	2532	8032	0.576762889559098	1	1	0.186253666882446
MULTICASE_TOX_PREDICTION	BSEP inhibition at 100uM	3	25	0.206319690745757	5436-43-1, 78-30-8, 79-94-7	11	3403	8032	0.643710095370395	1	1	0.206319690745757
MESH	Benzene Derivatives	3	25	0.291896008772812	5436-43-1, 78-30-8, 79-94-7	9	730	5450	2.48858447488584	1	1	0.291896008772812
MESH	Phenols	2	16.6666666666667	0.34033986052226	5436-43-1, 78-30-8	9	276	5450	4.38808373590982	1	1	0.34033986052226
HTS_ACTIVE	cytotoxicity_H2AX/activation	4	33.3333333333333	0.388814959402494	29761-21-5, 5436-43-1, 78-30-8, 79-94-7	10	808	4173	2.06584158415842	1	1	0.388814959402494
MULTICASE_TOX_PREDICTION	Human plasma protein binding, %bound	4	33.3333333333333	0.527352202944437	68937-41-7, 5436-43-1, 78-30-8, 79-94-7	11	3622	8032	0.80638522162542	1	1	0.527352202944437
MESH	Hydrocarbons, Aromatic	3	25	0.640282750789173	5436-43-1, 78-30-8, 79-94-7	9	978	5450	1.85753237900477	1	1	0.640282750789173
HTS_ACTIVE	cytotoxicity_VDR/agonism	3	25	0.653846214452603	5436-43-1, 78-30-8, 79-94-7	10	705	4173	1.77574468085106	1	1	0.653846214452603
MESH	Hydrocarbons, Cyclic	3	25	0.66784490387594	5436-43-1, 78-30-8, 79-94-7	9	1105	5450	1.64404223227753	1	1	0.66784490387594
MESH	Hydrocarbons	3	25	1	5436-43-1, 78-30-8, 79-94-7	9	1471	5450	1.23498753682302	1	1	1

Annotation Cluster 43	Enrichment Score: 0.5059690120414
Category	Term	Count	%	PValue	CASRNs	List Total	Pop Hits	Pop Total	Fold Enrichment	Bonferroni	Benjamini	FDR
TOXPRINT_STRUCTURE	bond:P=O_phosphate_alkyl_ester	4	33.3333333333333	7.70420895068242e-05	1241-94-7, 115-96-8, 29761-21-5, 13674-87-8	11	74	8337	40.968058968059	1	0.0310479620712502	7.70420895068242e-05
CTD_CHEM2GENE_25	AR	4	33.3333333333333	0.000415679053734167	115-86-6, 115-96-8, 13674-87-8, 79-94-7	7	190	6732	20.2466165413534	1	0.163361868117527	0.000415679053734167
MULTICASE_TOX_PREDICTION	Allergic contact dermatitis, guinea pig and human	2	16.6666666666667	0.00693590260561124	115-96-8, 13674-87-8	11	4433	8032	0.329430100691098	1	1	0.00693590260561124
CTD_CHEMICALS_DISEASES	Prostate cancer, familial	3	25	0.0402822347157824	1330-78-5, 115-86-6, 13674-87-8	7	477	8530	7.66397124887691	1	1	0.0402822347157824
TOXCAST_ACTIVE	OT_FXR_FXRSRC1_1440	3	25	0.0624173669639862	1241-94-7, 1330-78-5, 13674-87-8	6	149	1723	5.78187919463087	1	1	0.0624173669639862
LEADSCOPE_TOXICITY	Genetic Toxicity -s. cerevisiae	4	33.3333333333333	0.0693412894135144	1330-78-5, 115-86-6, 115-96-8, 13674-87-8	9	942	7444	3.51214909176693	1	1	0.0693412894135144
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic_Urinary_Kidney	2	16.6666666666667	0.0911177473122021	115-96-8, 13674-87-8	4	31	990	15.9677419354839	1	1	0.0911177473122021
CTD_CHEMICALS_DISEASES	Neuroblastoma	3	25	0.103084274367938	56803-37-3, 1330-78-5, 13674-87-8	7	804	8530	4.54690831556503	1	1	0.103084274367938
CTD_CHEMICALS_DISEASES	Spinal Cord Injuries	3	25	0.103978064079227	1330-78-5, 13674-87-8, 79-94-7	7	808	8530	4.52439886845827	1	1	0.103978064079227
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-Cl_ethyl	2	16.6666666666667	0.106169126109407	115-96-8, 13674-87-8	11	93	8337	16.2991202346041	1	1	0.106169126109407
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic_Urinary	2	16.6666666666667	0.135900431677666	115-96-8, 13674-87-8	4	47	990	10.531914893617	1	1	0.135900431677666
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-X_ethyl	2	16.6666666666667	0.152770022025416	115-96-8, 13674-87-8	11	137	8337	11.0643662906437	1	1	0.152770022025416
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_PathologyClinical_ClinicalChemistry	3	25	0.158816668049812	1330-78-5, 115-96-8, 13674-87-8	4	250	990	2.97	1	1	0.158816668049812
CTD_CHEMICALS_DISEASES	Psoriasis	3	25	0.175492833125261	1241-94-7, 1330-78-5, 13674-87-8	7	1101	8530	3.32035811599844	1	1	0.175492833125261
TOXREFDB	SUB_mouse_DevelopmentalReproductive	2	16.6666666666667	0.19503955856465	1330-78-5, 115-96-8	4	69	990	7.17391304347826	1	1	0.19503955856465
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OrganWeight	3	25	0.205636309302958	1330-78-5, 115-96-8, 13674-87-8	4	289	990	2.56920415224914	1	1	0.205636309302958
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-X_primary	2	16.6666666666667	0.230985209585531	115-96-8, 13674-87-8	11	216	8337	7.01767676767677	1	1	0.230985209585531
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-X_ethyl_generic	2	16.6666666666667	0.230985209585531	115-96-8, 13674-87-8	11	216	8337	7.01767676767677	1	1	0.230985209585531
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_PathologyClinical	3	25	0.231200424644094	1330-78-5, 115-96-8, 13674-87-8	4	309	990	2.40291262135922	1	1	0.231200424644094
TOXREFDB	SUB_mouse_SystemicCarcinogenic_adult_Urinary_Kidney	2	16.6666666666667	0.268786612248908	1330-78-5, 115-96-8	4	98	990	5.05102040816327	1	1	0.268786612248908
TOXREFDB	CHR_mouse_SystemicCarcinogenic_adult_PathologyProliferative_AccessoryDigestive_Liver	2	16.6666666666667	0.268786612248908	1330-78-5, 115-96-8	4	98	990	5.05102040816327	1	1	0.268786612248908
TOXREFDB	CHR_mouse_SystemicCarcinogenic_adult_PathologyProliferative_AccessoryDigestive	2	16.6666666666667	0.290721547623788	1330-78-5, 115-96-8	4	107	990	4.62616822429907	1	1	0.290721547623788
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic_Endocrine	2	16.6666666666667	0.307475470266168	115-96-8, 13674-87-8	4	114	990	4.34210526315789	1	1	0.307475470266168
MULTICASE_TOX_PREDICTION	RCA sperm toxicity, mammal	2	16.6666666666667	0.350449353198351	115-96-8, 13674-87-8	11	339	8032	4.30785733440601	1	1	0.350449353198351
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_Endocrine_AdrenalGland	2	16.6666666666667	0.362911670133212	1330-78-5, 13674-87-8	4	138	990	3.58695652173913	1	1	0.362911670133212
TOXREFDB	SUB_mouse_SystemicCarcinogenic_adult_OrganWeight_AccessoryDigestive	2	16.6666666666667	0.367392935590477	1330-78-5, 115-96-8	4	140	990	3.53571428571429	1	1	0.367392935590477
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OrganWeight_Urinary	2	16.6666666666667	0.400334454362979	115-96-8, 13674-87-8	4	155	990	3.19354838709677	1	1	0.400334454362979
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations_Mortality	2	16.6666666666667	0.404638261708136	115-96-8, 13674-87-8	4	157	990	3.15286624203822	1	1	0.404638261708136
TOXREFDB	SUB_mouse_SystemicCarcinogenic_adult_OrganWeight	2	16.6666666666667	0.408921427321193	1330-78-5, 115-96-8	4	159	990	3.11320754716981	1	1	0.408921427321193
TOXREFDB	SUB_mouse_SystemicCarcinogenic_adult_AccessoryDigestive_Liver	2	16.6666666666667	0.446549227119713	1330-78-5, 115-96-8	4	177	990	2.79661016949153	1	1	0.446549227119713
TOXREFDB	SUB_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative	2	16.6666666666667	0.460739586810578	1330-78-5, 115-96-8	4	184	990	2.69021739130435	1	1	0.460739586810578
TOXREFDB	CHR_mouse_SystemicCarcinogenic_adult_PathologyProliferative	2	16.6666666666667	0.490326389945889	1330-78-5, 115-96-8	4	199	990	2.48743718592965	1	1	0.490326389945889
TOXREFDB	CHR_rat_DevelopmentalReproductive	2	16.6666666666667	0.520670976620633	1330-78-5, 13674-87-8	4	215	990	2.30232558139535	1	1	0.520670976620633
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNeoplastic	2	16.6666666666667	0.526223000918334	115-96-8, 13674-87-8	4	218	990	2.27064220183486	1	1	0.526223000918334
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations_ClinicalSigns	2	16.6666666666667	0.562144700774896	1330-78-5, 115-96-8	4	238	990	2.07983193277311	1	1	0.562144700774896
CTD_CHEMICALS_DISEASES	Endometriosis	2	16.6666666666667	0.56966860756162	1330-78-5, 13674-87-8	7	1118	8530	2.17991311014567	1	1	0.56966860756162
TOXPRINT_STRUCTURE	bond:CX_halide_alkyl-X_generic	2	16.6666666666667	0.575371207529448	115-96-8, 13674-87-8	11	684	8337	2.21610845295056	1	1	0.575371207529448
TOXREFDB	SUB_rat_SystemicCarcinogenic	2	16.6666666666667	0.598759784199622	1330-78-5, 115-96-8	4	532	990	0.930451127819549	1	1	0.598759784199622
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OtherSystemic	2	16.6666666666667	0.608678049639148	1330-78-5, 115-96-8	4	517	990	0.957446808510638	1	1	0.608678049639148
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_AccessoryDigestive_Liver	2	16.6666666666667	1	1330-78-5, 115-96-8	4	365	990	1.35616438356164	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OrganWeight_AccessoryDigestive	2	16.6666666666667	1	1330-78-5, 115-96-8	4	323	990	1.53250773993808	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OrganWeight	2	16.6666666666667	1	1330-78-5, 115-96-8	4	385	990	1.28571428571429	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	529	990	1.40359168241966	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_PathologyNonProliferative	2	16.6666666666667	1	1330-78-5, 115-96-8	4	405	990	1.22222222222222	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_Urinary_Kidney	2	16.6666666666667	1	1330-78-5, 115-96-8	4	310	990	1.59677419354839	1	1	1
TOXPRINT_STRUCTURE	bond:X[any]_halide	4	33.3333333333333	1	115-96-8, 13674-87-8, 5436-43-1, 79-94-7	11	2431	8337	1.24707378183314	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	551	990	1.3475499092559	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations	2	16.6666666666667	1	1330-78-5, 115-96-8	4	477	990	1.0377358490566	1	1	1
TOXREFDB	CHR_mouse_SystemicCarcinogenic_adult_AccessoryDigestive_Liver	2	16.6666666666667	1	1330-78-5, 115-96-8	4	312	990	1.58653846153846	1	1	1
TOXREFDB	CHR_mouse_SystemicCarcinogenic	2	16.6666666666667	1	1330-78-5, 115-96-8	4	486	990	1.01851851851852	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_PathologyNonProliferative	2	16.6666666666667	1	1330-78-5, 115-96-8	4	399	990	1.2406015037594	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OtherSystemic_PathologyClinical_ClinicalChemistry	2	16.6666666666667	1	1330-78-5, 115-96-8	4	333	990	1.48648648648649	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations	3	25	1	1330-78-5, 115-96-8, 13674-87-8	4	505	990	1.47029702970297	1	1	1
CTD_CHEMICALS_DISEASES	Stomach Neoplasms	2	16.6666666666667	1	1330-78-5, 13674-87-8	7	1974	8530	1.23462150817774	1	1	1
TOXREFDB	SUB_mouse_SystemicCarcinogenic	2	16.6666666666667	1	1330-78-5, 115-96-8	4	248	990	1.99596774193548	1	1	1
TOXREFDB	CHR_mouse_	2	16.6666666666667	1	1330-78-5, 115-96-8	4	374	990	1.32352941176471	1	1	1
TOXREFDB	CHR_mouse_SystemicCarcinogenic_adult_PathologyNonProliferative	2	16.6666666666667	1	1330-78-5, 115-96-8	4	305	990	1.62295081967213	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OrganWeight_AccessoryDigestive_Liver	2	16.6666666666667	1	1330-78-5, 115-96-8	4	323	990	1.53250773993808	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OtherSystemic_PathologyClinical	2	16.6666666666667	1	1330-78-5, 115-96-8	4	384	990	1.2890625	1	1	1
LEADSCOPE_TOXICITY	Genetic Toxicity -salmonella	2	16.6666666666667	1	115-96-8, 13674-87-8	9	1163	7444	1.42237508359606	1	1	1
TOXREFDB	SUB_rat_SystemicCarcinogenic_adult_OtherSystemic_InLifeObservations_BodyWeight	2	16.6666666666667	1	1330-78-5, 115-96-8	4	441	990	1.12244897959184	1	1	1
TOXREFDB	CHR_rat_SystemicCarcinogenic_adult_Urinary_Kidney	2	16.6666666666667	1	115-96-8, 13674-87-8	4	265	990	1.86792452830189	1	1	1

